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MORE CONFIDENCE IN A N T I T H R O M B O T IC  THERAPY
«  .
New Guidelines for 
Antithrombotic Therapy 
In Surgical Cases
-
i
The American College of Chest Physi­
cians and the National Heart, Lung and 
Blood Institute recently issued new 
guidelines for antithrombotic therapy.1 
There were four Grade A recom­
mendations for the use of warfarin 
(Coumadin®) in surgical cases. In each 
of these four (and other Grade A and B recommendations for C 
ratio of 1.2-1.5 (rabbit emphasized for clinical 
reduced side-effects risk.
-  4
INDICATIONS: Elective hip surgery/ 
surgery for fractured 
hips.
" . . .  patients undergoing elective hip surgery 
should be pretreated prophylactically with 
adjusted-dose heparin or moderate-dose war­
farin sodium . .
. patients undergoing surgery for fractured 
hips should be treated prophylactically with 
moderate-dose warfarin.
INDICATION: Prophylaxis o f venous 
throm boem bolism .
"It is strongly recommended that the 
therapeutic range for prophylaxis. . . in high- 
risk medical or surgical patients should be 
equivalent to an INR o f 2.0-3.0 (corresponding 
rabbit brain thromboplastin ratio 1.2-1.5)."
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CONDITION: B ioprosthetic heart valves.
. . all patients with bioprosthetic heart valves 
in the mitral position be treated for the first 
three months after valve insertion with less 
intense warfarin . .
m re believe these recommendations will be of value to practicing physicians.
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CONDITION: Prophylaxis of venous 
throm boem bolism .
"It is recommended that anticoagulant therapy 
should be continued for three months using 
oral anticoagulants to prolong prothrombin 
tim e. . . "
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Bard introduces the Harvard PCA 
Patient'ControlIed Analgesia System.
Now, there’s a much better way to 
control pain. Because now there’s 
the Harvard PCA* System.
It’s far more effective than intra­
muscular injections. It infuses in­
travenous analgesics on patient 
demand. . .  but only under physician- 
prescribed dosages and intervals.
By just pushing a button, patients 
can self-administer small doses of 
medication more frequently. Relief 
is immediate. Patient anxiety is 
reduced.
And because there’s optimal serum 
concentration, the cycles of pain 
and sedation are minimized.
Plus, research+ indicates that 
patients using a PCA pump may 
require less medication, experience 
faster recovery time and prefer PCA 
to I.M. injections.
NOW,
PAIN CONTROL 
IS RIGHT 
AT HAND...
Accuracy, to ±1%, special 
security, detailed recall.
The Harvard PCA* System is accu­
rate to ±1% to prevent overmedica- 
tion. It’s safe, with a broad range of 
status alarms, and a locked narcotics 
compartment and access code.
For flexibility (and cost savings), 
the system can be used in a PCA 
mode, a PCA/Basil mode and a 
Continuous Infusion mode. All three 
modes use a 60 cc syringe that’s not 
prefilled. So you can choose your 
own medication and concentration.
And a detailed history recall 
provides hour-by-hour review of 
patient cumulative dose attempts,
rRMrom
Bard Canada Inc.
2345 Stanfield Road 
Mississauga, Ontario L4Y 3Y3
1-800-268-2862
injections, and prescribed dose and 
interval.
To evaluate the Harvard PCA* 
System in your hospital, call Bard 
Canada Inc. 1-800-268-2862.
Or just clip and return the coupon 
below.
Now, physician-prescribed, patient- 
controlled pain relief is right at 
hand.
Clip and mail to: ^
Bard Canada Inc.
2345 Stanfield Road ♦
Mississauga, Ontario 
L4Y3Y3
Please send details on the Bard 
Harvard PCA* Patient-Controlled 
Analgesia System.
N am e________________________
Address_______________________
City_____________ Prov.______ Postal Code
Hospital Affiliation_____________________
Phone( )________________________
* Trade mark
+ Bennett, R.L., Gritfen, W.Q.,: Patient Gmtrolled Analgesia. 
Contemporary Surgery. 23:75-89; 1983.
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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Reversal of Female Sterilization: a Reappraisal
Microsurgical reversal of sterilization can 
be remarkably successful, with subse­
quent live birth rates as high as 78.8Vo.1 
This procedure requires above-average 
skill and is expensive. Furthermore, not 
all women requesting reversal will be 
suitable for surgery. I propose to discuss 
the outcome in women requesting rever­
sal of sterilization and to suggest methods 
by which at least some could be dissuaded 
from undergoing the original sterilization.
Siegler and colleagues2 devised an ele­
gant theoretical flow chart, suggesting 
that 30 women out of every 1000 sterilized 
would regret the operation. Of these, 23 
would consult a physician, at which time 
3 would voluntarily withdraw and 3 
would be rejected because of other fer­
tility factors; the other 17 would undergo 
laparoscopic screening and 7 would be 
rejected because of irreparably damaged 
tubes. Thus, of the original 30, only 10 
women would be offered microsurgery 
and only 6 would ultimately deliver a 
healthy baby. This represents a true suc­
cess rate of either 20% if it is regarded 
as 6 out of 30 who had initial regrets, or 
26% if it is regarded as 6 of the 23 who 
consulted a physician.
We tested this theoretical model by 
studying 378 women who consulted us 
requesting reversal of sterilization.3 
Twenty-nine were rejected for medical 
reasons at the first visit and 108 (29%) 
made no further effort to pursue rever­
sal. Of the remaining 241 patients, 105 
(28% of the total) were rejected because 
insufficient tube remained to permit 
repair. Of the 136 offered microsurgery, 
32 refused; thus, only 104 (28%) of the 
original 378 women actually underwent 
reparative surgery. Unfortunately, we 
could not follow up all these patients, so 
we cannot assess the true pregnancy rate. 
Nevertheless, if we take Siegler’s realis­
tic figure of 60% of those operated upon, 
this would represent 62 (16.4%) women 
of the total 378 who consulted us.3 The 
emotional cost to those rejected for med­
ical grounds, or in whom the surgery
failed, is high. The fiscal cost to the Cana­
dian taxpayer in the provinces where 
reversal of sterilization is an insured serv­
ice is also high, if only for preliminary 
consultations and laparoscopy, not con­
sidering the cost of the major surgery.
To reduce these costs, can we identify 
before sterilization the woman who is 
likely to change her mind?
Gomel4 and Winston5 independently 
published profiles of the woman who was 
requesting reversal of sterilization. She 
was relatively young (25 years or youn­
ger) at the time of request and had few 
children (three). The major reason for 
requesting reversal was a change in mar­
ital status. The factor of few children is 
not particularly germane because not 
many families in Canada have more than 
three children. Youth and an unstable 
marital relationship, however, did seem 
to be important.
We recently performed two controlled 
studies — the first comparing women 
satisfied with sterilization and those
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requesting reversal, and, second, women 
requesting reversal with those about to be 
sterilized.6 At the same time, Divers7 
compared 180 women requesting reversal 
with 180 women who were apparently 
satisfied with sterilization. Although the 
information obtained did not permit iden­
tification of the individual woman, it 
allowed us to develop a profile of the 
woman who is at high risk of changing 
her mind. She is young at the time of her 
first relationship, first and last births and 
at the time of the request for sterilization. 
Her spouse has refused to consider vasec­
tomy as an alternative form o f steriliza­
tion and usually her marital relationship 
is unstable. If, at initial interview, she 
fails to indicate that the completeness of 
her family is the primary reason for 
sterilization, she should be regarded with 
concern. Her personality tends to be hys­
terical, she is generally naive and lacks 
insight.7 She must not be expected to 
bear full responsibility for regretting 
sterilization. For example, the woman 
who is coerced by her physician into being 
sterilized as a condition for receiving a 
therapeutic abortion, is much more likely 
to experience regret.
How, then, should the physician deal 
with such a patient? Often, the very per­
sonality characteristics that ultimately 
lead her to request reversal, also mitigate 
against her being able to use the more 
traditional forms of contraception.
Recent media attention to the side effects 
of oral contraceptives and the intense liti­
gation in the United States against the 
intrauterine contraceptive devices are 
making these approaches less acceptable. 
If the marriage is unstable, reliable con­
traception will be one of her primary 
requirements. Although a sympathetic 
physician may endeavour to allay her 
fears about the more effective forms of 
contraception, she most likely will insist 
on being sterilized, despite the advice. It 
may be of value to describe to her the 
woman who is at high risk and to draw 
her attention to the fact that she falls into 
this category. If, following counselling, 
the woman still insists on being sterilized, 
it is vital that the physician, if only for 
medicolegal reasons, ensures and docu­
ments that the patient understands the 
irreversible nature of the procedure.
In sterilizing the high-risk woman the 
surgeon should use a method that carries 
a low risk of failure but offers the best 
possibility for reversal. The failure rates 
with the more recent Hulka and Filshie 
clips are comparable to those of the more 
destructive forms of sterilization. Those 
procedures that destroy a minimal 
amount of the isthmus are the most 
amenable to surgical correction.1
Using this approach, the physician may 
be able to dissuade a woman from under­
going sterilization or will be able to steri­
lize her by a method that offers the best
chance for reversal should she experience 
regret. However, it is stressed that the 
patient must be clearly informed that 
sterilization should be regarded as 
irrevocable and under no circumstances 
should she be advised that she has been 
“ sterilized by a method that is easily 
reversed” .
Patrick J. Taylor, md, frcsc, frcog 
Member,
Editorial Board.
Director,
Endocrine Infertility Clinic,
University of Calgary,
Health Sciences Centre,
3330 Hospital Dr. NW,
Calgary, Alta.
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Urinary Stress Incontinence
The question of whether a woman with 
urinary stress incontinence should see a 
gynecologist or a urologist, or both, can 
lead to lively debate. Gynecologists know 
that the incontinence is often a conse­
quence of multiple pregnancies, large 
babies or hysterectomy. Patients usually 
go to them first, since the cause is rather 
obvious — big baby or hysterectomy, fol­
lowed by a need for pads. And, as sur­
geons of the female genital tract, gyne­
cologists respond to the challenge. 
Urologists are surgeons of the genitouri­
nary tract of men and the urinary tract 
o f women and, as such, claim expertise 
in the management of urinary stress 
incontinence. Interestingly, what has been 
considered the “ gold standard” of the 
surgical repair — the Marshall-Marchetti 
operation — was devised by a urologist 
(Marshall) and a gynecologist (Mar- 
chetti). The third author of the classic
1949 paper was K.E. Krantz, whose 
specialty is uncertain; he gets, at most, a 
passing recognition when the operation is 
booked as an MMK.
As with many problems that cross 
disciplinary boundaries, a scholarly 
approach is more often a reflection of an 
individual, than of a specialty. This is 
amply demonstrated by the article on 
stress incontinence by Boyd in this issue 
(pages 157 to 159). Dr. Boyd, a gynecol­
ogist, has evidently studied the subject 
and writes authoritatively on topics that 
many would consider urologic, such as 
the “ unstable” bladder, or “ urodynamic 
studies” . As a urologist, one can’t help 
but admire such willingness to learn 
another man’s language.
On the other hand, I suspect that many 
of my fellow urologists would take issue 
with some of the remarks made in Boyd’s 
paper. 1 shall discuss these bones of con­
tention in a moment. But first let me 
review the aspects of this disorder and 
repair that are less contentious.
Stress incontinence occurs, most often, 
when the ligamentous support for the ure­
thra at the level of the bladder neck is lost. 
There are other causes, such as the weak 
urinary sphincter that Boyd mentions, or 
the congenitally or iatrogenically short 
urethra that he does not.
If the urethra herniates downward and 
backward, causing incontinence, it seems 
logical that continence could be restored 
by repositioning the urethra upward and 
forward, completing the repair in such a 
fashion that the urethra will not drop 
again. That there are more than 70 vari­
ations on this theme seems simply 
astounding.1
I do not pretend to know all the varia­
tions, but common sense dictates that 
many claims to an original contribution
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must be considered inconsequential. An 
approach through the anterior wall of the 
vagina can push the urethra back into 
position, but it can be held there only by 
approximating soft tissue to soft tissue. 
Predictably, as has always been the 
problem, this repair is unlikely to last. A 
suprapubic, extraperitoneal approach 
allows access to the tough fascial lining 
of the vagina, which can then be fixed to 
the periosteum of the pubic bone 
(Marshall-Marchetti) or to the more later­
ally placed Cooper’s ligament (Burch 
procedure). In either case, the urethra will 
be repositioned upward and forward.
I identify the level of the bladder neck 
by pulling on the Foley catheter, assum­
ing that the position of the balloon coin­
cides with the level of the bladder neck. 
Digitally the vagina is tented up on each 
side of the urethra at that level. I then 
place a stitch into the thick vaginal wall, 
on each side of the urethra, pull up the 
stitches and fix them to adjacent solid tis­
sue, whether it be the periosteum of the 
os pubis or Cooper’s ligament. Because 
of a lack of confidence in the long-term 
results I have not yet switched over to 
stitches placed into the vaginal wall using 
a long needle guided from above (Peyrera 
method).
Now, for the bones of contention. 
Most urologists do not shy away from 
placing stitches in the periosteum of the 
os pubis. Osteitis pubis is a horrible com­
plication but exceedingly rare. Its cause 
is not clear, although wound infection
may have a role. The Burch procedure 
may be appropriate for some, but not 
necessarily all, patients.
In the routine first-time repair, urolo­
gists would consider it totally unnecessary 
and inappropriate to open the bladder 
and check the patency of the ureter. I 
have seen repair sutures that have 
occluded the ureteral orifice, and sutures 
that approximated the anterior of the 
bladder to the posterior wall -  these are 
inexcusable mishaps for first-time repairs. 
On the other hand, during repeat repairs, 
when there is considerable scarring and 
the identification of the bladder neck is 
uncertain, deliberate opening of the blad­
der and proper identification of anatom­
ical landmarks is prudent and practical.
Finally, a word about urodynamics — 
urethral pressure profile and cystometro- 
grams. When a woman with stress incon­
tinence has no irritation, most urologists 
think there is no need for cystometry. 
When there are irritative symptoms, even 
urgency incontinence, and no urinary 
findings, urethral pressure profile and 
cystometric studies are mandatory. The 
two conditions, stress and urgency incon­
tinence, often occur together and, as 
Boyd advises, the current approach is to 
fix the stress component by surgery and 
to manage the urgency component with 
drugs and antibacterials if the urine is 
infected, anticholinergics (Ditropan) if 
there is an unstable bladder.
The recordings of the water pressure 
necessary to overcome resistance at differ­
ent levels of the urethra (urethral pressure 
profile), and water pressure readings 
generated within the bladder when artifi­
cially filled by catheter (cystometrogram) 
have become more reproducible tests in 
recent years. Nevertheless, different 
results can be obtained by varying the rate 
of fluid infusion or by changing the posi­
tion of the patient from a supine to an 
upright position. Thus, urologists are 
guided by these studies when the results 
correspond to their clinical assessment. 
When results don’t correspond, the case 
is reviewed. Often, they find they are 
wrong; occasionally, they find that the 
cystometric result was an aberration. The 
cystometrogram and the urethral pressure 
profile are still less precise than the elec­
trocardiogram or electroencephalogram.
Today, there is less quarrel over which 
specialty should be managing the patient 
with urinary stress incontinence. As long 
as the appropriate operation is done for 
the right reason, and done well, it doesn’t 
matter whether the surgeon is a urologist 
or gynecologist.
Y. Ta g u ch i, m d , ph  d , frcsc
Urologist,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
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New Hope in Cancer of the Breast
As a side-line cheerleader when it comes 
to the treatment of carcinoma of the 
breast, I have been impressed with several 
developments that improve survival and 
decrease morbidity in this leading cause 
of death among Canadian women aged 
35 to 54 years. One notable advance is the 
wide acceptance of randomized trials of 
therapy, which are appropriately based on 
the collection of patients from multiple 
centres. Several studies have clearly 
shown that the most reliable predictor of 
failure at any given time after primary 
treatment is involvement of the axillary 
lymph nodes by tumour. Other factors 
that have negative prognostic features 
include: tumour dimension greater than 
5 cm, a high nuclear or histologic grade,
tumour necrosis, lymphatic and vascular 
permeation, a high thymidine labelling 
index and negative estrogen and 
progesterone receptors.1
On the basis of these findings, what 
should we be doing for patients at 
increased risk after definitive local con­
trol of the disease? The National Insti­
tutes of Health consensus panel on breast 
cancer states that “ optimal therapy for 
any subset of patients has not been 
defined” and we should continue to 
enter our patients into clinical trials.2 
But several recommendations can be 
made.
For premenopausal women with posi­
tive lymph nodes, treatm ent with 
established chemotherapy such as
cyclophosphamide, methotrexate and 
5-fluorouracil (5-FU) or an Adriamycin- 
containing regimen is recommended.2 
For premenopausal women with negative 
nodes, adjuvant chemotherapy is not 
recommended. For postmenopausal 
women with positive nodes and positive 
hormone-receptor levels, tamoxifen is the 
treatment of choice. For postmenopausal 
women with positive nodes and negative 
receptor levels, chemotherapy is not 
recommended as standard practice. For 
postmenopausal women with negative 
nodes, regardless of hormone-receptor 
levels, there is no indication for routine 
adjuvant therapy.2
While these recommendations are use­
ful and of proven value, more innovative
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approaches are clearly required for both 
premenopausal and postmenopausal 
women who have more than four lymph 
nodes involved, particularly those with 
more than 10 positive nodes who are 
receptor-negative.
The prospect o f autologous bone- 
marrow harvesting with later transplan­
tation after large-dose chemotherapy 
could be useful in these high-risk groups. 
Many tumours in the human, including 
breast cancer, show a dose-response rela­
tion to antineoplastic drugs. The amount 
given is primarily limited by the toxic 
effects on bone marrow. In cases in which 
the bone marrow is involved with tumour 
it appears possible to remove potentially 
contaminating tumour cells by immuno­
logic, pharmacologic or physical tech­
niques.3
Initial clinical results indicate that high- 
dose chemotherapy, followed by autolo­
gous bone-marrow transplantation, 
produces responses in patients whose 
tumours were resistant to conventional 
doses of the agents.4 Randomized clini­
cal trials will be needed to define clearly 
the benefits and limitations of these new 
findings.
For patients with advanced cancer of 
the breast, alkylating agents and cis- 
platinum in combination are being used 
in doses 10 to 20 times those convention­
ally possible.
It is tempting to think that this therapy 
might be possible and more effective in 
patients with high-risk lesions before 
advanced disease develops. It is possible, 
even now, to remove bone marrow and 
store it for 7 years with the prospect of 
using this therapy later if the patient 
shows clinical evidence of spread while on 
conventional treatment.
One of the advantages of multicentre 
trials is that everyone learns sooner. Solid 
information from trials o f new therapies 
that might not be randomized is not as 
quickly available for clinical application. 
In this setting, a central registry of all 
patients with cancer o f  the breast receiv­
ing autologous bone-marrow transplan­
tation would be a useful method of mak­
ing sure the maximum number of patients 
receive the best possible therapy. Who 
will do this for Canada?
Lloyd D. MacLean, md, frcsc 
Coeditor.
Surgeon-in-chief,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
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BOOK REVIEWS
DISEASES OF BLOOD VESSELS. Orville 
Horwitz, Peter R. McCombs and Brooke 
Roberts. 429 pp. Illust. Lea & Febiger, 
P hiladelphia, 1985. $69 .25 . ISBN 
0-0821-0926-0.
The editors of this book are an internist and 
two surgeons from the University of Pennsyl­
vania. The orientation of the material is such 
that from a surgical standpoint the coverage 
is brief, and one wonders to whom the book 
is directed.
Two sections make up the book. The first, 
basic considerations, deals with the patho­
physiology of atherosclerosis, the relation 
between diabetes mellitus and vascular disease, 
the physiology of thrombosis, and a consider­
ation of anticoagulation and vasoactive drugs. 
These chapters are informative and well 
written.
Clinical considerations, the second section 
making up about 80% of the book, comprises 
19 chapters covering the clinical spectrum of 
vascular disorders. Cerebrovascular and coro­
nary artery disease, thoracic and abdominal 
aortic problems, extremity ischemia, renal vas­
cular disease and hypertension, arteritides, dis­
ease of the peripheral venous system and lym­
phatics, as well as discussions of invasive and 
noninvasive diagnostic procedures are all con­
sidered. The chapters are generally organized 
into discussions of pathophysiology, clinical 
presentation, diagnostic maneuvers, medical 
management and surgical therapy. The last 
named assumes a rather minor role, and data 
regarding results of therapy are generally 
sketchy. In the chapter on diseases of the arter­
ies of the extremities, for example, 2'h of 24 
pages are devoted to surgical therapy.
This text appears best suited for medical stu­
dents, interns, residents in internal medicine, 
and primary care physicians. For such an 
audience it will provide an excellent overview 
of the subject, and hence should be available 
in medical libraries. For the resident or surgeon 
with an interest in vascular surgical diseases, 
however, the book does not offer sufficient 
detail, nor is it appropriately oriented.
Elliot T. Gelfand, md, frcsc, facs 
Ste. 1002,
8215 — 112th Street,
Edmonton, Alta.
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ENDOUROLOGY. Edited by Culley C. 
Carson and N. Reed Dunnick. 331 pp. 
Illust. Churchill Livingstone, Edinburgh; 
Academic Press Canada, Don Mills, Ont., 
1985. $93.25. ISBN 0-443-08367-3.
Endoscopic procedures have formed a major 
component of urologic practice for many years, 
beginning with cystoscopy and progressing to 
transurethral resection of the prostate and 
bladder tumours, and retrograde manipulation 
of ureteric calculi. Similar approaches to the 
kidney awaited the development of specialized 
fiberoptic instruments with microlens systems 
and the application of manipulative radiologic 
techniques. The first step was to develop a tech­
nique to establish a percutaneous nephrostomy 
tract using fluoroscopic control. When this was 
accomplished a few years ago, open surgical 
nephrostomy to relieve urinary tract obstruc­
tion not manageable with a retrograde ureteric 
catheter was rendered obsolete.
With slight modifications, percutaneous 
nephrostomy has become the principle route 
through which various procedures are per­
formed. Although a few centres are using this 
approach to cure ureteropelvic obstruction or 
to treat some tumours of the renal pelvis, its 
primary application has been in the manage­
ment of patients with kidney stones (percutane­
ous nephrostolithotomy). Percutaneous tech­
niques have allowed a simple and safe 
extraction of kidney stones through a small 
flank puncture that necessitates patient 
hospitalization for only a couple of days com­
pared with the week in hospital and extended 
convalescence previously required. Reduced 
patient morbidity and substantial cost benefit 
and more rapid return to work have been 
clearly documented. Now that extracorporeal 
shock wave lithotripsy (ESWL) is becoming 
more available (currently there are only two 
units in Canada — in Vancouver and Halifax), 
percutaneous stone extraction will be per­
formed less often. However, it continues to be 
the procedure of choice for stones larger than 
3 cm in dimension and for staghorn calculi.
The successful application of percutaneous 
nephrostomy has evolved using a team ap­
proach, with the radiologist correctly placing 
the nephrostomy tract and the urologist using 
endoscopic instruments to visualize and extract 
the stone. It is appropriate, therefore, that this 
book has been written by a group of ex­
perienced American urologists and radiologists
continued on page 154
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Arthroscopic Cost Containment
To the editors.—I agree with Profitt and 
Giachino (Can JSurg  1986; 29: 301) that 
distension of knee joint as a first step in 
arthroscopy is not necessary.
After cadaver trials, with the knee 
flexed at 45° and a parapatellar tendon 
puncture into the intercondylar notch, I 
found that the sharp trocar is nowhere 
near the articular cartilage. Hence, all my 
60 arthroscopies have been without dis­
tension. Besides saving time, it avoids the 
“ space-zero G vision” effect. I use short 
periods of irrigation when needed. This 
serves the purpose and leaves a dry oper­
ative field.
T.D. Ram , mb, bs, frcsc
13/1, Andree Rd.,
Shanthinagar,
Bangalore -  560 027,
India
Mammography as a Screening 
Procedure for Breast Cancer
To the editors.—In the September 1986 
issue (pages 299-300) Charles Wright 
asked “ Should the hunt for nonpalpable 
breast lesions be called off?” This ques­
tion arose from his commentary on an 
article by Luoma and associates in the 
same issue (pages 315-318) who reported 
their experience with fine-wire localiza­
tion breast biopsies for nonpalpable 
breast lesions detected mammographi- 
cally. We submit that the answer to 
Wright’s question will be obtained from 
the National Breast Screening Study 
(NBSS) to which neither he nor Luoma 
and associates referred, even through 4074 
of the women reported on by Luoma’s 
group were participants in the study at the 
British Columbia Centre.
Wright concedes that the benefit from 
screening is probably real, though he calls 
that an assumption. In practice, nearly all 
commentators have accepted that screen­
ing using mammography or mammogra­
phy plus physical examination has 
resulted in a demonstrated reduction in 
the death rate from breast cancer in at 
least two randomized trials and two case- 
control studies.1 Indeed, the participants 
in a recent workshop of the International 
Union Against Cancer concluded that in 
countries where breast cancer is common 
and where the necessary resources are 
available, screening using mammography 
alone or mammography plus physical 
examination is applicable as public health 
policy. The greatest initial benefit will be 
obtained by concentrating the screening 
on women aged 50 to 69 years.1
However, Wright has reservations as to 
whether the benefit is sufficiently large in 
relation to the morbidity and costs. We 
share this concern and we point out that 
the NBSS, at least in one of its major 
objectives, was designed to answer the 
question, “ How much does mammogra­
phy add to the presumed benefit from 
annual physical examinations and the 
teaching of breast self-examination?” , 
taking into consideration both the reduc­
tion in deaths from breast cancer and the ■ 
costs of mammography and associated 
procedures.2
The costs of biopsies are known and 
experience with screening indicates the 
extent to which additional biopsies are 
required following physical examination 
and mammography. A sensitivity analy­
sis one of us (A.B.M.) conducted some 
years ago3 indicated quite clearly that the 
critical factor was not the cost and num­
ber of biopsies, but whether the benefit 
outweighed these costs. Thus, we have to 
wait for the results of the NBSS to answer 
the question Dr. Wright poses. Mean­
while, it is important to avoid perpetrat­
ing misconceptions. Wright is incorrect in 
his statement that in both the New York 
HIP study and in the Swedish randomized 
trial, all-cause mortality, with the excep­
tion of breast cancer, was identical in 
those screened and in the controls. The 
death rate from breast cancer was, 
however, reduced in the screened group.
Wright also fails to recognize that a 
benefit of screening may be reassurance. 
This is most important to many women.
Further, Luoma and associates appear 
to have misunderstood the probability of 
detecting breast cancer in asymptomatic 
women attending a breast screening 
project and in women, many of whom 
will have symptoms, referred for mam­
mography by their physicians. Numerous 
studies have demonstrated that the case 
detection rate is much higher in the 
referred group than in the asymptomatic 
group. Thus, their hypothesis that the 
varied methods of mammography — film 
mammography in the case of their 
screened participants and xeromammog­
raphy in the referred group — could 
account for the difference is simply incor­
rect. Several studies have shown almost 
identical case detection rates in similar 
series of women referred for film or 
xeromammography. Interestingly, there 
have been several instances in the NBSS 
in which abnormalities detected on film- 
screen mammography were not detected 
subsequently on xeromammography per­
formed for localization. In our view, 
therefore, film-screen mammography 
should be used not only for screening but 
also for localization.
A.B. M iller , mb, frcpc
Director
C.J. Baines, m d , m sc 
Deputy director
National Breast Screening Study,
McMurrich Building,
3rd Floor,
University of Toronto,
Toronto, Ont.
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To the editors.—It is timely for Drs. 
Miller and Baines to point out that the 
National Breast Screening Study (NBSS) 
will bring further useful information to 
this controversy but, as the central issue 
is one o f benefit versus cost, it is unlikely 
that the debate will subside. As with many 
other issues, it is interesting to see how 
different people draw different conclu­
sions from the same data. The question 
is, How great is the benefit in relation to 
what cost? and, surely, all aspects o f the 
cost, including dollars, unnecessary sur­
gery, morbidity and false hope, must be 
included. This debate would be absurd in 
most countries, and what I am suggest­
ing (apparently unpopularly) is that even 
in our wealthy society the small benefit 
does not justify the large costs.
I acknowledge the point made by Miller 
and Baines concerning the all-cause mor­
tality. The latest all-cause mortality 
figures from the New York and Swedish 
studies are not yet available and the 
differences to date have been relatively 
small and certainly not statistically signifi­
cant. I cannot accept the contention, 
however, “that a benefit o f screening may 
be reassurance” . It is of no benefit at all 
to tell a woman that she does not have 
one o f  the slower growing types of breast 
cancer (which are the types detected on 
mammography). No meaningful reassur­
ance can be offered as so many cancers 
are either missed by screening or develop 
during the screening interval.
The benefit-cost ratio could certainly 
be enhanced by improving the specificity 
o f mammography, but there is a limit to 
this, already reached in many centres, 
beyond which the sensitivity must suffer. 
In other words, one can be more specific 
about what findings must be present to 
justify a “positive call” at mammogra­
phy, but the tighter these criteria become 
the more cases will be missed. The other 
way to improve the benefit-cost ratio is 
by raising the prevalence o f the disease 
in the population screened, in other 
words, restrict the screening drive to those 
women with known high-risk factors. 
Advocacy of mass screening, and the con­
sequent reallocation of resources that 
would be necessary, cannot be condoned 
after any reasonable look at the balance 
sheet.
C h a r l e s  J . W rig h t , m b , c h  b , m sc ,
FRCSC, FRCS, FRCS(EDIN)
Head, Division of General Surgery, 
University Hospital,
University of Saskatchewan,
Saskatoon, Sask.
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from well-known centres. They describe how to 
perform these new techniques and avoid com­
mon pitfalls, and they outline the complications 
and their management. The numerous x-ray 
reproductions are excellent, and the drawings 
clearly illustrate important points in the text. 
There is some repetition in the technique of 
creating a percutaneous tract and the ap­
proaches to various stones, but these differ­
ences reflect experience and preference of the 
contributing centres and add an important 
dimension to the book.
The management of calculi impacted in the 
ureter form the basis of a chapter on ure- 
teroscopy. These stones can be approached 
from above through a percutaneous tract with 
a rigid or flexible nephroscope or from below 
using a rigid or flexible ureteroscope passed 
through the urethra into the ureteral orifice and 
up the ureter to the stone. Depending on its 
size, the stone is either extracted directly or 
fragmented and removed ultrasonically or with 
an electrohydraulic probe.
A chapter on chemolysis of kidney stones 
gives a useful description of the basic princi­
ples, the available solutions and techniques 
used.
This book is essential for those beginning to 
perform nephrostolithotomy or ureterorenos- 
copy for diagnosis and extraction of ureteral 
calculi. The chapters describing management 
of complex stones, calyceal and staghorn cal­
culi contain helpful information useful in treat­
ing these calculi.
M icha el  A . R o b in ette , m d , frcsc
Division of Urology,
Toronto General Hospital,
Toronto, Ont.
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FLEXIBLE SIGMOIDOSCOPY. Ronald M. 
Katon, Emmet B. Keeffe and Clifford S. 
Melnyk. 159 pp. Illust. Grune & Stratton, 
Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1985. $50.25. 
ISBN 0-8089-1701-3.
This book, devoted to the theory and practice 
of flexible sigmoidoscopy, is divided into 11 
chapters. The first gives a historical perspec­
tive. It contains information that is not gener­
ally known about the development of sig­
moidoscopy. While it might seem to appeal 
only to collectors of medical trivia, it is 
nevertheless valuable to the serious student of 
diseases of the colon and rectum. The second 
chapter describes the optical principles and also 
the care and maintenance of the instruments. 
The third is a clear and lucid description of the 
technique. This chapter puts into words clearly 
the secrets of good endoscopic technique and 
the mistakes made by inexperienced operators. 
The fourth chapter, concerning consent and the 
keeping of records, reflects the thorough com­
position of this book which includes all aspects 
of sigmoidoscopy however trivial they may 
appear. The pros and cons of rigid versus flex­
ible sigmoidoscopy extending to different dis­
tances are discussed in well-written chapters 
that are balanced in their recommendations. 
The controversial question of who is compe­
tent to perform which procedure is discussed 
in an unbiased manner. The merits of a longer 
sigmoidoscope, the indications and the com­
plications of the procedure are also considered.
The 10th chapter is about screening. It 
reflects the current views, but these may change 
since data about the best way of screening are 
by no means clear and the science of this area 
is evolving. However, the recommendations in 
this book are pragmatic and are the ones gener­
ally followed in most centres. The final chap­
ter, explained with clear photographs, is an 
exposition of the sigmoidoscopist’s view of 
colorectal disease.
I liked this book, it is a lucid and compact 
manual that is certainly of value to anyone 
beginning to undertake flexible sigmoidoscopy, 
and this includes general practitioners and resi­
dents in medicine and surgery. It also has sec­
tions that may be informative to the 
experienced specialist.
K .N. J eejee b h o y , m b , bs, fr cpc
Rm. 9-223 
College Wing,
Toronto General Hospital, 
200 Elizabeth St.,
Toronto, Ont.
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HANDBOOK OF REGIONAL ANES­
THESIA. Edited by P. Prithvi Raj. 285 pp.
Illust. Churchill Livingstone, Edinburgh;
Academic Press Canada, Don Mills, Ont.,
1985. $58. ISBN 0-443-08285-5.
One should beware of multiple-authored 
books; they are often disjointed and repetitive, 
and the chapters may vary in quality. For­
tunately, in general, this is not the case in this 
book because 18 of the 19 authors are from 
the same department and because the book has 
been well edited. The Department of Anesthe­
sia at the University of Cincinnati is noted for 
its leadership in regional anesthesia through­
out North America.
This book is directed primarily toward 
anesthesiologists. Conscious of the readership 
of this journal, I have attempted to evaluate 
the book from a surgeon’s viewpoint. There 
is an excellent chapter on physiology, pharma­
cology and toxicity of local anesthetics, essen­
tial reading for anyone who uses these drugs. 
Likewise the chapters on complications, adju­
vant techniques, postoperative and chronic 
pain are good. The index is well organized. I 
found it pleasing that I could readily find infor­
mation on local anesthesia for specific surgi­
cal procedures such as herniorrhaphy, gas­
trostomy, meniscectomy and thyroidectomy. 
All of the information for each technique is 
not necessarily in one place, but the index is 
well cross-referenced making search for addi­
tional information quite simple. Probably the 
most outstanding feature of the book is the 
numerous anatomic illustrations used to high-
continued on page 219
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Mandatory Retirement
At a time when “ underfunding” appears 
in almost every article about hospitals in 
Canada, the Vancouver General Hospi­
tal will be spending hundreds of thou­
sands of dollars pursuing the right to 
withdraw admitting privileges from phy­
sicians aged 65. Recently it filed notice of 
an appeal of the decision by Justice Mar­
tin Taylor who, last summer, effectively 
put an end to compulsory retirement from 
hospitals in British Columbia. In response 
to the hospital’s move, the plaintiffs 
registered a cross-appeal in an attempt to 
change findings of the original judgement 
with which they were not completely 
satisfied.
On July 23, 1986, after 24 days of trial 
and extensive written arguments in the 
challenge of the hospital by 14 senior 
MDs, Justice Taylor found that hospitals 
were government institutions and there­
fore subject to the provisions in the Cana­
dian Charter of Rights and Freedoms and 
province’s Human Rights Act, both of 
which forbid discrimination on the basis 
of age.
In his reasons for judgement, Justice 
Taylor said, “ I find that a rule establish­
ing age 65 as the ‘expected retirement 
date’ for members of the medical staff, 
and authorizing special scrutiny of appli­
cations for continued admitting privileges 
from doctors over that age does not con­
stitute ‘discrimination’ under Section 15 
[of the Charter], nor can it be said to con­
stitute ‘denial of liberty’ under Section 7. 
I find that the application of such a rule 
so as to terminate the admitting privileges 
of all members of the medical staff over 
65 who d o . not have unique skills, 
however, constitutes a violation of both 
sections.”
He went on to summarize the hospital’s 
regulation “ that every doctor over 65 who 
wishes to have his or her admitting
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
privileges renewed will receive individual 
consideration based on the circumstances 
of his or her case, his or her health, per­
formance and, no doubt, such factors as 
the type and extent of his or her prac­
tice....That is also, in my view what the 
Charter requires....”
Whether the judgement has national 
significance is unclear at present, but the 
potential is there, according to the law­
yers for the plaintiffs who outlined their 
thinking in a letter to the Canadian Med­
ical Association: “ Mr. Justice Taylor 
determined in the Judgment that the rules 
of hospitals — even if operated by a non­
governmental organization — fall within 
the scope of ‘acts of the government of 
a province’ within the meaning of section 
32 (1) (b) of the Charter. This... decision 
guarantees to doctors the protection of 
their rights under the Charter.” 
Lawson, Lundell, Lawson & McIntosh 
noted, “ Mr. Justice Taylor also held that 
the Charter applies to the manner in 
which policies are applied. This...ensures 
a second level of protection in circum­
stances in which (as was the case here) the 
regulation or policy itself is found to not 
offend the Charter.”
The lawyers considered that another 
conclusion of the judgement “may afford 
protection to doctors suffering other 
unrelated interference with a part of their 
practice from government agencies” : 
“ ...interference with only part of a doc­
tor’s professional activity (the admitting 
privileges of general practitioners, who 
were found by the Judge to not rely on 
access to the hospital to anywhere near 
the same extent as specialists) can amount 
to a denial of ‘liberty’ within the mean­
ing of section 7 of the Charter” .
The provinces and territories all have 
legislation guaranteeing protection of 
human rights and prohibiting discrimina­
tion on the basis of age, but several have 
provisions that permit mandatory retire­
ment. Ontario, for example, defines 
“ age” as between 18 and 65 for employ­
ment so the province’s Human Rights 
C om m ission takes on cases for 
individuals only between those ages. New­
foundland and New Brunswick accept 
pension plans as the determinant of age 
of retirement. Such provisions may be 
challenged in future. Quebec and 
Manitoba already prohibit compulsory 
retirement.
Since the challenge to VGH’s tactics 
was launched, at least 2 of the 14 plain­
tiffs have retired, all having given about 
30 years of service to the hospital. Now, 
doctors who are approaching 65 and who 
wish to defer retirement must speak to the 
department head and apply to the board, 
which in turn will request a recommen­
dation from the medical advisory com­
mittee. These steps are in line with the 
hospital’s regulations — deemed accept­
able by Justice Taylor — and were stan­
dard practice until 1985.
One of the plaintiffs who is still prac­
tising — Clayton Robinson, FRCS, 
FRCSC — spoke to CJS about the events 
to date, “ Although the hospital has 
always had a rule that seniors had to be 
assessed and interviewed by the head of 
the department each year after age 65 and 
although all of the seniors in 1985, includ­
ing myself, had received testimonials, the 
trustees, who were mainly laymen, sud­
denly decided that no one could go on 
practising after 65 unless he had unique 
skills needed by the hospital. What the 
Supreme Court justice said was that age 
per se should not be a factor in determin­
ing whether a doctor is fit for practice. 
Everybody agrees that doctors have to 
have peer review, certainly as seniors but 
probably while younger, too.
“ Nobody told us why the lay board of 
trustees suddenly wanted to cut off the 
seniors, but they might have thought, 
‘if we get rid of these seniors, there will 
be more billing numbers for the young 
guys’.”
Even if the courts find mandatory 
retirement illegal, hospitals could get 
around the legislation by building into 
contracts an agreed time of retirement — 
a fact that has some people wondering
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why the hospital is determined to pursue 
the matter.
The court date for the appeal has not 
been set and, according to Norm Finlay- 
son, acting executive director for the Brit­
ish Columbia Medical Association, it will 
probably be at least a year away. Said 
Finlayson in a brief interview with CJS, 
“ We’re rather disturbed that a hospital 
is spending money earmarked for health 
care in an activity that doesn’t benefit the 
hospital or the taxpayers. The British 
Columbia Medical Association, in sup­
porting the action by the physicians, has 
spent in excess of $300 000 so far and we 
have heard rumours that the Vancouver 
General Hospital has spent even more.
“ If the Vancouver General Hospital is 
successful in its appeal — if it can enforce 
retirement at age 65 — the government 
will have one more means to control num­
bers of physicians and will be limiting 
access to health care by cutting back on 
the providers. The government, through 
its controls on billing numbers being 
issued to physicians, is already able to 
control doctors at the beginning of their 
careers.”
Organ Donor Awareness Week
As part of organ awareness week last 
month, physicians across Canada received 
organ donor cards, information about 
donations and a letter from Health 
Minister Jake Epp and CM A President 
Jake Dyck encouraging them to donate 
and to take an active role in urging others 
to do the same. The campaign was autho­
rized by CMA’s General Council at the 
annual meeting in August.
Surgical Match Success
Without a hitch, the Canadian Intern 
and Resident Matching Service filled the 
74 residencies in general surgery availa­
ble at the 13 medical schools participat­
ing in the first surgical match last fall.
Of the 145 students seeking a slot, 129 
were graduates of Canadian medical 
schools, 21 of them women. Of the 74 
positions available, 72 were eventually 
filled by Canadian graduates and most 
(60) were filled in the first round (by stu­
dents who picked the school as first 
choice).
As one might expect, the odds of get­
ting a position were best (70%) for recent 
graduates, whereas 38 of the 57 graduates 
from previous years were unmatched — 
14 of the unmatched group being from 
foreign medical schools.
Students from the Universite de Mont­
real (6 of 8 graduates), McGill (15 of 20) 
and Queen’s (9 of 10) had better than
average luck finding positions. Queen’s, 
with only two residencies available for 
general surgeons, saw seven of its gradu­
ates accepted by schools of their first 
choice. Laval, Sherbrooke and Manitoba 
declined to participate in the match but 
will join the first match for obstetrics and 
gynecology next November. (Participa­
tion may still be only 13 schools, as 
Queen’s, McMaster and Calgary have not 
committed themselves.)
More Kudos for Keon
Last month at a dinner held in his 
honour, Wilbert Keon, FRCSC, chair­
man of the department of surgery, 
University of Ottawa, received the medi­
cal achievement award from the Cana­
dian Association of Manufacturers of 
Medical Devices for his development 
work on lasers.
Province Donates $10 Million 
to Ottawa Heart Institute
The University of Ottawa Heart Insti­
tute will receive $10 million from the 
provincial government to help finance a 
seven-story research centre. The centre, 
which will include 48 laboratories, is to 
be headed by Adolpho de Bold, Ph D,
director of research and professor of 
pathology at the University of Ottawa, de 
Bold received the Gairdner award last fall 
for his research on cardionatrin and other 
atrial natriuretic factors — the polypep­
tides that regulate levels of serum sodium 
and blood volume in humans and other 
mammals. The Heart Institute launched 
a fund-raising campaign on Mar. 10 and 
Ontario Premier David Peterson was on 
hand to commit funds toward the 
$ 17-million facility slated for completion 
in November 1988. A former patient of 
the institute, Zeev Vered, added another 
$500 000 to the coffers — the largest 
donation by an individual — noting that 
Wilbert Keon, FRCSC, had helped him 
through open-heart surgery and that he 
was reciprocating with his time and 
money. Vered and his wife, Sara, are 
heading the campaign.
New Chief of Surgery 
in Saint John
Gerald Stiles, FRCSC, replaces retiring 
chief of surgery, W. Douglas Miller, 
FRCSC, at the Saint John Regional 
Hospital. Miller is a senior member of the 
Canadian Medical Association and a 1945 
graduate of Dalhousie University.
Amy Chouinard
SESAP V Question
210. A 23-year-old man is undergoing celiotomy for suspected appendi­
citis. Oxygen, nitrous oxide, halothane, and succinylcholine used for anesthe­
sia. The patient develops a tachycardia as the peritoneum is being closed, and 
the anesthesiologist notices spasm of the masseter muscles. The carbon diox­
ide cannister is hot. Appropriate treatment at this time should include all of 
the following EXCEPT
(A) hyperventilation with 100% oxygen
(B) intravenous administration of potassium chloride
(C) cessation of anesthetic agents and muscle relaxants
(D) intravenous dantrolene
(E) vigorous cooling
For the incomplete statement above, select the one completion that is best of 
the five given.
For the critique of Item 210 see page 184.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and 
Self-Assessment Program No. 5. For enrolment in the Surgical Education and 
Self-Assessment Program No. 5, please apply to the American College of Sur­
geons, 55 East Erie St., Chicago, IL 60611.)
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Stress Incontinence of Urine
At rest, continence of urine depends on 
intraurethral pressure being higher than 
intravesical pressure. Intraurethral pres­
sure is produced by elastic fibres and 
engorged urethral venous sinuses. Low 
intravesical pressure is preserved by 
bladder muscle relaxation. Urgency 
incontinence will result if bladder muscle 
does not relax. A sudden increase in 
abdominal pressure may overcome this 
urethral-vesical pressure gradient and 
cause stress incontinence. The mechan­
isms that prevent this from happening 
are unclear. The pressure gradient would 
not change if the abdominal pressure 
was transmitted equally to the urethra 
and the bladder. Continence could also 
be protected by pressure of the urethra 
against the symphysis pubis or pelvic 
muscles. Stress and urgency inconti­
nence cannot be differentiated clinically 
with certainty. If surgical correction of 
stress incontinence is planned, preopera­
tive urethrocystometry is mandatory. The 
Burch colposuspension is the operative 
procedure of choice. The suspension is 
done with Prolene sutures; their correct 
placement is ensured through the use of 
intraoperative cystostomy.
Au repos, la continence urinaire se pro- 
duit lorsque la pression intrauretrale est 
superieure a la pression intravesicale. La 
pression intrauretrale est produite par les 
fibres elastiques et I'engorgement des 
sinus veineux uretraux. Une pression 
intravesicale basse est maintenue grace 
au relachement du muscle vesical. 
L'incontinence d'urgence se manifeste si
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le muscle vesicale ne se relache pas.
Une augmentation soudaine de la pres­
sion abdominale peut surmonter ce gra­
dient de pression uretral-v£sical et 
induire une incontinence de stress. Les 
mecanismes qui inhibitent ce phenomene 
ne sont pas clairs. Le gradient de pres­
sion ne change pas si la pression abdo­
minale est transmise equitablement a 
I'uretre et a la vessie. La continence peut 
aussi etre protege en exercant une pres­
sion de I'ur6tre contre la symphyse 
pubienne ou les muscles pelviens. 
L'incontinence de stress et l'incontinence 
d'urgence ne peuvent pas etre clairement 
differenciees sur le plan clinique. Si la 
correction chirurgicale de l'incontinence 
de stress est envisagee, des etudes 
d'ur£trocystometrie preoperatoire sont 
necessaires. La colposuspension de 
Burch est la technique chirurgicale de 
choix. La suspension est effectue a I'aide 
de sutures de Prolene dont le placement 
adequat est assure par I'usage d'une 
cystostomie intraoperatoire.
The surgical management o f stress incon­
tinence is usually first undertaken by the 
general gynecologist, urologist or sur­
geon. It is important that they select their 
patients carefully, choose the appropri­
ate surgical procedure and realize that 
their first effort will afford the best 
opportunity for cure.
In the past, the problem was managed 
mainly by the gynecologist. The indica­
tion for surgery was the clinical demon­
stration o f stress incontinence, usually 
accompanied by cystocele, and the oper­
ation o f choice was anterior vaginal 
repair. Preoperative investigation was 
generally confined to the radiologic 
demonstration o f various urethral angles.
Urologists are now more involved in 
the management o f stress incontinence. 
The surgery is predominantly abdominal, 
and the Marshall-Marchetti-Krantz oper­
ation, introduced in 1950,1 has been 
superseded by the Burch colposuspen­
sion.2 Preoperative urologic investigation
is considered mandatory, and uro- 
dynamic studies have generally replaced 
radiologic investigations.
This review will contrast the physiol­
ogy o f normal urinary continence with the 
pathophysiology o f  stress incontinence. 
The means o f diagnosis, in particular the 
value o f urodynamic studies, will be 
detailed and preferred surgical therapy 
discussed. I shall not deal with the 
management o f complex problems o f 
incontinence, but focus on the patient 
who is seen for the first time and who 
complains o f recent incontinence.
Physiology of Continence and Pathophysiology of Stress 
Incontinence
Continence o f urine is maintained if  
pressure in the bladder is lower than the 
pressure in the urethra.3 This balance is 
maintained by keeping the pressure in the 
bladder low and the pressure in the ure­
thra high.
Maintenance o f  Low Pressure 
in the Bladder
Low pressure in the bladder depends on 
the ability o f  bladder muscle to relax 
when confronted with an increasing 
volume o f  urine. Inability to do so will 
result in spontaneous and inappropriate 
contractions, giving symptoms o f  fre­
quency, urgency and urgency inconti­
nence. The last is the most important for 
it may be confused with stress inconti­
nence.4
Maintenance o f  High Pressure 
in the Urethra
High pressure in the urethra is main­
tained by two means: intraurethral 
closure pressure, operating with the 
patient at rest, and transmission o f  pres­
sure, occurring when the bladder is sub­
ject to a sudden increase in intra­
abdominal pressure such as occurs with 
coughing.
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Patient at rest — intraurethral closure 
pressure.—The urethral wall through its 
various structures has an inherent pres­
sure — the “ urethral closure pressure” . 
The urethral mucosa, while capable of 
close apposition, is not capable of exert­
ing pressure. In the submucosa is a unique 
vascular complex that makes an impor­
tant contribution to intraurethral pres­
sure.5 Numerous venous sinuses and 
arteriovenous connections are found in 
this layer; when they fill with blood, the 
mucosal surfaces are compressed together 
forming a watertight seal. Fibroelastic 
fibres in the urethral wall contribute to 
urethral tone, but the few associated 
smooth-muscle fibres play a minor role. 
These fibres are extensions of smooth 
muscle from the bladder trigone and run 
only longitudinally. On the other hand, 
there are large numbers of skeletal mus­
cle fibres in the urethral wall itself or in 
close proximity to it that play a major 
role. They may be considered in two 
separate groups. Intimately involved are 
the small-diameter “ slow-twitch” fibres 
that have a circular arrangement and are 
particularly well developed in the middle 
third of the urethra. They can maintain 
a constant tone over a long period;6 they 
ensure blood flow to the submucosal vas­
cular complex. The second group consists 
of the large-diameter “ fast-twitch” 
fibres; they are not intimately involved 
with the urethral wall but rather lie along­
side it. They originate from the medial 
part of the levator ani and function at 
times of acute stress.6,7
Patient stressed — transmission o f  
pressure.—With a sudden cough, the 
bladder may be subject to pressures in 
excess of 120 cm H20 . Urethral closure 
pressure, which is 100 cm H20  or less, 
should be overcome in these circum­
stances and urine lost. Why women don’t 
lose urine at such times is central to the 
understanding of stress incontinence and 
to the principle of corrective surgery. 
Because the proximal two-thirds of the 
urethra is intra-abdominal, pressure 
exerted on the bladder is exerted equally 
along the upper urethra, thus maintain­
ing urethral-vesical pressure differences. 
For example, if the pressure in the blad­
der was originally 20 cm H 20  and in the 
urethra 100 cm H20 , the addition of a 
pressure of 200 cm H20  to both bladder 
and urethra would maintain the status 
quo; there would be no change in the 
pressure differences and continence 
would be maintained. For changes to be 
equal in both bladder and urethra, the 
urethra must be in the abdomen. It is nor­
mally held in position and prevented from 
falling downward and backward by a liga­
ment that binds it to the symphysis pubis.
Although transmission of in tra­
abdominal pressure is central to our 
understanding of continence, other fac­
tors may be involved. It has been sug­
gested that a “ cough reflex” is present 
although it is difficult to differentiate it 
from pressure transmission.8 The cough 
reflex is thought to cause rapid contrac­
tion of the pelvic floor muscles when 
intra-abdominal pressure is suddenly 
raised. The contraction then causes the 
intraurethral pressure to rise and may also 
serve as a “ backboard” over which the 
increased pressure can be transmitted to 
the urethra.8
Another explanation of stress inconti­
nence relates to neuromuscular coordina­
tion. It has been shown9 that in some 
patients pelvic muscle function is dis­
turbed as a result of motor nerve damage. 
Such damage prevents the pelvic floor 
from effectively contracting and support­
ing the urethra in its intra-abdominal 
position.
Stress Incontinence
The anatomical fault in most cases of 
stress incontinence is a weakening of the 
fixation of the proximal urethra to the 
symphysis pubis. Rising intra-abdominal 
pressure forces the urethra through the 
pelvic floor and not against the well- 
supported vagina. When this happens the 
intra-abdominal pressure cannot be trans­
mitted to the proximal urethra and incon­
tinence results.3
A small subset of patients have severe 
stress incontinence for a different ana­
tomical reason. They are incontinent 
because of a fault in the proximal urethral 
muscles that causes the intraurethral pres­
sure to be abnormally low. This can be 
confirmed by demonstrating the low ure­
thral pressure profile on twin-channel cys­
tometry, or by demonstrating an open 
bladder neck on cystography. At surgery, 
with the bladder open, the laxity of the 
urethra can also be confirmed by the ease 
with which a finger can be introduced 
alongside the urethral catheter.10 The 
etiology is often apparent, a common 
cause being trauma to the urethra result­
ing from previous vaginal surgery. In 
approximately 10% of such cases the 
defect is the primary cause of inconti­
nence.11
These cases are of particular interest, 
for they contribute disproportionately to 
surgical failures. The usual stress incon­
tinence surgery will fail in this group of 
patients; they are best managed with a 
sling operation.
Examination
The patient’s history alone is not suffi­
cient for an accurate diagnosis of blad­
der dysfunction; if no diagnostic aids are 
used a therapeutic error as high as 50% 
is possible.12 14 The major problem is 
differentiating those with stress inconti­
nence of urine from those with an unsta­
ble bladder. Sixty percent of patients with 
stress incontinence complain of stress 
alone; in this group of patients an unsta­
ble bladder is uncommonly found (5%) 
on cystometric studies. The remaining 
40% complain of both stress and urgency; 
the majority of these patients have an 
unstable bladder.11
On physical examination the loss of 
urine from a full bladder with cough 
should be demonstrated. Cystocele or 
uterine prolapse may be an associated 
finding in up to 50% of cases. The Mar­
shall test, in which the physician mimics 
the anticipated operative result by manu­
ally elevating the vagina, is not always 
helpful. The test simply compresses or 
elongates the urethra and it is neither 
indicative of the need for surgery nor 
always predictive of the result of such 
surgery.15
Urodynamics
The knowledge obtained from uro- 
dynamic studies should allow rational 
treatment. It is important to have uro- 
dynamic confirmation of both stress 
incontinence and the absence of bladder 
disease. An improperly functioning ure­
thra or a bladder that is incapable of emp­
tying should not be diagnosed for a first 
time during a complicated postoperative 
course.
Investigation begins with culture of 
urine, cystoscopy and the measurement 
of residual urine. Twin-channel ure- 
throcystometry using microtransducers 
permits the simultaneous measurement of 
urethral and bladder pressures; measure­
ments are obtained with and without 
coughing. Usually no other studies are 
necessary.
Electromyography and videourethro­
cystography, which shows the shape and 
mobility of the bladder neck and the 
action of the urethra, are expensive and 
unnecessary as routine procedures.
A common finding is the urologic 
demonstration of both stress incontinence 
and an unstable bladder in a patient with 
mixed symptoms. Surgery used to be con­
traindicated in such cases. However, it is 
now suggested that such patients should 
be treated surgically like patients with iso­
lated stress incontinence. In 80% of cases, 
both stress and urgency are relieved; in 
only a small percentage (5%) does 
urgency persist.11
Surgery
Surgery for stress incontinence is elec­
tive. Individual fitness, social circum­
stances and reaction to the disability 
influence the need for surgery. The oper­
ative approach chosen may be vaginal or 
abdominal. Despite disputes over the defi­
nition of failure and means of confirm­
ing cure, most physicians will have bet-
158 VOLUME 30, NO. 3, M A Y  1987 /  THE CANADIAN JOURNAL OF SURGERY
ter results with abdominal surgery.2'16-18 
Anterior repair with its minimal mor­
bidity is especially useful in the obese or 
infirm with a coexisting cystocele or 
prolapse.
Burch Procedure
The Burch procedure is the intra­
abdominal procedure of choice; it has 
superseded the Marshall-Marchetti- 
Krantz procedure.19-20 Disabling osteitis 
pubis, which occurs in a number of 
patients after the Marshall-Marchetti- 
Krantz procedure, contributed to this 
change.21 It is also apparent at surgery 
that a firmer hold of tissue can be 
obtained when the strong vaginal fascia 
is sutured to the ileopectineal ligament 
(Cooper’s) than when attempts are made 
to suture it to the fascia on the posterior 
surface of the pubis.
Surgery aims at elevating the bladder 
neck and urethra so that increased intra­
abdominal pressure can be transmitted to 
the proximal urethra;22 other effects of 
the surgery include compression of the 
bladder neck against the symphysis 
pubis20 and the production of increased 
outflow resistance.23
The Burch colposuspension begins with 
dissection of the paravaginal and paraves­
ical spaces so that the fascia covering the 
anterior vaginal wall can be visualized. In 
order to do so, the fat overlying the fas­
cia must be removed or pushed aside. 
Large friable veins are present in this fatty 
tissue and during removal of the fat they 
are liable to rupture. Although venous 
hemorrhage responds to pressure or the 
application of hemoclips, prudence sug­
gests that the dissection of the fat be 
limited to the area of the vagina that will 
accept a suture. This dissection is not 
always easy; the patients are often obese, 
exposure may be less than ideal and bleed­
ing can be brisk.
Confirmation of the effect of suture 
placement on the bladder trigone, the ure­
ters and the urethral orifice is only possi­
ble if the dome of the bladder is 
opened.18 This step is straightforward 
and safe and is done before the paravesi­
cal sutures are inserted. The vaginal finger 
pushes up on the vaginal wall lateral to 
the urethra at the level of the urethroves- 
ical junction. A monofilament nylon 
suture (Prolene, 0) on a half-circle, 
2.0-cm, round-bodied needle is used to 
take a deep grasp of the paravaginal fas­
cia at the level of the bladder neck. A 
similar suture is inserted on the opposite 
side of the urethra. These are the two 
most important sutures, but, depending 
on the mobility and capacity of the 
vagina, other sutures may be inserted. 
Various descriptions suggest placement of 
such sutures lateral, proximal20 or 
distal24 to the bladder neck. The interior 
of the bladder is inspected, inadvertent
suture placement through the bladder wall 
may be discovered and can be corrected. 
The sutures are then attached to the 
ileopectineal ligament. The anterior 
aspect of the urethra is brought to the 
posterior aspect of the symphysis pubis. 
Care is taken not to obstruct the urethra; 
it should be possible to insert a finger 
between the upper urethra and symphy­
sis pubis. Seven knots are taken and the 
suture ends are further secured with a 
hemoclip. Patency of the ureters is then 
confirmed. This is most easily done by 
observing the free flow of urine from each 
ureteric orifice following the intravenous 
injection of 40 mg of furosemide (Lasix; 
Hoechst Canada Inc., Willowdale, Ont.). 
An alternative measure is the passage of 
an infant feeding tube up each orifice.
At the time of bladder closure, a supra­
pubic catheter is inserted; a Jackson- 
Pratt drain is then passed into the retro­
pubic space.
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THE ONLY THING 
COMPETITIVE ABOUT 
BECTON DICKINSON 
IS THE PRICE.
AT EVERYTHING EISE WE 
BEAT THE COMPETITION 
HANDS DOWN.
We can sharpen our pencil with the 
best of them.
Price is important! We know that! When 
you’re shopping around, you’ll find we’re as 
competitive as anyone.
But price isn’t everything. What 
really counts is value; knowing that when 
you place an order, you’ll be getting 
superior quality products backed by a com­
pany that's in business for the long term.
That describes Becton Dickinson. 
We've been in business in Canada since 
1951 and we plan to do business here for 
many years to come. If we didn’t intend 
staying around, we wouldn’t be undergoing 
a major expansion of our office, ware­
house and production facilities.
So while it’s nice for you to know 
that we're just as price conscious 
as you are, it’s also good to 
know that we refuse to 
compromise on 
quality and
Product "  service,
quality puts us 
out ahead.
At Becton Dickinson, we base our 
success on a reputation for product 
quality, innovative design and unequalled 
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producer of disposable hypodermic 
syringes and needles. We’re also 
a world leader in evacuated blood col­
lection systems. Our BARD-PARKER* 
surgical blades have been the choice of 
leading surgeons around the world for 
over 75 years. In hospitals, clinics and 
physicians' offices, TRU-TOUCH* brand vinyl 
medical gloves are providing the protection 
that health care professionals require.
That’s the Becton Dickinson differ­
ence. We stand behind our products after 
they’ve left our plant.
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network.
When you deal with Becton Dickinson, you’re 
dealing with a sophisticated, integrated, 
manufacturing/distribution delivery system.
Our large and expanding warehouses 
in Mississauga and in Calgary provide fast, 
easy access to inventory.
Our network of established distribu­
tors work with us to ensure that you get 
the supplies you need promptly and efficiently.
For you it means no waiting for 
deliveries. For us it means satisfied customers 
who keep coming back.
We lead the field in technical 
support services.
You get more than 
quality health care 
products when
you buy from 
Becton Dickinson. 
Every product we sell 
is backed by highly experi­
enced support professionals.
Technical support specialists will help 
you with advice and assistance on the use 
of our products. Our own sales force, located 
in major centres across the country, backs 
the efforts of our distributors. Our personnel 
are always available to provide in-service 
training in the use of our products.
You’re assured of on-the-spot back­
up service. There are no overseas phone 
calls to track down a manufacturer. No frus­
trating, time-consuming wait to get an 
answer. At Becton Dickinson we’re just a 
phone call away.
So if you’re buying from one of our 
competitors now, give us a call.
We thrive on competition.
*BARD-PARKER, B-D and TRU-TOUCH are registered 
trade marks of Becton Dickinson and Company 
reg. user Becton Dickinson Canada Inc.
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Recent reported experience with in-situ 
vein grafting has been positive and 
encouraging. At the Queen Elizabeth 
Hospital in Charlottetown, PEI, since 
January 1983, 111 in-situ vein grafts 
have been placed. Fifty-one were to sites 
distal to the tibioperoneal trunk; 18 were 
to the ankle and foot and included grafts 
to the tarsal and plantar arteries. All 
patients requiring distal grafts com­
plained of rest pain or had tissue 
necrosis.
The early in-hospital and 1-month 
patency of the 51 distal grafts (93%) 
was similar to that of 60 femoropopliteal 
grafts (87%), but the 3-year patency 
rate of the distal grafts was only 50% 
compared with 82% for the femoro­
popliteal grafts.
The high late failure rate of the distal 
grafts was disappointing. It was not 
related to the level of the distal anasto­
motic site in the lower leg or foot, to the 
level of the proximal anastomotic site, 
the particular vessel chosen for the distal 
site, or to whether the distal site was 
visualized by contrast roentgenography 
or located preoperatively by ultrasonog­
raphy. Continued smoking was an impor­
tant factor in failure, and mechanical 
trauma to the distal saphenous vein may 
have been important.
Intimal hyperplasia was the usual 
cause of failure and may be a negative 
aspect of the vitality of in-situ vein 
grafts. Its clinical presentation and histo­
logic features were florid and distinctive.
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Une experience recemment rapportee de 
greffe veineuse in situ s'est averee posi­
tive et encourageante. A I'hopital Reine 
Elizabeth de Charlottetown, depuis jan- 
vier 1983, 111 greffes veineuses in situ 
ont 6te realisees. Cinquante et une 
etaient a des sites distaux du tronc tibio­
peroneal; 18 Etaient au niveau de la che- 
ville et de pied et incluant des greffes 
artgrielles tarsiennes et plantaires. Tous 
les patients necessitant des greffes dista­
les se plaignerent de douleur au repos ou 
manifesterent des necroses tissulaires.
Au cours de la phase hospitalise pre- 
coce et apres un mois, la prise des 51 
greffes distales (93%) dtait similaire a 
celle des 60 greffes f^moropoplitees 
(87%). Cependant, aprbs 3 ans, la prise 
des greffes distales n'etait que de 50%  
comparativement au taux de 82% dans 
le cas de greffes femoropoplitees.
Le taux elev§ d'6chec tardif des gref­
fes distables fut decourageant. II n'etait 
relid ni au niveau du site anastomotique 
distal dans le bas de la jambe ou du 
pied, ni au niveau du site anastomotique 
proximal, ni au vaisseau choisi comme 
site distal, ni au fait que le site distal 
etait visualise par roentgenographie de 
contraste ou localise prealablement par 
ultrasonographie. Le fait de continuer a 
fumer fut un facteur d'echec important, 
le traumatisme mecanique de la veine 
saphene distale ayant pu etre conside­
rable.
L'hyperplasie intimate fut la cause 
usuelle d'echec et peut constituer un 
aspect negatif de la vitality des greffes 
veineuses in situ. Sa manifestation Clini­
que et ses caracteristiques histologiques 
furent bien visibles et distinctes.
Before 1980, many vascular surgeons 
believed that patients with advanced 
ischemia o f the foot requiring a distal vein 
graft for revascularization were poor can­
didates for surgery, so they were fre­
quently treated conservatively or by 
amputation. In-situ grafting by the valve- 
incision technique o f Leather and
associates1,2 changed this perspective. 
The early results of in-situ grafting to dis­
tal vessels for limb salvage have been 
good and appear to be independent of 
many of the conditions limiting the appli­
cation o f reverse vein grafting.
This paper describes an experience with 
51 distal in-situ vein grafts out of a total 
of 111 in-situ grafts placed over 3 V2 years. 
The experience is illustrated by the fol­
lowing case report.
Case Report
A 74-year-old diabetic man had a femoro- 
peroneal in-situ vein graft inserted for necro­
sis of the foot. The graft functioned well and 
allowed skin grafting of the necrotic area. Six 
months later, rest pain recurred and an arteri­
ogram (Fig. 1) showed a markedly stenotic seg-
FIG. 1—Arteriogram showing stenotic ori­gin of in-situ femoroperoneal vein graft.
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ment at the proximal end of the graft, with 
patency being maintained by a fistula just 
beyond that segment. The distal graft remained 
patent with no proximal inflow. The proximal 
stenotic segment suggested ischemic mobiliza­
tion injury, but subsequent histologic study 
showed the process to be myointimal hyper­
plasia. The lesion was corrected and normal 
indices were restored, but myointimal hyper­
plasia progressed elsewhere in the graft caus­
ing it to fail 3 months later.
Patients
Fifty-one patients had in-situ grafting 
distal to the tibioperoneal trunk. They 
were similar in most respects to 60 
patients who received grafts to the 
popliteal artery, but they were older (4 ± 
0.02 years) and had more compelling rea­
sons for intervention (100% versus 84% 
had rest pain or tissue necrosis). Thirty- 
three of the 51 distal grafts were to the 
tibial and peroneal arteries — 9 to the 
anterior tibial, 10 to the posterior tibial 
and 14 to the peroneal artery. The other 
18 were to the ankle and foot and 
included 3 grafts to the medial plantar 
artery, 1 to the lateral plantar artery (Fig. 
2a), 1 to the medial tarsal artery (Fig. 2b) 
and 2 to the perforating branch of the 
peroneal artery (Fig. 2c). Seven grafts 
were to the dorsalis pedis artery and four 
to the posterior tibial artery. Nine grafts 
were to vessels that could not be visual­
ized by a contrast medium but were 
located in the foot or lower leg by 
ultrasonography. Twelve patients had a 
popliteal pulse, and in 8 the proximal 
anastomotic site was in the distal super­
ficial femoral or popliteal artery.
Technique and Methods Late Distal-Graft Failure
The grafts were placed by techniques 
and with instruments developed by the 
Albany group.1 The valves were incised 
above the knee under pressure with the 
valve cutter in 43% and with a metal 
retrograde valvulotome in the remainder. 
Below the knee, the valves were incised 
with the retrograde valvulotome. The seg­
ment of the saphenous vein from its usual 
level of duplication, a few centimetres 
above the ankle, to its junction below the 
tibial plateau often presented special 
difficulty. The saphenous vein above and 
below this level is usually adequate in size, 
but the duplicated segment is smaller and 
relatively fixed between the skin and 
medial tibial surface. In addition, the 
ankle and foot interfere with parallel 
alignment of the shaft of the meral val­
vulotome with the vein (Fig. 3). Fistulas 
were located above the knee by arteriog­
raphy and below the knee by Doppler 
using an 8-MHz probe (Bach-Simpson 
Ltd., London, Ont.).
Cumulative Patency Rates
The 1-month cumulative patency rate 
of 51 distal grafts was 93% (Fig. 4). At 
1 year, the rate was 80%, at 2 years 60% 
and at 3 years only 50% (p = 0.12). The 
patients receiving distal grafts, especially 
the late failures, were reviewed to examine 
the nature of responsible lesions and their 
pathogenesis and to seek any common or 
causative factors.
In 11 of 16 distal grafts that failed late, 
the responsible anatomic lesion was
FIG. 3—Operative photograph showing 
difficulty in aligning shaft o f metal valvulo­
tome (arrows) with fixed curving vein in ankle 
and lower leg.
FIG. 4—Cumulative life-table graph show­
ing progressive loss of patency among distal 
grafts (p = 0.12).
Fig. 2a Fig. 2b Fig. 2c
FIG. 2—In-situ grafts (arrows) to (a) lateral plantar artery, (b) medial tarsal artery, (c) perforating branch of peroneal artery.
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demonstrated (Table I). They were exa­
mined by direct exploration and throm­
bectomy, with angiography when possi­
ble, and histologically in all instances. 
Intimal hyperplasia frequently involved 
the entire graft. Grossly, the graft showed 
concentric thickening of the intimal layer, 
a pale thick inner ring as distinguished 
from the pink and tan of the media and 
adventitia (Fig. 5). The vascular lumen 
was often reduced to a pinpoint and when 
explored before occlusion occurred dis­
played a thin jet of blood through the 
transected lesion. Five other failed grafts 
were not studied; two of the patients had 
amputation elsewhere and three refused 
further intervention.
On light microscopy the lesions with 
early changes showed active hyperplasia 
of myocytes and fibroblasts within the 
internal elastic membrane, which was 
usually fragmented and duplicated. Often 
a distinct endothelial layer was not 
present. The adventitial layer was sur­
rounded and infiltrated by inflammatory 
cells and active proliferation of the vasa 
vasorum was frequently present (Fig. 6a). 
Occasionally, the vasa vasorum appeared 
to share in the myointimal process (Fig. 
6b). At greater magnification (Fig. 6c), 
the process is seen to be floridly active 
with variation in nuclear characteristics 
and frequent mitoses. Sometimes, the 
myointimal cells showed loss of their 
usual orientation with polarization 
toward the lumen (Fig. 6d). The lesions 
with late changes showed varying degrees 
of maturity with collagen deposition and 
hyalinization (Fig. 6e), but at times these
T a b le  1— L e s io n s  in  F a ile d  G r a f t s
L e s io n
N o .
o f  p a t ie n ts
M y o in t im a l  h y p e r p la s ia ,  
lo n g  s e g m e n t 5
M y o in t im a l  h y p e r p la s ia ,  
s h o r t  s e g m e n t 2
Is c h e m ic  m o b iliz a t io n  in ju ry 1
T r a u m a 1
E m b o lic  o b s tru c t io n 1
P ro g re s s io n  o f  d is ta l  d is e a s e 1
FIG. 5—Myointimal hyperplasia showing 
pale, thick intima.
late lesions were also highly cellular. Most 
biopsies, taken from the proximal, mid­
dle and distal levels, in the failed grafts, 
showed the same process to varying 
degrees.
Electron microscopy defined the nature 
of the early changes more clearly (Fig. 
7a). The intimal and subintimal layers 
were replaced and the lumen was dimin­
ished by a proliferation of typical smooth-
Fig. 6a
Fig. 6c
Fig. 6d
Fig. 6b
FIG. 6—(a) Fragmentation (arrow) of inter­
nal elastic membrane and proliferation (arrow) 
of vasa vasorum within inflammatory cell reac­
tion (elastic stain, original magnification x 
25). (b) Higher-power view showing hyperpla­
sia within vasa vasorum (hematoxylin and 
eosin, original magnification X 100). (c) Florid 
cellular activity with frequent mitoses and var­
iation in nuclear characteristics (Masson 
trichrome stain, original magnification X 400). 
(d) Myointimal cells have altered in polariza­
tion (arrow) and are directed toward lumen 
(Masson trichrome stain, original magnifica­
tion x  400). (e) Later, more-mature lesion with 
collagen deposition (Masson trichrome stain, 
original magnification x  100). Fig. 6e
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muscle cells with coarse endoplasmic 
reticulum in a bed of fibrin strands and 
collagen bundles. Elastic units were 
present in some areas (Fig. 7b).
Analysis of Data
The 16 distal grafts that failed late were 
compared with 31 distal patent grafts to 
see if any important factors could be iden­
tified. Sixteen patient, technical and ana­
tomic factors (Table II) were studied by 
comparison of the mean values and by 
stepwise regression analysis. When mean 
values were compared, the only factor of 
significance (p = 0.0042) was continued 
smoking in those who had failed grafts. 
A stepwise regression model was deve­
loped with the 16 factors listed in Table 
II; again smoking was the only important 
variable (R2 = 0.1429, SD = 0.896).
Discussion
Success or failure of reversed vein 
grafting depends on many factors,^  but 
only continued smoking showed statisti­
cal significance in late failure among the 
51 patients receiving distal in-situ grafts.
Myointimal hyperplasia typically 
occurs at the heel and toe, at the lower 
end of the graft and in the floor of the 
recipient artery.7 The process has not 
been regarded as especially virulent, or 
occurring especially early, but in this 
group of patients, myointimal hyperpla­
sia occurred at all levels. The lesions were 
frequently early (in the first few months) 
and progressed rapidly. These patients, 
followed monthly by vascular laboratory 
assessment, often progressed from hav­
ing normal indices at rest to critical ste­
nosis or occlusion of their grafts between 
visits.
Myointimal hyperplasia is thought to 
be related to intimal injury, exposure of 
collagen and stimulation of muscle-cell
duplication by growth factor derived 
from locally aggregated platelets or 
injured endothelium.8 Intimal injury is 
an integral part of the in-situ procedure, 
as each valve leaflet is incised. The seg­
ment of saphenous vein between the knee 
and the ankle is especially subject to 
injury in patients receiving distal grafts. 
The vein is smaller and relatively fixed 
here, and parallel alignment of the metal 
valvulotome is difficult. Myointimal 
hyperplasia may be the result of valvulo­
tome injury at this site. Concentric layer­
ing of hyperplastic cells would cause loss 
of area lumen and become critical soonest 
in the smallest diameter of graft.
During the study period, 16 more 
patients received nonreversed ex-situ 
grafts (failed in-situ grafts, absent in-situ 
vein and upper extremity disease), with 
valve incision carried out as for the in-situ 
procedure. In none of these patients has 
graft myointimal hyperplasia been recog­
nized. It may be that the vitality of in-situ 
vein, which confers its remarkable non- 
thrombogenicity, also makes it more reac­
tive to trauma and to general conditions 
such as the effects of cigarette smoking.
Summary
In this group of 51 distal in-situ grafts, 
early patency was gratifying, but late 
failure occurred in 16 patients at intervals 
up to 36 months, with a patency rate by 
life-table analysis of only 50% at 3 years. 
The most frequently encountered lesion 
was myointimal hyperplasia. Continued 
smoking was significant in cases of 
failure, but trauma to the venous 
endothelium was probably critical.
I thank Merrill Smith and Dr. Ian Craig of 
the Queen Elizabeth Hospital, Charlottetown, 
Dr. Anthony Trillo of Dalhousie University, 
Halifax, and Dr. Harry Love of the Univer­
sity of Prince Edward Island, Department of 
Mathematics, for their assistance in this work.
Fig. 7a
FIG. 7—(a) Electron micrograph showing smooth-muscle cells in hyperplastic lesion wii 
cellular zones in bed containing fibrin strands and collagen bundles (original magnification 
hyperplasia (original magnification x 3000).
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Table II—Factors Studied In Late 
Distal Graft Failure
Age
Sex
Hypertension 
Diabetes mellitus 
Serum cholesterol 
Persistent smoking 
Use of valve cutter
Distal anastomotic site not visualized by 
angiography
Early thrombectomy required 
Duration of procedure
Low proximal anastomotic site, below common 
femoral artery
Low distal anastomotic site, below middle of 
tibia
Specific vessel used for distal site 
Anterior tibial 
Posterior tibial 
Peroneal
Ankle-foot artery
Fig. 7b
Ih coarse endoplasmic reticulum and dense inter- 
X 4500). (b) Elastic unit in area of myointimal
166 VOLUME 30, NO. 3, M A Y  1987 /  THE CANADIAN JOURNAL OF SURGERY
F.M. Ameli, mb, bs, frcs(edin>, facs, frcsc; T. Minas, md; M. Weiss;
J.L. Provan, mb, bs, ms, frcs, facs, frcsc
Consequences of “Conservative” Conventional Management
of Axillary Vein Thrombosis
To evaluate the long-term effects of 
"conservative" management (heparin ini­
tially then Coumadin for 3 months) on 
patients with axillary vein thrombosis, 
the authors studied 20 patients (average 
age 44 years) who presented at the 
Wellesley Hospital in Toronto between 
1975 and 1984. The diagnosis of axil­
lary vein thrombosis was made from his­
tory, findings on physical examination 
and Doppler studies. In 12 patients, the 
diagnosis was confirmed by venography. 
Three patients subsequently underwent a 
first-rib resection for thoracic outlet syn­
drome. The average follow-up was 42 
months. The cause of the thrombosis in 
3 patients was an intravenous-line 
catheter, in 7 it was effort thrombosis 
and in 10 the cause was unknown. Two 
patients had had a previous deep venous 
thrombosis in the lower limb.
Results of conservative treatment 
showed that only five patients had 
residual minimal swelling and two had 
minor discomfort. These symptoms did 
not interfere with either leisure or work 
activities in any of the patients. Fifteen 
patients were asymptomatic. One patient 
had nonfatal pulmonary embolism.
The conservative management of axil­
lary vein thrombosis is safe, effective, 
relatively inexpensive and gives excellent 
long-term results. The prognosis is good, 
irrespective of the cause of the thrombo­
sis and, in view of this, a more aggres­
sive approach, using either streptokinase 
therapy or thrombectomy, does not 
appear to be justified.
Pour ^valuer les effets a long terme d'un
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traitement conservateur (heparine initiale- 
ment. suivie de Coumadin pendant 3 
mois) chez des patients atteints de 
thrombose veineuse axillaire, les auteurs 
ont conduit une etude sur 20 patients 
(age moyen de 44 ans) qui se presentd- 
rent a I’hdpital Wellesley de Toronto 
entre 1975 et 1984. Le diagnostic de 
thrombose veineuse axillaire fut 6tabli 
aprds analyse des antecedents medicaux, 
examen physique et etudes de Doppler. 
Chez 12 patients, le diagnostic fut con- 
firme par veinographie. Trois patients 
subirent subsequemment une resection 
du nerf pour soulager un syndrome tho- 
racique. Le suivi moyen fut de 42 mois. 
La cause de thrombose chez 3 patients 
fut ('introduction d'un catheter intravei- 
neux, chez 7 d'entre eux il s'agissait 
d'une thrombose a I'effort et pour les 10 
autres la cause etait inconnue. Deux 
patients manifesterent anterieurement 
une thrombose veineuse profonde au 
niveau du membre inf6rieur.
Les resultats d'un traitement conserva­
teur demontrent que seulement cinq 
patients ont manifeste une inflammation 
minime residuelle et deux ont eu des 
malaises mineurs. Ces symptomes 
n'interferent pas avec les activity de loi- 
sir ou de travail des individus. Quinze 
patients 6taient asymptomatiques. Un 
patient subit une embolie pulmonaire non 
fatale.
Le traitement conservateur de la 
thrombose veineuse axillaire est securi- 
taire, efficace, relativement peu couteux 
et donne d'excellents resultats d long 
terme. Le pronostic est bon, quelle que 
soit I'origine de la thrombose. A la 
lumi&re de ces resultats, une approche 
plus agressive, utilisant la streptokinase 
ou la thrombectomie, semble injustifiee.
Deep venous thrombosis of the upper 
extremity is rare. It was first described by 
Sir James Paget in 1875 and then in 1884 
by Von Schroetter. The condition was 
later termed Paget-Schroetter’s syndrome 
by Hughes.1 It has also been referred to 
as primary thrombosis, effort thrombo­
sis and traumatic thrombosis o f  the axil­
lary or subclavian vein. It is estimated to 
occur in only 1% to 2% o f all deep
venous thromboses.2,3 No large prospec­
tive studies to assess, classify and describe 
the natural history of the disease and best 
methods of treatment have been carried 
out. Delays in diagnosis and misdiag­
noses, such as compartment syndrome, 
infection or allergy, may prevent prompt 
therapy.4 For all these reasons, classifi­
cations vary and therapies are numerous 
and controversial. A pulmonary embolus 
complicating deep venous thrombosis o f  
the upper extremity is even rarer; in 
reported series, its frequency has varied 
from 0%5 to 12%.1 A  case o f venous 
gangrene has been reported by Adams 
and associates.1 Late disabling symp­
toms have been reported to occur 
infrequently6 or in as many as 74% of 
patients.1,7,8
Therapy has included rest and elevation 
alon e,1 anticoagulation for variable 
periods, ligation of the vein proximal to 
the thrombosis,9 thrombolysis with uro­
kinase or streptokinase. Streptokinase has 
been given either locally or systemically 
by infusion.10,11 Surgical treatment has 
included venous thrombectomy and exci­
sion of the first rib, scalenus anterior 
muscle, cervical bands and subclavius 
muscle.7,10,12
Our purpose was to evaluate the long­
term effects o f conservative therapy 
(heparin initially then Coumadin for 3 
months) on patients with the diagnosis o f 
axillary vein thrombosis.
Patients and Method
At the Wellesley Hospital, Toronto, 
between 1975 and 1984, 20 patients (12 
men and 8 women, average age 44 years) 
were found to have axillary or subclavian 
venous thrombosis, or both. A chart 
review was carried out and 18 patients 
were followed up for an average of 42 
months. Two patients were followed up 
for only 6 months; they had no residual 
symptoms but could not be contacted 
again for complete follow-up.
The presenting complaint o f all patients 
was the sudden onset o f swelling of the 
arm, made worse by use o f the limb. 
Other complaints were bluish discoloura­
tion and distended veins o f the arm. The
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onset was often striking, with findings 
present on awakening, presumably trig­
gered by stasis and dependency overnight. 
Physical examination revealed a swollen 
arm with or without bluish discoloura­
tion. All patients had distended veins in 
the upper arm extending over the chest 
and shoulder. Diagnosis was confirmed 
by Doppler venous studies and the 
majority had supplementary venography.
Treatment consisted of hospitalization, 
elevation of the affected arm and immedi­
ate anticoagulation with a heparin bolus 
(10 000 units) followed by heparin 
intravenously for 1 week and then Cou­
madin orally for 3 months.
All patients were seen in the vascular 
clinic for follow-up.
Findings (Table I)
Of the 20 patients diagnosed to have 
axillary vein thrombosis, the right upper 
extremity was involved in 11 patients and 
the left in 9. Two patients gave a history 
of deep venous thrombosis of the lower 
extremity. In three patients the axillary 
vein thrombosis was due to introduction 
of a venous catheter in two and a 
pacemaker catheter in one. From their 
history, effort thrombosis was diagnosed 
in 7; 10 had thrombosis of unknown etiol­
ogy, 1 of whom had polycythemia and 
rubra vera. One patient suffered nonfa- 
tal pulmonary embolism. There were no 
other early complications.
At 6 months’ follow-up, none of the 
original 20 patients had any serious 
residual symptoms. After 42 months one 
of us (F.M.A.) assessed the remaining 18 
patients. Minimal symptoms of mild 
edema and discomfort were noted in five 
patients (Table II), but these symptoms 
did not interfere with either leisure or 
work activities.
When evaluated according to cause, 
patients with effort thrombosis had a 
higher incidence of residual minimal 
symptoms. There were no cases of 
venous gangrene, recurrent axillary vein 
thrombosis or chronic disabling edema.
Discussion
Axillary vein thrombosis is rare, 
accounting for the small numbers of cases 
reported. Our series of 20 patients is com­
parable in number to others reported in 
the literature. Prescott and Tikoff6 pro­
posed five mechanisms contributing to the 
low incidence.
• There is no analogy to the soleal 
venous network of the lower extremity. 
These lower limb veins become progres­
sively patulous with age and are believed 
to be the site of origin of most deep 
venous throm boses in the lower 
extremity, especially with the patient in 
the recumbent position.
• Venous valves in the upper extremity
are fewer and smaller. This observation 
is important, as some thrombi are 
thought to originate at these locations.
• Conscious patients are more likely to 
move upper than lower extremities while 
lying in bed.
• There is less hydrostatic pressure in 
the arms than the legs.
• Increased fibrinolytic activity has 
been reported in the venous endothelium 
of upper extremities compared with the 
lower.13-14
The frequency of post-phlebitic symp­
toms in lower extremities also may be due 
to the extensive venous intimal damage, 
as thrombogenesis usually originates in 
the soleal network and propagates prox- 
imally with few collaterals. In compari­
son, axillary vein thrombosis is usually 
short and segmental, with the develop­
ment of many collaterals, which may 
explain why none of our patients had dis­
abling symptoms following axillary vein 
thrombosis. Also, in the lower limb there 
can be severe venous ambulatory hyper­
tension following an episode of deep 
venous thrombosis.
In our study, residual symptoms were 
infrequent, and there was no permanent 
swelling of the upper limb or of venous 
gangrene. Reports in the literature regard­
ing permanent disabling swelling have 
been conflicting, with rates ranging from 
0%6 to 74% .*’7’8 In this series it was 
apparent that some patients were treated 
earlier than others and this appears to 
have had a marked effect on long-term 
outcome.
An early report by Tilney and 
associates4 noted that residual symptoms 
did not vary with primary or secondary 
causes, nor did they depend on the locali­
zation of the thrombus. Although a 73% 
incidence of residual symptoms is 
reported, there is no indication of how 
and when these patients were treated ini­
tially. Tilney and associates noted that 
symptoms tended to be associated with 
venous hypertension (20 to 30 mm Hg); 
patients with a pressure of less than 10
mm Hg were asymptomatic. Initial treat­
ment consisted of hospitalization, rest 
and elevation of the extremity. Only 54% 
of their patients, however, received sys­
temic anticoagulation for 6 days.
Roos8 used persistent symptoms as a 
reason for more aggressive treatment in 
attempting to recanalize the vessel. He 
noted that the efficiency of venous return 
through collaterals is greatly reduced, as 
their radius is much smaller than the origi­
nal vein. However, it is our contention 
that an increase in venous pressure com­
pensates for the reduction in flow that 
would occur at normal pressure through 
the collaterals.
The venograms in our series were not 
done to assess recanalization, thus we are 
not certain what effect this may have on 
long-term results. It is likely the vein 
rarely recanalizes and symptoms are 
alleviated by collateral circulation alone.
Adams and colleagues1 in 1965 
demonstrated thrombosis of the vein by 
venography. However, their patients were 
treated by rest and elevation alone, and 
all remained symptomatic. Campbell and 
colleagues7 advocated surgical thrombec­
tomy and extrinsic decompression of the 
thoracic outlet. Of the 24 patients in their 
report, 6 underwent this procedure, 
producing objective improvement in 
venous outflow but seldom relieving 
symptoms, particularly in patients with 
obstruction from extrinsic compression. 
One patient was asymptomatic after 
surgery.
Steed and associates11 treated seven 
patients who had upper extremity deep 
venous thrombosis with streptokinase lo­
cally or systemically. Although symptoms 
resolved clinically, only one axillary vein 
was patent on repeat venography. They 
postulated that aggressive surgical 
management of the underlying cause be 
added, where indicated.
Druy and associates10 noted that if 
patency is achieved by the use of strep­
tokinase, thrombosis may recur, as hap­
pened in two of their five patients.
T a b le  1— S u m m a r y  o f  P a t ie n ts
C a u s e  o f  
th ro m b o s is N o .
A v e r a g e  f o l lo w - u p ,  
m o
N o . o f  p a t ie n ts  
f o l lo w e d  up
N o . o f  re s id u a l  
s y m p to m s
In tr a v e n o u s  lin e 3 4 6 3 1
E f f o r t 7 4 1 6 3
U n k n o w n 1 0 4 3 . 5 9 1
T a b le  I I - - S y m p t o m s
C a u s e  o f  
th r o m b o s is N o .
N o . o f  
p a t ie n ts  
f o l lo w e d  up
S y m p to m s
M ild
e d e m a
M ild
d is c o m fo r t C o n tin u o u s  In te r m it te n t
In t r a v e n o u s 3 3 1 0 1 0
lin e
E f f o r t 7 6 3 1 0  3
U n k n o w n 1 0 9 1 1 0  1
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As noted, these reports are often con­
flicting and no clinical prospective ran­
domized studies have been carried out. 
Thus, it can be seen that aggressive addi­
tional treatment such as thrombectomy, 
streptokinase administration and first-rib 
resection, does not appear to improve the 
patency of the axillary vein or give relief 
of symptoms. It has been our experience 
that prompt diagnosis and immediate 
treatment with heparin for 7 days and 
then Coumadin for 3 months give good 
results.
The heparin/Coumadin therapy has 
three purposes: (a) to prevent propaga­
tion of thrombus into collateral channels,
(b) to prevent pulmonary embolism and
(c) to allow endogenous endothelial fibro- 
lytic activity to proceed in the upper 
extremity. Heparin when used early after 
the onset of symptoms has been very 
effective in preventing long-term seque­
lae. This agrees with the results and 
recommendations of Prescott and 
Tikoff6 and Demeter and colleagues.5
Coon and Willis2 agreed that the early 
start of anticoagulants (within 7 days of 
the onset of symptoms) gave a more 
favourable prognosis.
On evaluating earlier studies quoting 
the late post-phlebitic sequelae, we found 
it apparent that the diagnosis in these ser­
ies was not made early and the patient did
not receive optimal conservative therapy. 
Regarding surgical intervention, the only 
reason for resection of the first rib is to 
deal with a thoracic outlet syndrome or 
other neurologic symptoms. This does not 
benefit collateral circulation of the axil­
lary vein or recanalize the thrombosed 
vein. Current reports regarding the use of 
streptokinase do not appear encouraging 
and further studies will have to be done 
to see if there is any advantage over con­
ventional conservative management.
Conclusions
Axillary vein thrombosis is a relatively 
benign disease, the pathophysiology 
differing from that of deep venous throm­
bosis in the lower limb. It should be diag­
nosed early and the diagnosis confirmed 
by venography. To achieve the best 
results, heparin should be started immedi­
ately and continued for 7 days, followed 
by Coumadin for 3 months. Using this 
conservative approach, we have had 
excellent results with minimal long-term 
symptoms. The use of first-rib resection, 
thrombectomy of the axillary vein and the 
use of streptokinase appears to be unwar­
ranted.
We thank Mrs Linda Thompson for her 
secretarial assistance in preparing this 
manuscript.
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Safety of Cholecystectomy With Abdominal Aortic Surgery
Many surgeons are reluctant to remove 
asymptomatic gallstones during aortic 
reconstruction for fear of increasing the 
risk of graft infection. This is a review of 
56 patients who underwent aortofemoral 
bypass or aortic aneurysm repair, with 
cholecystectomy, to determine if the 
morbidity or mortality was increased 
with the concomitant procedure. Follow­
up averaged 25 months (range from 1 to 
125 months). Three patients were lost to 
follow-up. Operative and postoperative 
hospital stay were not increased. One 
patient suffered a graft infection and a 
pseudoaneurysm; the infection was not 
related to the cholecystectomy since it 
occurred after a secondary procedure for 
repair of an infected false aneurysm. 
There were three superficial infections 
and three postoperative deaths, none of 
which specifically related to the 
cholecystectomy. The only related com-
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Reprint requests to: Dr. F. Michael Ameli, Ste. 313, E.K. Jones Building, 160 Welles­ley St. E, Toronto, Ont. M4Y 1J3
plications were three bile leaks, one liver 
injury due to a retractor and bleeding 
from the gallbladder bed in one patient 
who required reoperation.
The authors conclude that concomitant 
cholecystectomy can be performed 
without increased risk to the patient but 
is advised only if the vascular procedure 
has been uncomplicated and the 
cholecystectomy appears straight­
forward.
Plusieurs chirurgiens sont refractaires a 
I'ablation des calculs biliaires asympto- 
matiques durant la reconstruction aorti- 
que a cause des risques accrus d’infec- 
tion. Cette 6tude porte sur 56 patients 
ayant subi une chirurgie aortofdmorale 
ou une reparation d'un anevrisme aorti- 
que, avec cholecystectomie. Elle vise a 
determiner si la morbidite ou la mortalite 
sont accrues avec I'operation concomi- 
tante. Le suivi moyen etait de 25 mois 
(allant de 1 6 125 mois). Trois patients 
furent perdus dans ce suivi. Les sejours 
a I'hopital lors des phases operatoires et 
postoperatoires ne furent pas accrus.
Un patient souffra d'infection et de pseu- 
doanevrisme; I'infection n'etait pas reliee 
a la cholecystectomie car elle survint 
apres une seconde operation visant a 
reparer un faux anevrisme infecte. On 
observa trois infections superficielles et 
trois deces postoperatoires, aucun de 
ces cas n'etait specifiquement relie a la 
cholecystectomie. Les seules complica­
tions rattach6es furent trois dpanche- 
ments de bile, une lesion hepatique due
& un retracteur et un saignement de la 
vesicule biliaire chez un patient qui 
necessita une seconde operation.
Les auteurs concluent que la cholecys­
tectomie concomitante peut etre realisee 
sans risques accrus pour la patient. 
Cependant, elle est recommandee seule- 
ment si la chirurgie vasculaire a ete sans 
complications et si la cholecystectomie 
apparait directe.
A vascular surgeon who encounters gall­
stones during aortic reconstruction for 
occlusive disease or aneurysm is con­
cerned whether a cholecystectomy will 
increase the risk of postoperative compli­
cations, particularly graft infection. The 
rationale for carrying out concomitant 
cholecystectomy is based on the natural 
history of the disease1'3 and the high 
morbidity and mortality of acute cal­
culous cholecystitis in the immediate 
postoperative period.4 In our early 
experience with aortic surgery, five cases 
of acute calculous cholecystitis occurred 
postoperatively, resulting in three deaths, 
and led us to perform cholecystectomy in 
conjunction with aortic surgery.
The purpose of this retrospective study 
was to determine if morbidity or mortal­
ity was increased when aortic surgery and 
cholecystectomy were performed at the 
same operation.
Method
A retrospective chart review was car­
ried out on 56 patients who underwent
Table l-Patient Characteristics
Follow-up,
mo
Average 
age, yr
Gallstones Total
no.Group Male Female Symptomatic Asymptomatic
Abdominal aortic aneurysm
Asymptomatic 24.8 69 18 3 6 15 21
7Symptomatic 9.4 71 6 1 2 5
Ruptured 38.6 78.5 4 0 0 4 4
Aortofemoral bypass grafting
Claudication 31.3 57 6 9 1 14 15
Limb salvage 25.9 65 3 6 1 8 9
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cholecystectomy in combination with aor­
tic surgery between 1974 and 1985 at the 
Wellesley and Toronto General hospitals. 
The abdominal aortic aneurysms were 
considered in three groups — asympto­
matic, symptomatic and ruptured. Aor- 
tofemoral bypasses were considered in 
two groups — patients who required 
operation for claudication or for limb sal­
vage. Each patient was assessed in regard 
to intraoperative complications, blood 
loss, operating time, postoperative com­
plications, death and length of hospital 
stay (Table I). Overall, the average length 
of follow-up was 25 months (range from 
1 to 125 months).
Results
Ten (18%) of 56 patients had biliary 
tract symptoms, either biliary colic or epi­
sodes of cholecystitis. Forty-six (82%) 
were asymptomatic, and gallstones were 
found incidentally at the time of opera­
tion or preoperatively by ultrasonog­
raphy.
During the aortic procedure 11 patients 
had a hypotensive episode, defined as sys­
tolic blood pressure less than 80 mm Hg. 
Three patients had cardiac problems — 
arrhythm ia, myocardial infarction, 
ischemic changes on the electrocardio­
gram or cardiac failure. Intraoperative
complications (Table II) directly related 
to the cholecystectomy were three minor 
bile leaks, either from the gallbladder or 
the gallbladder bed at the time of surgery 
and one minor injury to the liver bed as 
a result of retractor trauma. All these 
patients had a smooth recovery.
The average blood loss for all patients 
having combined procedures was 800 ml 
(range from 250 to 3025 ml). The aver­
age total operating and anesthetic time 
was 238 minutes (range from 171 to 255 
minutes) (Table III). These results are in 
the same range as those for aortic recon­
struction without cholecystectomy at our 
hospitals.
One patient became jaundiced for no 
apparent reason and the jaundice resolved 
spontaneously. Another patient had to be 
operated on again to control hemorrhage 
from the gallbladder bed. There were no 
abnormal liver function test results and 
no pancreatitis, duct injury or residual 
stones. Other than the one patient who 
had excessive bleeding from the gallblad­
der bed, none of these postoperative com­
plications was related to the cholecystec­
tomy. Other postoperative complications 
included 3 superficial wound infections, 
2 cases of renal failure, 4 respiratory 
problems (atelectasis and pneumonia), 14 
cardiac events, 6 cases of hypotension, 1 
trash foot and 1 groin lymph leak (Table 
IV).
The average postoperative stay was 18 
days — 11 days for asymptomatic 
aneurysm repair but 24 days for ruptured 
aneurysm, 9 days for those who had an 
aortofemoral bypass for claudication and 
17 days for limb salvage. Three patients 
died early postoperatively (within 30 days 
of surgery) from complications of coro­
nary artery disease. The results of late 
follow-up are listed in Table V. More 
than 30 days after surgery, three patients 
died of myocardial infarction, one of a 
cerebrovascular accident and one of com­
plications that developed after the total 
occlusion of his aortobifemoral bypass 
graft at 10 years. One patient died 3 
months after surgery, of gangrenous 
bowel.
In this series there was one graft infec­
tion, which probably resulted from con­
tamination at the time of surgery for 
repair o f a false femoral aneurysm, 15
T a b le  I I — In t r a o p e r a t iv e  C o m p lic a t io n s
G ro u p H y p o te n s io n
C a r d ia c
e v e n t
B ile
le a k
L iver
in ju ry
A b d o m in a l a o r t ic  a n e u ry s m
A s y m p t o m a t ic 3 0 0 i
S y m p t o m a t ic 3 3 0 0
R u p tu re d 3 0 1 0
A o r t o f e m o r a l  b y p a s s  g r a f t in g
C la u d ic a t io n 1 0 2 u
L im b  s a lv a g e 1 0 0 0
T o t a ls 1 1 3 3 1
T a b le  I I I — B lo o d  Loss a n d  O p e r a t in g  T im e
G ro u p B lo o d  loss, u n i ts  ( 3 0 0  m l) O p e r a t in g  t im e , m in
A b d o m in a l a o r t ic  a n e u ry s m
A s y m p to m a t ic 6 . 9 2 1 0
S y m p to m a t ic 6 . 1 4 2 4 2
R u p tu re d 1 0 . 2 5 1 7 1
A o r t o f e m o r a l  b y p a s s  g ra f t in g
C la u d ic a t io n 4 . 9 3 2 3 0
L im b  s a lv a g e 4 . 3 3 2 5 5
A v e r a g e s 6 .1 2 3 8
T a b le  IV - P o s t o p e r a t iv e  C o m p lic a t io n s
G ro u p H y p o te n s io n
C a r d ia c
e v e n t
In fe c te d
w o u n d J a u n d ic e
H e m o r r h a g e  
f r o m  liv e r  
b e d
A b d o m in a l a o r t ic  a n e u ry s m
A s y m p to m a t ic 1 0 0 0 1
S y m p to m a t ic 2 6 1 1 0
R u p tu re d 2 3 0 0 0
A o r to fe m o r a l b y p a s s  g r a f t in g
C la u d ic a t io n 0 4 1 0 0
L im b  s a lv a g e 1 1 1 0 0
T o t a ls 6 1 4 3 1 1
T a b le  V - L a t e  F o llo w  u p
G ro u p
G r a f t
in f e c t io n
F a ls e
a n e u r y s m A liv e
E a r ly
d e a th
D e a d  on  
f o l l o w u p
L o s t  t o  
f o l lo w - u p
A b d o m in a l a o r t ic  a n e u r y s m
A s y m p to m a t ic 0 0 1 9 0 0 2
S y m p to m a t ic 0 0 5 2 0 0
R u p tu re d 0 0 3 1 0 0
A o r t o f e m o r a l  b y p a s s  g r a f t in g
C la u d ic a t io n 1 1 1 3 0 2 0
L im b  s a lv a g e 0 0 7 0 1 1
T o ta ls 1 1 4 7 3 3 3
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months after the original aortobifemoral 
bypass graft procedure. The patient had 
a right femoral pseudoaneurysm that 
was repaired without evidence of sepsis, 
but 1 month later he presented with a 
right groin abscess, which improved with 
antibiotic therapy. Nine months later, an 
infected right femoral anastomotic false 
aneurysm was resected and a transobtu­
rator, left-to-right, crossover procedure 
was carried out. No specific cause for the 
infection was identified.
Discussion
Abdominal aortic aneurysm, aortoiliac 
disease and cholelithiasis are more com­
mon in the older patient.1-3 There is 
agreement that symptomatic gallstones 
require cholecystectomy. However, the 
surgical management of the asympto­
matic patient is controversial. In earlier 
studies,1-3 when the asymptomatic 
patient was followed up, symptoms deve­
loped in 20% to 45.5% of them.
The complications resulting from 
the development of acute calculous 
cholecystitis postoperatively are well 
recognized. Ottinger4 in 1976 noted a 
47% death rate in patients who under­
went surgery for acute cholecystitis as a 
postoperative complication. Three of 
these patients had aortic surgery. Ottinger 
discussed the possible mechanisms, which 
included bile stasis, inspissation of bile, 
obstruction to outflow of the biliary tract,
fasting, dehydration, fever and narcosis. 
Sixty percent of these cases were compli­
cated by gangrene of the gallbladder, per­
foration, empyema or cholangitis.
Small groups of patients in whom gall­
stones have been discovered at the time 
of aortic surgery and not removed have 
been reported. For 2.9 years Ouriel and 
colleagues5 followed up 11 patients 
whose abdominal aortic aneurysms were 
repaired without removal of incidental 
gallstones; 9 of them subsequently 
suffered acute cholecystitis. String6 fol­
lowed up 17 similar patients, 9 of whom 
had cholecystitis requiring cholecystec­
tomy, 2 had symptoms and 6 were asymp­
tomatic.
Our experience agrees with that of 
others,5-10 showing no increase in mor­
bidity or mortality attributable to 
cholecystectomy performed during aor­
tic reconstructive surgery.
Our blood loss and operating time were 
not changed substantially by the addition 
of cholecystectomy. The complications
that could be directly related to the 
cholecystectomy were minor — three bile 
leaks and a mild liver injury that had no 
long-term effects. The only major 
problem was a hemorrhage from a gall­
bladder bed that required reoperation for 
control. The length of hospital stay was 
not affected by the combined procedure 
and follow-up did not reveal further 
biliary tract problems such as common- 
duct stones or bile-duct stricture. The 
major fear of a graft infection in this 
group of patients appears unwarranted. 
The single graft infection was not related 
in any way to the performance of the 
cholecystectomy. In fact only one graft 
infection has been reported in a total of 
240 cases collected from the literature and 
added to our experience (Table VI5-10). 
This was reported by Ouriel and 
colleagues5 who pointed out that the 
cholecystectomy in this case was carried 
out before closure of the peritoneum over 
the graft. The incidence of acute calculous 
cholecystitis associated with aortic surgery
Tab le V I- A ortic  S u rg e ry  and C h o le cys te c to m y
Series C ases G ra ft in fection Death ra te , %
Ochsner and asso c ia te s , I9 6 0 9 51 0 5.8
Tompkins and a sso c ia te s , 19738 15 0 9 .0
Thomas and asso c ia te s , 1 9 8 3 7 3 9 0 9.0
B ick e rs ta ff and a sso c ia te s , 198410 4 5 0 3.7
Ouriel and a sso c ia te s , 1 9 8 3 s 18 1 5.5
String, 1 9 8 4 6 16 0 0.0
Present series , 198 6 56 0 5.3
4
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A Great Achievement
The patient successfully recovered and released 
For many patients with community-acquired intra-abdominal 
and gynecological infections MEF0X1N* can provide 
effective therapy.
For over seven years, MEF0X1N* has been earning the 
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to be regarded as a highly effective antibiotic.
srtlefoxiri
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most strains of enterococci, many strains of 
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staphylococci, and Listeria monocytogenes.
^Trademark
MFI-7-475-JA
is unknown, but when it occurs it can be 
lethal because of difficulty in making the 
diagnosis and subsequent delay in treat­
ment. As noted earlier,1-3 asymptomatic 
gallstones become symptomatic in 20% 
to 45.5% of cases, and if cholecystectomy 
is not done at the same time as the aortic 
surgery the patient may require a second 
operation.
Intraoperative complication rate, mor­
bidity and mortality and the risk of graft 
infection related to cholecystectomy are 
minimal. The combined operation does 
not increase cost with respect to hospital 
stay, and if a further operation is avoided 
then it is, in fact, cost effective. However, 
some guidelines must be followed. The 
surgeon should be familiar with biliary 
tract surgery, the aortic reconstruction 
has to be completed without complication 
and the peritoneum must be closed over 
the graft to exclude it from possible con­
tamination during the cholecystectomy. 
The cholecystectomy should be straight­
forward. If the common-duct exploration 
is required it is better to carry out the 
cholecystectomy later.
Conclusions
Cholecystectomy may safely be com­
bined with aortic grafting procedures 
without increasing patient risk. Chole­
cystectomy should be performed at the 
time of aortic surgery provided the vas­
cular surgery has been uncomplicated and
the cholecystectomy appears to be 
straightforward.
We thank Mrs. Linda Thompson for her 
secretarial assistance in the preparation of this 
manuscript.
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Miller, B. Bakirtzian, A. Hadjipavlou 
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Current Status of Transluminal Angioplasty
Although the published results of translu­
minal angioplasty have been satisfactory, 
its role in the practice of vascular sur­
gery has not been well documented.
Of 137 members of the Canadian Society 
for Vascular Surgery polled, 102 (74.5%) 
responded to a questionnaire drawn 
up to assess the current status of trans­
luminal angioplasty in Canada. Of 1343 
angioplasties reported, 64% were iliac, 
21% femoral, 12% renal and 3% of 
other arteries. Claudication was the indi­
cation in 80%, limb salvage in 20% . In 
15% angioplasty was used as an adjunct 
to subsequent arterial surgery. The lesion 
and results of treatment were assessed 
by clinical, noninvasive and pressure- 
gradient evaluation in most hospitals. 
Complications varied widely, reflecting 
the large number of physicians reporting. 
Most angioplasties were performed by 
vascular radiologists, and joint decision­
making by radiologist and surgeon was 
the most common approach. The use of 
angioplasty increased in hospitals carry­
ing out the most intensive evaluation, 
suggesting that it should have an 
expanded role.
Bien que les resultats publics de I'angio- 
plastie transluminale se soient averes 
satisfaisants, son rdle dans la pratique 
de la chirurgie vasculaire n'a pas 6t6 bien 
documents. Cent deux (74.5%) mem- 
bres de la Soci6t6 canadienne de chirur­
gie vasculaire ont repondu a un question­
naire 6tabli pour prOciser I'Otat de 
I'angioplastie transluminale au Canada.
Des 1343 cas d'angioplasties reports, 
64% Otaient iliaques, 21%  fOmoraux,
12% r6naux et 3% au niveau d'autres 
arteres. La claudication Otait Vindication
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dans 80% des cas et la recuperation du 
membre pour les autres 20% . Dans 15%  
des cas, I'angioplastie fut utilisee comme 
adjuvant de la chirurgie arterielle subsO- 
quente. La lesion et des resultats du trai- 
tement furent etablis par evaluation Clini­
que, non evasive, et utilisant un gradient 
de pression dans la plupart des h6pitaux. 
Les complications etaient trds variables, 
refietant le grand nombre de rapports 
medicaux. La plupart des angioplasties 
furent realisees par des radiologues vas- 
culaires, et la prise de decision conjointe 
par le radiologue et le chirurgien 6tait 
I'approche la plus commune. Le recours 
& I'angioplastie 6tait plus fr6qv'mt dans 
les hdpitaux ou revaluation et wM^^is 
complete, suggerant que celle- p  ^ ^ R it  
jouer un r&le accru. A
Transluminal dilatation was initiated by 
the late Charles Dotter1 in 1964 but has 
taken many years to achieve acceptance 
by the majority of physicians. However, 
with constantly improving technology, 
increased experience of well-trained vas­
cular radiologists and a better under­
standing of the pathophysiology of 
angioplasty, results have improved. There 
is the added influence of the rapidly 
expanding role of adjunctive drug ther­
apy, including heparin, antispasmodic, 
antiplatelet and fibrinolytic drugs. The 
explosion of interest in angioplasty 
resulted in the publication of 309 major 
articles in 1985: 168 on coronary arter­
ies, 30 on peripheral arteries, 30 on renal 
arteries, 50 on a wide variety of other 
arteries and 51 discussing the philosophy 
and pathophysiology of this procedure.
One of the main functions of the Cana­
dian Society for Vascular Surgery is to 
assess and improve the standards of treat­
ment of vascular disease. Most reports on 
transluminal angioplasty come from large 
centres with excellent results, where indi­
cations are fairly clear and the procedures 
are carried out and assessed by 
experienced clinicians with sophisticated 
equipment. However, its role in the treat­
ment of vascular disease throughout the 
world is more difficult to assess. A ques­
tionnaire (Fig. 1) was sent to most mem­
bers of the Canadian Society for Vascu­
lar Surgery early in 1986 in order to arrive 
at a considered opinion about the value 
of transluminal angioplasty in daily prac­
tice. Of 137 members polled, 102 (74.5%) 
responded; many questionnaires were 
completed with the involvement of the 
vascular radiologist, and a number of 
members took the opportunity to analyse 
their own results. The complete 
experience (1078 procedures) of 34 major 
hospitals in nine provinces was 
documented, ranging from 16 hospitals 
in Ontario to 1 in Prince Edward Island. 
Fourteen hospitals performed more than 
35 angioplasties, and in the others, the 
number of angioplasties varied from 3 to 
31 procedures. Another 265 procedures 
were reported by individual surgeons, in 
addition to the major hospital experience 
(Table I). The response has made this a 
comprehensive and informative review.
Eighteen hospitals stopped performing 
femoral angioplasties because of poor 
results, and some renal lesions were 
managed by radiologists and nephrolo­
gists with little input by the vascular sur­
geon, thus influencing the total numbers.
The 38 angioplasties of other arteries 
consisted of 15 distal popliteal, 6 aortic, 
2 brachial, 2 subclavian, 2 superior 
mesenteric artery, 1 tibial and 1 vein
Transluminal Angioplasty Review
I. Mow many transluminal angiop lasties were performed in t9*5 on your
(W 'len 's: _________  and In your hosp ital: _________
2'. Please l i s t  the approximate number of:
lil a c  _________  Femoral _________  Renal _________  Other _______
J. What percent of the number done were for
Claudication _________  Limb salvage _________
Adjunct to  associated reconstructive surgery _________
Pressure gradients a t time of angioplasty ________
b. Results overall fo r fomoral angioplasties have been
Excellent _________  S a tisfactory  _________  Fair
8. Complications have included l p lease l i s t  number)
Radiologist _________  Other _________
angioplasty are being made by:
*°u _________  Radiologist _________  Jo in tly  __________
11. How Important is  transluminal angioplasty In treatment of your 
pa tien ts :
Very Important _________  Important _________
12. Are you using transluminal angioplasty more now than you were a few
FIG. 1—Sample questionnaire on translu­
minal angioplasty.
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graft. In nine instances the involved artery 
was not stated.
The type of lesion treated was not 
requested in the review, so I have used the 
Toronto General Hospital experience 
(Johnston KW: Personal communication, 
1986) as an example of the current state 
of the art. In 1985, 129 peripheral 
angioplasties were performed at this 
hospital. Of these, 84 were iliac — 52 
common iliac (43 for stenosis, 9 for 
thrombosis), 26 external iliac (25 for ste­
nosis, 1 for thrombosis) and 6 combined 
common and external iliac (all for steno­
sis) — 34 were femoropopliteal — 2 com­
mon femoral, 1 deep femoral, 31 
femoropopliteal (25 for stenosis, 6 for 
thrombosis) — and the others included 
distal popliteal in 8, aorta in 2 and tibial 
in 1.
Indications for Angioplasty
Claudication was the commonest indi­
cation, 80% in most provinces, and limb 
salvage was the indication in 20%. The 
procedure was done as an adjunct to sub­
sequent arterial reconstruction in 50% in 
a few reports but averaged 15%.
The indications for percutaneous trans­
luminal coronary angioplasty were not 
included in the review but it should be 
stated that they have become more liberal 
(Keon WJ: Personal communication, 
1986) and include the following:
• Clinically important myocardial 
ischemia shown by limiting angina of 
effort and substantial ST-segment devia­
tion or transient thallium-201 defect with 
exercise.
• Discrete stenosis of more than 70% 
in an epicardial coronary artery (other 
than the left main stem) or major branch. 
Short total occlusions if present for less 
than 4 months.
• Acute disease in certain patients with 
unstable angina or early (less than 4 
hours), large, evolving, first transmural 
infarct.
In these cases, cardiologists are respon­
sible for clinical assessment, coronary 
angiography, hemodynamic evaluation 
and coronary angioplasty. This
The methods used to assess the lesion 
and the results of treatment have included 
clinical assessment, noninvasive studies 
and pressure gradients at the time of 
angioplasty. All three were used in 28 of 
the responding hospitals, clinical evalua­
tion and noninvasive studies were used in 
16, clinical evaluation and pressure gra­
dients in 6 and clinical evaluation alone 
in 4.
Pressure gradients of substantial degree 
must be present before angioplasty, and 
after3 should show a fall of at least 40 
mm Hg or be reduced to a gradient of less 
than 10 mm Hg.
One of the major problems in evaluat­
ing percutaneous transluminal angio­
plasty is the wide discrepancy in report­
ing methods in many large series and the 
lack of an organized approach, which 
m ust include careful clinical and 
hemodynamic evaluation and follow-up.
The recommended methods are those 
described by Johnston and colleagues4 
and in a less stringent fashion by O’Mara 
and colleagues5 as follows.
• Patient’s symptoms improved by at 
least one clinical grade.
• Ankle pressure index improved by 
more than 0.10.
• Monophasic Doppler waveform 
became biphasic or triphasic.
• Pulsatility index from femoral artery 
increased to greater than 5.0 or from the 
popliteal artery greater than 6.0.
• Treadmill walking time doubled or 
increased to 5 minutes.
• After exercise testing, the ankle sys­
tolic blood pressure did not fall.
This is a more demanding evaluation 
than usually used to assess the results of 
reconstructive arterial surgery.
Results
The replies from members of the Cana­
dian Society for Vascular Surgery indicate 
general satisfaction with the results of 
iliac angioplasty (28 excellent, 21 satisfac­
tory), less so with renal (5 excellent, 13 
satisfactory, 1 fair, 1 poor) and poor for 
femoral angioplasties (1 excellent, 19 
satisfactory, 11 fair, 4 poor). The differ­
ences in numbers between the three 
groups suggest that not all vascular sur­
geons may be involved with renal 
angioplasty, and a number of vascular 
surgeons may have stopped recommend­
ing femoral angioplasty because of poor 
personal results, indicating an even worse 
assessment if they were included in 
femoral artery evaluation.
Published reports of the results of per­
cutaneous transluminal angioplasty are 
often difficult to analyse because of 
differences in patient selection and evalu­
ation. As for other vascular surgery 
procedures, if only discrete lesions with 
good inflow and outflow, in otherwise
T a b le  l - C a n a d a  -  T ran s lu m in a l A n g io p lasty  1 9 8 5
P ro v in ce
N o . of 
p a tie n ts
N o . o f 
p ro ced u res Iliac
A rte ry , no. (% ) 
F em o ra l R enal O th er
O n ta rio 7 4 7 7 7 0 4 8 4  (6 3 ) 1 8 9  (2 5 ) 7 2  (9) 2 5  (3 )
Q ueb ec 2 2 3 2 2 3 1 4 9  (6 7 ) 3 4  (1 5 ) 3 1  (1 4) 9  (4 )
B ritis h  Colum bia 1 1 7 1 2 5 71 (5 7 ) 2 5  (2 0 ) 2 7  (2 2 ) 2  (2 )
A lb e rta 6 6 6 6 4 6  (7 0 ) 9  (1 4 ) 1 0  (1 5) 1 (1)
N o v a  S c o tia 4 3 4 3 3 5  (8 1 ) 7  (1 6 ) 0 1 (2)
N e w fo u n d la n d 3 6 3 6 2 2  (6 1 ) 4  (1 1 ) 1 0  (2 8 ) 0
N e w  B ru n sw ick 2 8 2 8 21  (7 5 ) 6  (2 1 ) 1 (4) 0
M a n ito b a 2 2 2 2 8 (3 6 ) 3  (1 4 ) 11 (5 0) 0
S a s k a tc h e w a n 2 0 2 0 1 0  (5 0 ) 7  (3 5 ) 3  (1 5 ) 0
P rin c e  E d w ard  Is lan d 1 0 1 0 1 0  (1 0 0 ) 0 0 0
T o ta ls 1 3 1 2 1 3 4 3 8 5 6  (6 4 ) 2 8 4  (2 1 ) 1 6 5  (1 2 ) 3 8  (3)
strengthens the management of these 
patients and avoids the division of respon­
sibility, a division that hinders optimal 
angioplasty in all other arteries. It may 
also explain the better-defined role of 
coronary angioplasty, which now replaces 
25% of coronary artery bypass grafts. 
Another major difference in the indica­
tion for treatment of coronary arteries by 
angioplasty as opposed to other arteries 
is the poor natural course of untreated 
angina, often the patient’s first cardiac 
symptom, and the good natural course of 
untreated claudication.
The indications for renal angioplasty 
are in patients with proven renovascular 
hypertension or failing renal function due 
to renal artery lesions. They include all 
cases of fibromuscular dysplasia, short- 
segment nonostial atherosclerotic lesions, 
restenosis after renal angioplasty and 
failed surgery.
The results in a cumulative review by 
Casarella2 of 916 patients showed as ini­
tial success rate of 77% to 94% and 
patency figures varying from 52% to 
93%. Many patients with renal lesions are 
referred to radiologists by nephrologists 
without vascular surgical consultation; 
this is not onri malmanagement. It is 
artery surgery is 
proved results of 
tfsluminal renal
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healthy patients, are selected, the results 
are better, but this approach does not 
provide optimal care of all patients. In 
Casarella’s review2 of 2142 iliac lesions, 
initial patency averaged 92% with 80% 
patency after 3 years. In a similar review 
of 2445 femoropopliteal lesions, 
Casarella2 reported an initial patency of 
76%, decreasing to 61% after 3 years. In 
the group who had angioplasty done for 
limb salvage,2 263 limbs were treated, of 
which 195 (74%) were saved and 68 
(26%) required amputation. Restenosis, 
requiring repeat angioplasty, occurred in 
28% resulting in a salvage rate of 67%, 
overall, at follow-up ranging from 1 to 
45 months. These are excellent results and 
challenge our operative results.
Complications
The complications reported varied 
greatly, probably reflecting the degree of 
follow-up and record keeping more than 
the actual clinical results, although some 
reports were detailed and excellent. There 
is often a lack of communication between 
the radiologist, referring doctor and vas­
cular surgeon, preventing detailed clini­
cal reporting. However, the figures do 
indicate that angioplasty is not a benign 
procedure, having caused a number of 
arterial thromboses, necessitated emer­
gency surgery and limb loss in five 
patients in 1985.
The complications are best assessed in 
a large cumulative review (Table II) such 
as that of Casarella,2 in which the 
reported death rate was 0.2% and other 
complications ranged in frequency from 
0.1% to 3.5%. These figures confirm 
that, in good hands, complications of 
angioplasty can be controlled and few 
patients are made worse despite failure of 
the procedure.
The complication rates vary depending 
on the site of the lesion, and in a cumula­
tive review of 453 angioplasties by
Gardiner and colleagues,6 3% to 5% 
were for iliofemoral procedures, 6% to 
15% for renal and 8% to 19% for 
popliteal-tibial angioplasties.
Control of Angioplasty
Questions were asked to determine who 
was performing angioplasties, who made 
the actual decision to do the procedure 
and the present importance of this proce­
dure to Canadian vascular surgeons.
Almost all angioplasties were done by 
radiologists with the exception of one 
centre in Quebec where half were done by 
surgeons.
The decision concerning the indication 
for angioplasty was made jointly in 39 
hospitals, by the surgeon alone in a fairly 
high number (13) and by the radiologist in 
2. Experience suggests that joint decision­
making is the ideal and a skilled vascular 
radiologist should provide optimal results 
if he is well trained and has a sufficient 
case load to maintain his skill.
Eleven hospitals considered angioplasty 
very important, 30 important, 8 less 
important and 1 not important; 31 are 
using it more and 17 are not. These 
figures confirm that there is still great 
continued interest in angioplasty by vas­
cular surgeons.
Impact of Angioplasty
What has been the impact of 
angioplasty on the practice of vascular 
surgery? Is it being used more, replacing 
traditional reconstructive surgery, or is it 
permitting treatment of a group of 
patients who previously would not have 
been considered candidates for major 
reconstruction?
An interesting study7 was done at the 
Plymouth General Hospital in Devon, 
England. Two groups of 100 referred 
patients with symptomatic peripheral 
arterial disease were compared, the first
in 1981 before angioplasty was available 
in the hospital and the second in 1984 
when it was. In 1981, 38 underwent arteri­
ography, 80 were treated conservatively 
and 20 had reconstructive surgery. In 
1984, 75 had arteriography, 53 were 
treated conservatively and the surgical 
number was relatively unchanged at 23, 
but 24 had angioplasty. This report sug­
gests that more frequent angiography rev­
ealed a new group of patients suitable for 
angioplasty and did not decrease the num­
ber of arterial operations. The conclusion 
was that this is better treatment than tell­
ing patients to walk more slowly. This 
reflects a philosophy that must be 
weighed against the risks of arteriography 
and angioplasty. However, it is probable 
that with outpatient angiography and 
experienced vascular radiologists, the 
indications for angioplasty might be broa­
dened to include patients who have clau­
dication interfering with life-style.
It is interesting to compare the num­
ber of angioplasties with the number of 
arterial reconstructions that might be 
treated by angioplasty. Ontario Hospital 
Insurance Plan billings for the 6 months 
April to September 1985 showed there 
were 1636 vascular procedures: 471 aor- 
toiliac, 64 iliofemoral, 76 isolated profun- 
daplasties, 190 extra-anatomic bypasses, 
684 femoropopliteal, 121 femorodistal 
and 30 renal. There were 621 translumi­
nal angioplasties for a ratio of 28% 
angioplasties to 72% reconstructive oper­
ations.
During the same period there were 2002 
coronary artery procedures — 1601 coro­
nary artery bypass grafting procedures 
(80%) and 401 percutaneous translumi­
nal coronary angioplasties (20%).
The relative incidence of angioplasties 
and reconstructive surgery performed for 
similar lesions in 1985 showed 63% 
arterial operations and 37% angioplasties 
at the Toronto General Hospital (John­
ston KW: Personal communication, 
1986), 69% arterial reconstructive oper­
ations and 31% angioplasties at The 
Montreal General Hospital (Blundell PE: 
Personal communication, 1986), at the 
University of Ottawa 76% surgery and 
24% angioplasties, at The Wellesley 
Hospital, Toronto, 78% surgery and 22% 
angioplasties (Ameli FM: Personal com­
munication, 1986), at The Moncton 
Hospital 84% surgery and 16% angio­
plasties (Murphy FG: Personal commu­
nication, 1986) and at the Hopital du 
Saint-Sacrement in Quebec City 98% sur­
gery and 2% angioplasties (Douville Y: 
Personal communication, 1986). For 6 
months in Ontario there were 72% 
arterial reconstructive operations and 
28% angioplasties. It is important to note 
that the highest percentages of angio­
plasties were in the Toronto General 
Hospital and The Montreal General 
Hospital, both of which have been most
T a b le  I I— C o m p lic a t io n s  o f  P e r c u t a n e o u s  T r a n s lu m in a l  A n g io p la s t y  —  
C u m u la t iv e  R e v i e w  (3 2 0 4  P a t ie n t s ) .*  A d a p te d  F r o m  C a s a r e lla 2
C o m p lic a tio n P a t ie n t s P e rc e n t
D e a t h 8 0 .2
M y o c a r d ia l  in f a r c t io n 6
C e r e b r o v a s c u la r  a c c id e n t 2
L im b  lo s s 6 0 .2
A r t e r io v e n o u s  f is t u la 4 0.1
H e m a to m a 1 0 8 3 .4
F a ls e  a n e u ry s m 17 0 .5
T h r o m b o s is 111 3 .5
In tim a l f la p 10 0 .3
D is ta l e m b o lis m 81 2 .5
A b d o m in a l b le e d in g 5 0 .2
A r t e r ia l  ru p t u re 9 0 .3
S u b in tim a l in ju r y 15 0 .5
O t h e r  (a c u te  t u b u la r  n e c r o s is , 3 0.1
s e p s is ,  b ra c h ia l p le x u s )
T o t a l 3 7 8 1 1 .8
‘ S u r g e r y  w a s  re q u ire d  f o r  c o m p lic a t io n  in 6 7  (2 .0 % ) p a t ie n t s .
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active in assessing the indications for and 
results of this procedure. This suggests 
that the use o f angioplasty increased with 
more intensive evaluation, and that it 
probably should have an expanded role 
in Canada. In discussing the increased 
role o f angioplasty in any hospital, it must 
be remembered that an experienced vas­
cular radiologist and modern facilities are 
vital to achieve optimal results and that 
each institution should be able to report 
its own experience and not rely on other 
figures.
There is a definite learning curve for 
angioplasty. Martin and colleagues8 
compared the results o f renal angioplasty 
between the first 100 and second 100 
patients, showing an increased primary 
success rate o f 97%, a decrease of total 
complications to 13%, a decrease in com­
plications requiring surgery to 2% and of 
renal failure to 5%.
A similar learning curve has been 
reported by the University of Ottawa 
Heart Institute (Keon WJ: Personal com­
munication, 1986) with the number of 
coronary angioplasties increasing each 
year from 29 in 1981 to 289 in 1985, and 
the success rate improving rapidly from 
59% in 1981 to 89% in 1985, reflecting 
better case selection and experience as 
well as improving technology.
Summary and Conclusions
This was a productive audit, reflecting 
the opinion of 74.5% o f our members 
and the assessment of 1343 angioplasties, 
a majority o f the angioplasties performed 
in Canada in 1985. Iliac lesions were 
treated in 64% of patients, with 28 of the 
questionnaire replies indicating excellent 
results and 21 satisfactory results. 
Femoral lesions were treated in 21% with 
1 excellent, 19 satisfactory, 11 fair and 4 
poor assessments. Eighteen hospitals have 
stopped performing femoral angioplasty 
because o f poor results and thus are not 
included in this group but reflect loss of 
confidence in femoral angioplasty. Renal 
lesions were treated in 12% with 5 excel­
lent, 13 satisfactory, 1 fair and 1 poor 
assessments, but this excludes a fair num­
ber of procedures performed without the 
involvement of vascular surgeons. Com­
plications and results were acceptable but 
require more detailed assessment and 
follow-up by the involved vascular sur­
geon and possibly should be added to our 
society audit. Most members are satisfied 
with the present role of angioplasty; they 
are using it mainly for claudication and 
less so for limb salvage. Angioplasty was 
used as an adjunct to other vascular sur­
gery in 15% of patients. Most decisions 
concerning angioplasty are being made 
jointly which should provide optimal 
results. An experienced vascular radiol­
ogist with sophisticated equipment is vital 
in all hospitals planning angioplasty and
should perform at least 35 procedures a 
year to maintain proficiency. With 
experience and improving technology, 
including laser therapy, angioplasty will 
become even more important in the care 
of patients and the members of our soci­
ety should direct this expansion and 
report their results.
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Long-Term Indwelling Silicone Catheters: 
a Simple, Safe Method for Venous Access
The increasing long-term use of 
intravenous chemotherapy has resulted 
in problems of venous access for a num­
ber of reasons, one being the sclerosing 
action of the drugs used. Silastic 
catheters were introduced to ameliorate 
this problem, initially with some caution 
because of potential complications and 
the lack of necessary equipment. The 
purpose of this paper was to show that 
the procedure is simple, effective and 
associated with few complications.
Ninety-six patients (32 men, 64 
women) with lymphoma (25), leukemia 
(28), metastatic breast cancer (28) or 
other malignant lesions (15) were 
referred for insertion of a Silastic perma­
nent indwelling catheter into the superior 
vena cava. The catheter was inserted 
through a subclavian vein using a Cordis 
Vein Dilator Kit, itself introduced over a 
guide wire inserted initially under 
fluoroscopic control.
Local sepsis at the insertion site 
occurred in 6 of the first 43 patients 
treated but in none of the remainder. Six 
catheters became thrombosed and 
required revision. There were no 
instances of bleeding, air embolism or 
pulmonary complications.
Patient acceptance of this method 
of venous access was high compared
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with that for peripheral, repeated 
venepuncture.
L'utilisation de plus en plus frSquente de 
la chimioth£rapie intraveineuse a long 
terme a amene des problemes d'acces 
veineux, et ceci pour plusieurs raisons, 
dont Faction sclerosante du medicament 
utilise. Les catheters de Silastic apparu- 
rent dans le but d'ameliorer cette situa­
tion; au debut leur usage 6tait entoure 
de precautions a cause des complica­
tions possibles et du manque d'equipe- 
ment necessaire. L'objectif de cet article 
est de montrer que cette procedure est 
simple, efficace et relive a un faible taux 
de complications.
Quatre-vingt-seize patients (32 hom- 
mes, 64 femmes) souffrant de lymphome 
(25), de Ieuc6mie (28), de cancer du sein 
avec metastases (28) ou d'autres lesions 
malignes (15) ont 6te regues pour inser­
tion d'un catheter de Silastic pos6 a 
demeure dans la veine cave superieure.
Le catheter a ete introduit via une veine 
sous-clavi&re a I'aide d'un dispositif de 
dilatation veineuse Cordis lequel fu t lui- 
meme introduit le long d'un fil introduit 
sous controle visuel fluoroscopique.
Une infection locale au point d'inser- 
tion est survenue chez 6 des 43 pre­
miers patients tra ils  mais chez aucun 
des suivants. Six catheters se sont 
thromboses et ont necessity une revi­
sion. II n'y a eu ni hemorragie, ni embo- 
lie gazeuse ou complication pulmonaire.
Le niveau d'acceptation de cette 
methode d'acces veineux par les patients 
a ete elev6 comparativement aux injec­
tions r6p6t6es dans les veines p6riph6- 
riques.
Advances in the use o f chemotherapeu­
tic drugs, either singly or in combination, 
for treating cancer have resulted in their
use for longer periods and with increas­
ing frequency. Since the majority o f such 
drugs are given intravenously, problems 
have arisen because o f  the sclerosing 
action they have on peripheral veins; 
readily available peripheral venous access 
sites are rapidly exhausted and cancer 
patients undergoing aggressive chemo­
therapy must suffer undue pain and anxi­
ety while less accessible sites are sought 
to continue treatments. Their misery is 
further compounded by the need for fre­
quent blood samples obtained by peri­
pheral venepuncture.
Fortunately, these problems can now 
be mostly circumvented by the use o f a 
long-term venous indwelling silicone rub­
ber catheter. The purpose o f this report 
is to show that the procedure is simple 
and safe and causes minimal complica­
tions.
Evolution of Silicone Catheter 
for Venous Access
The need for a suitable means o f  long­
term venous access was first appreciated 
by Scribner and associates1 in their 
search for alternative methods o f venous 
access in patients who required long-term 
infusions o f parenteral nutrients for 
chronic disabling intestinal diseases. 
Before they designed a silicone rubber 
catheter for this use,2 the method o f 
choice was a surgically created arteri­
ovenous shunt. Unfortunately, the shunts 
were usually unsuitable for long-term use 
because o f  their propensity to thrombose 
and cause phlebitis. They explored, there­
fore, the possibility o f using catheters in 
large central veins as a means o f  access. 
A t that time, the use o f central veins for 
the placement o f intracardiac pacemakers 
had been quite successful.
A fter the 1973 report by Broviac and 
associates3 o f  the use o f a silicone rubber 
catheter in 18 patients, others reported the
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use and results of this method for the care 
of patients requiring total parenteral 
nutrition for prolonged periods (Table 
I3"10). In 1979, Hickman and associates4 
reported the use of this method in 75 
patients who required bone-marrow 
transplantation for the treatment of 
hematologic malignant disease. Their 
modification of the catheter used by 
Broviac and associates3 had a larger 
internal diameter in order to accept the 
more viscous infusate and to permit the 
repeated withdrawal of blood samples. 
There followed several reports support­
ing the use of a silicone catheter both for 
the delivery of total parenteral nutri­
tion5-7 and chemotherapeutic drugs.8-10 
However, the long-term use of these 
catheters was not without complication — 
the presence of a foreign body fostered 
sepsis both at the exit site on the skin sur­
face and systemically as septicemia. This 
was not unexpected, since the patients 
being treated were susceptible by the 
nature of their diseases and the immu- 
noinhibitory effects of chemotherapy. 
Other complications were mechanical dis- 
lodgement and blockage, usually due to 
thrombus formation. The major compli­
cations of air embolism, thromboem­
bolism and pneumothorax were rare. 
Since further modification of the 
catheter, whereby the skin exit site is 
eliminated by using a portal with a sili­
cone diaphram attached to the catheter, 
many of the septic complications previ­
ously reported are now uncommon. The 
portal and attached catheter are perma­
nently buried subcutaneously after venous 
access has been achieved. Thereafter, 
medications are given and blood samples 
withdrawn transcutaneously by a needle 
attached either to a syringe or to intra­
venous tubing inserted into the silicone 
diaphram.
Patients and Methods
Ninety-six patients (64 women, 32 men) 
with leukemia (28), lymphoma (25), 
metastatic breast cancer (28), other malig­
nant disease (13) or osteomyelitis (2) were 
referred to the Surgical Service of Mount 
Sinai Hospital in Toronto between April 
1983 and April 1986 for the insertion of 
a long-term indwelling silicone rubber 
catheter into the superior vena cava 
(Table II). The catheter initially used was 
that modified by Hickman and associates. 
It is a barium impregnated silicone rub­
ber catheter with an internal diameter of 
1.6 mm, the proximal end moulded to 
accept a male luer-lock adapter and with 
a Dacron cuff encasing the catheter in its 
middle portion. The Dacron cuff is meant 
to be located in the subcutaneous tunnel 
near the catheter exit site. Its purpose is 
to create a barrier to infection migrating 
along the catheter and, by its incorpora­
tion in the healing fibrous tissue, to act 
as an anchor for the catheter (Fig. 1). 
Later, however, a newer catheter (Port- 
A-Cath; Pharmacia [Canada] Inc., Dor- 
val, PQ) was introduced and is now our 
catheter of choice. It is similar to that 
already described but the proximal end is 
connected to a stainless steel portal fit­
ted with a silicone diaphragm (Fig. 2).
The technique for inserting the catheter 
has been described elsewhere.11,12 All 
catheters were inserted in the operating 
room. Initially, the Hickman catheter was 
inserted into the cephalic vein, near its 
junction with the subclavian vein, and 
threaded into the superior vena cava (Fig.
1). This technique was difficult because 
of the disparity between the lumen of the 
cephalic vein and the outer diameter of 
the catheter. It was soon abandoned in 
favour of a more direct access using a per­
cutaneous approach directly into the sub­
clavian vein. This was accomplished by 
a modification of the Seldinger tech­
nique,13 using a permanent transvenous 
pacemaker lead-introducer kit (Cordis 
Kit; Cordis Corp., Miami, Fla.), the 
details of which have been described 
previously.14
Table 11-Diagnoses of 96 Patients Referred 
for Insertion of Silicone Catheters
Diagnosis No. of patients
Leukemia 28
Lymphoma 18
Hodgkin's disease 
Cancer of
7
Breast 28
Colon 2
Pancreas 1
Stomach 1
Urinary bladder 1
Ovary 1
Liposarcoma 1
Leiomyosarcoma 1
Ewing’s sarcoma 2
Other sarcomas 2
Myeloma 1
Osteomyelitis 2
FIG. 1—Position of Hickman catheter 
showing skin exit site and position of Dacron 
cuff.
FIG. 2—Stainless steel portal of Port-A- 
Cath system shown at bottom of illustration 
with metal tube extension for attachment to 
catheter.
Table 1— Evolution of Use of Silicone Rubber Catheter for Long-Term 
Venous Access After Its Design in 1970 by Atkins and Associates2
Year Author No. of patients Use
1973 Broviac and associates3 18 TPN
1976 Jeejeebhoy and associates5 12 Home TPN
1976 Riella and Scribner6 43 Home TPN
1979 Hickman and associates4 75 Bone-marrow transplantation
1980 Miller and associates7 94 Gastrointestinal malabsorption diseases
1980 Blacklock and associates8 25 Hematologic malignant disease
1980 Thomas and associates9 84 Prolonged chemotherapy and TPN
1981 Wade and associates10 74 Acute leukemia (47 silicone catheter, 
27 arteriovenous shunt)
TPN = total parenteral nutrition.
Table Ill-T y p e  of Catheter and Route of Access
Period Type Route No.
1983 -  1984 Hickman Subclavian vein 17 (12 L, 5 R)
Port-A-Cath Subclavian vein 2 (R)
1984 -  1986 Hickman Subclavian vein 1 (L)
Port-A-Cath Subclavian vein 72 (59 L, 13 R)
Portal vein 1
Jugular vein 2 (1 L, 1 R)
Mesenteric artery 1
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Fifty patients had induction therapy 
through the catheter as inpatients and 46 
had outpatient chemotherapy at weekly 
to monthly intervals. Of the 50 inpatients, 
22 had acute leukemia that required, in 
most instances, urgent or emergent inter­
vention; the other 28 patients had lym­
phoma. Of the 46 treated as outpatients, 
27 had metastatic breast cancer, 8 had 
various types of sarcoma and 11 had 
metastatic carcinoma of the colon, pan­
creas, liver, ovary, stomach or urinary 
bladder.
To prevent thrombosis in the catheter, 
it was flushed with a heparin-in-saline 
solution at least every 2 weeks. This was 
mandatory after chemotherapy or after 
the injection of contrast material during 
a radiologic examination. Outpatients 
were instructed to return to the Oncology 
Clinic every 2 weeks for the nurse to flush 
the catheter. These were mostly patients 
receiving chemotherapy on a monthly 
basis; others — the majority — had their 
catheters flushed at the time of the 
chemotherapy treatments.
The patients were cared for in general 
wards and clinics. Most patients with 
leukemia or lymphoma were admitted to 
a particular ward staffed by hematologists 
or medical oncologists.
Results and Discussion
The type of catheter used and the 
routes of circulatory access are shown in 
Table III. The first three catheters used 
in 1983 were inserted into a cephalic vein; 
they were the Hickman type. Of the 
remainder, 89 were inserted percutane- 
ously directly into a subclavian vein, using 
the transvenous pacemaker lead-intro­
ducer kit. In two instances, the catheter 
had to be inserted into a jugular vein 
because the subclavian veins were inac­
cessible. In two patients a catheter was 
used for circulatory access directly into 
the liver for the treatment of metastases 
in that organ — into the portal vein for 
venous access in one and into the hepatic 
artery through the gastroduodenal artery 
in the other. The preferred route was into 
the left subclavian vein. The gentle curve 
made by the junctions of the subclavian 
and innominate veins with the superior 
vena cava in most patients seemed to
facilitate the passage of the flexible guide 
wire. It is crucial that the position of the 
guide wire be determined accurately using 
an image intensifier before inserting the 
catheter. The flexible tip of the wire is 
capable of wandering unexpectedly into 
tributary branches and even up the jugu­
lar veins!
The Port-A-Cath is preferred over the 
Hickman catheter because of the absence 
of an exit skin site. As Table III shows, 
the Port-A-Cath became our catheter of 
choice soon after its introduction in 1984.
The most frequent complications in our 
series are compared with those of others 
in Table IV. Our series is the only in the 
table that used the Port-A-Cath. The fact 
that there is no skin exit site in that sys­
tem may account for the marked differ­
ences in the rate of septicemia and exit 
infections. Exit infections associated with 
the use of the Hickman catheter refer to 
sepsis within the subcutaneous tunnel in 
contrast to a cellulitis of the skin overly­
ing the portal in the other system (Table 
V).
A partial slough of skin over the sub­
cutaneously placed portal occurred in two 
patients. This complication was obviously 
not found in patients having Hickman 
catheters. Undue skin tension was the 
cause in one man and the use of a curved 
flap of skin to cover the portal the cause 
in the other. In one patient, the skin 
slough was minimal and healing occurred 
spontaneously, but in the other, skin heal­
ing did not take place until the catheter 
was removed.
One probable explanation for the lower 
rate of sepsis in our series is related to a 
change in the referral pattern. Initially, 
the Surgical Service was asked to insert 
catheters only when other methods of 
venous access had failed. This usually 
occurred when the patients were receiv­
ing therapy and when they were leuko­
penic, thrombopenic and susceptible to 
sepsis. As the fear of major complications 
diminished, physicians tended to refer 
patients with exacerbation of their disease 
but before further therapy.
The overall infection rate was lower 
with the portal catheter system than with 
the Hickman catheters (Tables III and 
IV).
The incidence of blocked catheters 
appears to be directly related to the posi­
tion of the catheter tip and the instilla­
tion of heparinized saline into the catheter 
(and portal) when it is not in use. In our 
series, the tip of all catheters was posi­
tioned in the superior vena cava, above 
the right auricle of the heart, under direct 
vision using an image intensifier. Post­
procedure x-ray films of the five blocked 
catheters in our series (all o f the Port-A- 
Cath system) revealed that the catheters 
had slipped into the innominate vein, a 
location with a higher incidence of 
catheter thrombosis due to slower blood 
flow. This is an important point that 
should be emphasized. The initial obser­
vation that the tip of the catheter should 
preferably be in the superior vena cava 
was made in connection with total paren­
teral nutrition.5 A 50% concentration of 
glucose in the alimentation solution is 
highly sclerotic to peripheral veins and 
will cause spontaneous venous thrombo­
sis. This is the rationale for placing the 
catheter in the superior vena cava where 
the size of the vein, the reasonably rapid 
flow of blood and the constant movement 
of the mediastinum together help to pre­
vent thrombosis at the catheter tip. Move­
ment is beneficial as it prevents the tip of 
the catheter from resting at one point on 
the wall of the vein. The same principle 
applies in the administration of chemo­
therapeutic agents. They are highly irritat-
Table V-Comparison of Complications With Use of Hickman 
and Port-A-Cath Systems
Period Type
No. of 
patients Exit sepsis Blocked
1983 -  1984 Hickman 16 2 0
Port-A-Cath 26 4 3
1985 -  1986 Hickman 1 0 0
Port-A-Cath 53 0 2
♦<
-
Table IV--Complications by Author Series
Series
Duration
of
study
No. of 
patients
Septicemia,
%
Exit
infection,
%
Blockage,
%
Dislodgement,
%
Sloughing,
%
** Present series 1983-86 96 1 6 6 2 2
Blalock and associates8 1980 25 44 56 24 4 0
4 Hickman and associates4 1979 75 28 ? 9 ? 0
Thomas and associates9 1977-79 84 9 ? 8 2 0
Miller and associates7 1970-78 94 24 18 17 ? 0
Jeejeebhoy and associates5 1971-76 12 33 ? 8 33 0
Riella and Scribner6 1970-76 43 15 4 30 ? 0
Broviac and associates3 1973 18 22 ? ? ? 0
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ing, thrombogenic substances. Therefore, 
it was not unexpected that catheters 
placed or migrating into the innominate 
vein could become blocked.
It is recommended that the catheters 
not be transfixed with a suture to main­
tain their position. This is because silicone 
is brittle and easily fractured by a suture. 
This may explain why no blockage oc­
curred in the Hickman catheters where a 
Dacron cuff serves to anchor the catheter 
in position. Two Hickman catheters 
became dislodged as a result of becom­
ing caught by clothing or bed clothes. 
Fortunately, the long subcutaneous tun­
nel between the exit site and the entrance 
to the vein prevents any serious conse­
quence and none occurred in our series. 
Obviously, no similar accidents occurred 
in patients with the Port-A-Cath.
The average duration of use was 7.2 
months (range from 19 days to 23 
months). One unusual complication 
related to a catheter left in situ for 23 
months deserves further description. The 
patient had a Port-A-Cath inserted into 
the left subclavian vein on Nov. 14, 1983. 
It functioned well until Oct. 10, 1985 
when he complained of vague chest pain. 
An x-ray film revealed that the distal 3
cm of catheter still located within the 
superior vena cava had separated and lay 
within the right auricle. It was successfully 
removed surgically with a favourable out­
come. This is the only instance of spon­
taneous fracture of a silicone catheter that 
we are aware of.
Conclusions
In contrast to earlier reports using a sili­
cone catheter for long-term venous 
access, our results suggest that the use of 
a total subcutaneous system without any 
exit skin site minimizes the complications 
of sepsis and dislodgement of the 
catheter. Furthermore, our series sup­
ports the findings of others that major 
complications, such as air embolism, 
thromboembolism, pneumothorax or 
hemorrhage, are extremely rare. Finally, 
both patient and physician compliance are 
high, particularly when intravenous 
chemotherapy for metastatic disease is 
required over a long period.
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SESAP V  Critique
ITEM 210
Malignant hyperthermia should be suspected because of unexplained tachycardia, tachypnea, or arrhythmia, or because 
of muscle spasm (particularly involving the masseter muscles), and because of the unusual heat production in the carbon 
dioxide cannister as well. Unstable blood pressure and flushing or cyanosis of the skin are other possible symptoms. The 
carbon dioxide cannister may be blue in color.
Malignant hyperthermia is a potentially lethal autosomal dominant syndrome and should be suspected among family 
members of patients who have had hyperthermic crises. Musculoskeletal abnormalities may be obvious, but most suscept­
ible patients appear normal. Myopathy may be detected by specific tests such as elevated CPK levels, but many have nor­
mal CPK levels. Fifty percent have had prior uncomplicated operations. In vitro tests using the response of muscle to 
caffeine or halothane stimulation are currently under development.
The syndrome is most commonly associated with general anesthetics that use muscle relaxants as well as halogenated 
compounds. Prompt recognition is critical for preventing a lethal outcome. The anesthetic agent should be stopped and 
the rubber anesthetic tubing changed, because of the problem of lipid soluble agents. Hyperventilation with 100% oxygen 
and vigorous cooling are important ancillary measures. Dantrolene, the only known specific therapeutic drug, must be 
given while muscle perfusion is still adequate, and should be available in all operating rooms. Potassium would be con­
traindicated because of hyperkalemia associated with the hypermetabolic state.
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Acute Gastrointestinal Manifestations 
of Systemic Lupus Erythematosus
Systemic lupus erythematosus is a com­
mon multisystem disorder of young 
women, and gastrointestinal symptoms 
are a frequent clinical manifestation. 
There is serious danger that appropriate 
therapy may be delayed in the patient 
with an acute abdomen when systemic 
oruthamntnfius is not considered as 
a cause.
This paper describes four patients with 
acute abdomen as a manifestation of 
systemic lupus erythematosus. They 
responded dramatically and without com­
plication to steroid therapy. The symp­
toms recurred in one patient but responded 
to plasmapheresis and intravenous 
administration of cyclophosphamide.
The other gastrointestinal manifesta­
tions of systemic lupus erythematosus 
and their pathogenesis are discussed.
Management requires consideration of 
systemic lupus erythematosus as the 
cause of acute abdomen, paracentesis 
for culture and treatment with high 
doses of steroids with or without broad- 
spectrum antibiotics. If there is no nota­
ble improvement within 24 hours, 
laparotomy should be performed.
Le lupus 6ryth6mateux diss6min6 est une 
affection polysyst6mique que I'on 
retrouve souvent chez la femme jeune. 
Les symptdmes gastro-intestinaux en 
sont une manifestation clinique fr6- 
quente. Quand une patiente pr6sente un 
ventre aigu, il existe un risque s6rieux 
que la mise en aBuvre du traitement 
approprie soit retard^ si le lupus 6ryth6- 
mateux diss6min6 n'est pas consid6r6 
comme pouvant en 8tre la cause.
Cet article d6crit les cas de quatre 
malades dont le lupus 6ryth6mateux dis- 
s6min6 s'est manifesto sous la forme 
d'un abdomen aigu. ils r6pondirent de 
fagon spectaculaire et sans complication 
k un traitement st6roidien. II y eut r6ci- 
dive des symptdmes chez un maiade.
From the *Department o f  Medicine and 
tDivision o f Rheumatology, Ottawa Civic 
Hospital, Ottawa, Ont.
Accepted fo r  publication Nov. 18, 1986
Reprint requests to: Dr. Gunnar Kraag, 
Chief, Division o f  Rheumatology, Ottawa 
Civic Hospital, 1053 Carting Ave., Ottawa, 
Ont. K 1Y4E9
mais ceux-ci cdddrent k la plasmaphdr&se 
et k I'administration intraveineuse de 
cyclophosphamide.
On commente les autres manifesta­
tions gastro-intestinales du lupus 6ryth- 
mdmateux dissdmind, de meme que leur 
pathogdndse.
La conduite k suivre devant un ventre 
myu ■ invoiKiiiu tjw —■. v.sage le lupus 6ry- 
thdmateux dissdmind comme pouvant en 
Stre la cause, que I'on procdde 6 une 
paracentdse pour fin de culture, et que 
I'on traite avec steroides k forte dose, 
avec ou sans les antibiotiques k large 
spectre. En I'absence d'une amelioration 
marquee dans les 24 heures, une laparo- 
tomie doit §tre pratiquee.
Systemic lupus erythematosus is a connec­
tive tissue disease of unknown cause 
involving many organ systems. The re­
ported incidence is 7.6 cases per 100 000 
and the prevalence is 1 in 2400.1 If one 
considers women between 15 and 64 years 
of age, the prevalence is 1 in 700.1 The 
clinical manifestations are remarkably 
diverse; they include fever, rash, poly­
arthritis, pleuritis, pericarditis, anemia, 
thrombocytopenia, and renal, neurologic 
and cardiac abnormalities (Table I2). 
Abdominal symptoms occur in about
Table I— Clinical Manifestations of 
Systemic Lupus Erythematosus*
Manifestation Incidence, % 2
Malar rash 40 -  65
Discoid rash 17 -  30
Photosensitivity 17 -  40
Oral ulcers 15 -  35
Arthritis 85 -  100
Serositis (pleuritis/pericarditis) 60
Renal disorder (proteinuria/casts) 40 -  70
Neurologic disorder (seizures!
psychosis) 15 -  20
Hematologic disorder (hemolysis!
leukopenia/thrombocytopenia) 50 -  75
Immunologic disorder (positive
lupus enteritis prep/anti-DNA
anti-DNA antibody/anti-Smith,
false-positive VDRL test) 30 -  70
Antinuclear antibody 95 -  100
*1982 Revised criteria classification of systemic 
lupus erythematosus (adapted from Rodnan GP, 
Schumacker HR (eds): Primer on Rheumatic 
Disease, 8th ed, Arthritis Foundation, Atlanta, 
1983, appendix 6).
one-third of patients at some point in 
their illness.3-5 Such patients frequently 
present to various subspecialties o f inter­
nal medicine but may also be seen first 
by a surgeon or an emergency physician 
because of an acute abdomen. In this set­
ting, systemic lupus erythematosus is fre­
quently not considered in the differential 
diagnosis.
We report four patients with severe 
abdominal pain in whom systemic lupus 
erythematosus was the underlying cause 
and we discuss the gastrointestinal 
manifestations and the management of 
the acute abdomen in this condition.
Case Reports
Case 1
A 22-year-old white woman, gravida 1, para 
0, was admitted at 28 weeks’ gestation with pre­
eclampsia. Because obstetrical ultrasonography 
showed intrauterine growth retardation, a 
cesarean section was scheduled. Three days 
postoperatively the patient complained of 
pleuritic left-sided chest pain. Five days after 
the cesarean section she became febrile with 
malaise and body temperatures reaching 
39.5°C for 5 days. On postoperative day 6 the 
following antibiotics were started: ampicillin 
500 mg orally every 8 hours and Flagyl 250 mg 
orally four times daily, gentamicin 80 mg intra­
venously every 8 hours and clindamycin 600 
mg intravenously every 6 hours. Two days later 
generalized abdominal pain developed with 
persisting fever. There was no history of 
nausea, vomiting or diarrhea. Numerous blood 
cultures were negative. A dilatation and curet­
tage and culdocentesis were performed 12 days 
postoperatively.
Further investigation revealed that she had 
had migratory polyarthralgias for 6 years. A 
positive antinuclear antibody test in a titre of 
1/160 and a documented false-positive VDRL 
test had been noted on a previous admission 
but a diagnosis of systemic lupus erythemato­
sus had not been made.
She remained ill and febrile. The abdomen 
was acutely and diffusely tender with rebound 
tenderness, and bowel sounds were diminished. 
L aboratory investigations revealed a 
hemoglobin of 79 g/L with mild Rouleaux for­
mation (admission hemoglobin 135 g/L) and 
haptoglobin levels 2'h times the normal level, 
suggesting hemolysis. The leukocyte count was 
27.0 x 109/L  with 88% polymorphonuclear 
leukocytes. Platelet count was 147.0 x 109/L. 
There was proteinuria of 1.63 g/d. Blood,
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urine, intrauterine and peritoneal fluid cultures 
obtained by culdocentesis were sterile. Serum 
and urine amylase levels were normal. Her 
antinuclear antibody test result was positive 
in a titre of 1/320 and anti-DNA antibody 
levels were elevated. Her complement levels 
were normal and both her prothrombin and 
partial thromboplastin times were normal. 
Lupus anticoagulant was not measured.
She was thought to have systemic lupus 
erythematosus complicated by serositis. She 
was treated  with m ethylprednisolone 
intravenously 125 mg twice daily, resulting in 
a marked response within 12 hours and com­
plete resolution of fever and abdominal pain. 
Her hemoglobin rose to 106 g/L within 24 
hours and 112 g/L  1 week later. Steroid ther­
apy was gradually reduced over a 6-month 
period. At follow-up, 2 years after discharge, 
she was taking only salicylates for joint pain.
Case 2
A diagnosis of systemic lupus erythemato­
sus was made in a 30-year-old white woman 
on the basis of migratory polyarthritis, fatigue, 
pleuritic chest pain, cervical and axillary lym- 
phadenopathy, a positive antinuclear antibody 
test in a titre of 1/1280, low complement levels, 
Coombs’-positive anemia and leukopenia. Two 
years later in 1983 she became pregnant; a mild 
flare-up of her systemic lupus erythematosus 
during her pregnancy was treated for 8 weeks 
with 20 mg/d of prednisone. An uncomplicated 
cesarean section was performed in February 
1984.
Four months later she came to the emergency 
department with a 2-day history of fever, upper 
respiratory infection, sinus tenderness and 
increasing headache. Ampicillin was prescribed 
and she was sent home. Four hours later she 
returned to the emergency department and was 
admitted with severe abdominal pain associated 
with nausea and vomiting but no hemateme- 
sis or diarrhea. Her temperature was 38.5°C. 
She was given codeine 30 mg intramuscularly 
and, 30 to 45 minutes later, she had an 
anaphylactic reaction that was treated with 
epinephrine 1:1000, 0.4 ml subcutaneously, 
naloxone 0.4 mg intravenously, and Solu- 
Medrol 250 mg intravenously. A microan­
giopathic anemia developed with throm­
bocytopenia of 54.0 x 109/L  and a leukocyte 
count of 10.5 x 109/L . Urinalysis showed 44- 
proteinuria and an active sediment on 
microscopy. Her blood urea nitrogen and 
creatinine levels were normal. She became 
hypertensive with sustained readings of 
240/160 mm Hg and had several grand mal sei­
zures. Her abdomen remained acutely and 
diffusely tender with marked guarding and 
rebound tenderness; bowel sounds were absent.
A surgeon was consulted but laparotomy 
was deferred because of her critical clinical 
state. She was given methylprednisolone intra­
venously 1000 mg/d, cefazolin intravenously 
1 g every 4 hours and Dilantin 1000 mg 
intravenously for generalized acute seizures 
then 300 mg/d intravenously, and aggressive 
antihypertensive treatment. Her abdominal 
pain was relieved within 24 hours but her blood 
pressure did not return to normal until minox­
idil (10 mg orally three times a day) was added. 
She remained confused and drowsy but 
improved over the next 3 days and the methyl­
prednisolone was decreased to 200 mg/d. Two 
days later she had an exacerbation of her
abdominal pain with marked rebound tender­
ness, rigidity, nausea, vomiting, decreasing 
level of consciousness and recurrent hyperten­
sion. By hemolysis the hemoglobin level fell to 
70 g/L and her blood urea nitrogen and creati­
nine levels rose. Her serum and urinary amy­
lase throughout her illness were normal.
She was given 1000 mg of methylpredniso­
lone intravenously but failed to improve and 
after another seizure she became responsive 
only to painful stimuli. She underwent plas­
mapheresis and was given cyclophosphamide 
intravenously 4 mg/kg for 2 consecutive days. 
This resulted in gradual improvement with 
resolution of her abdominal pain and other 
clinical problems. She was discharged. Steroids 
were slowly decreased over 1 year. Two years 
after discharge she was asymptomatic and nor- 
motensive and was not taking any drugs.
Case 3
A 27-year-old white woman was admitted to 
hospital June 1977 with a left hemiparesis. 
Fever developed on day 3 and she had abdomi­
nal pain, generalized abdominal tenderness, 
guarding and diminished bowel sounds. Find­
ings on laparoscopy were normal. Ampicillin 
and tobramycin were prescribed and her 
abdominal pain resolved over the next 16 days. 
One month later while she was still in hospital 
a pleural effusion developed; it resolved in 10 
days. A false-positive VDRL test result and an 
elevated partial thromboplastin time were 
noted. Splenomegaly was identified on a liver 
and spleen scan. Charts from the hospital 
stated the final diagnosis as a right hemispheric 
infarct. She was discharged with residual weak­
ness of the left arm and leg.
She experienced three spontaneous abortions 
between 1980 and 1981, and in 1983 had an 
amaurosis fugax. Investigations revealed a 
positive antinuclear antibody test in a titre of 
1/640, positive anti-DNA antibodies and 
elevated partial thromboplastin time (44 
seconds, control 25 to 34 seconds), but a nor­
mal prothrombin time. Lupus anticoagulant 
was present by the tube dilution method but 
anti-cardiolipin levels were not measured. Her 
previous cerebrovascular accident was thought 
to represent lupus vasculitis.
In May 1984 she was admitted to hospital 
with severe colicky abdominal pain, nausea, 
vomiting and diarrhea, but no hematemesis or 
hematochezia. On examination she was febrile 
(body temperature 38.5°C) with generalized 
and rebound abdominal tenderness, guarding 
and no bowel sounds. She subsequently com­
plained of pleuritic chest pain radiating to the 
shoulder that was relieved by sitting. We 
believed that her abdominal pain was related 
to an exacerbation of her systemic lupus 
erythematosus. Laboratory investigations rev­
ealed a hemoglobin level of 125 g/L and leu­
kocyte count of 16.5 x 109/L  with a shift to 
the left. The platelet count was normal as were 
the prothrombin and partial thromboplastin 
times. X-ray films of the chest and abdomen 
appeared normal.
Methylprednisolone 125 mg twice daily was 
given intravenously. There was a notable 
response within 24 hours, leading to complete 
resolution of all her symptoms. She was dis­
charged from hospital on a regimen of 20 mg/d 
of prednisone. This was gradually tapered. At 
6 weeks after discharge she remained symptom- 
free on a dosage of prednisone of 7.5 mg/d
and at 12 weeks she was off prednisone and 
still free of symptoms. In 1985 she became 
pregnant, with the presence of a circulating 
lupus anticoagulant, and was delivered in 1986 
of a normal child by cesarian section after pro­
tection throughout pregnancy with 40 mg/d of 
prednisone.
Case 4
A 28-year-old white woman had fever, 
diffuse abdominal pain, rebound tenderness, 
nausea and vomiting. No hematemesis, diar­
rhea, hematochezia or melena was found. Note 
was made of a Coombs’-positive hemolytic 
anemia, mild thrombocytopenia, a positive 
antinuclear antibody test in a titre of 1/80 and 
decreased complement levels. Her clinical 
presentation was compatible with serositis. She 
was managed with prednisone 40 mg/d and her 
symptoms resolved over approximately 2 
weeks.
She was readmitted 8 months later with a 
1-day history of fatigue, anorexia, abdominal 
pain, diffuse bifrontal headaches and the ina­
bility to concentrate. Her abdominal pain 
became more severe with diffuse tenderness, 
guarding, rebound tenderness and nausea with 
vomiting. There was no diarrhea, hematoche­
zia, hematemesis or melena. The associated 
findings included hematuria, proteinuria, a 
Coombs’-positive hemolytic anemia, mild 
thrombocytopenia, lymphopenia, a positive 
antinuclear antibody test in a titre of 1/80, 
positive anti-DNA antibodies and low comple­
ment levels.
Within 24 hours of treatment with gentami­
cin intramuscularly 80 mg every 8 hours, 
cefazolin intravenously 1 g every 6 hours and 
methylprednisolone intravenously 125 mg twice 
daily, her abdominal pain cleared, and her cen­
tral nervous system symptoms resolved within 
3 days. Blood, urine and sputum cultures were 
negative. Her hemoglobin returned to normal 
within a week but her proteinuria persisted. 
Antibiotics were discontinued when cultures 
were sterile. At the time of discharge serum and 
urine amylase levels were normal and she was 
asymptomatic. She was taking prednisone 25 
mg/d. On follow-up she was well and her pred­
nisone dose had been reduced to 10 mg/d. She 
was able to discontinue the prednisone 6 
months later, but had to take it again when 
abdominal pain recurred with nephritis. Two 
years after discharge from hospital she remains 
on a regimen of 25 mg/d of prednisone.
Discussion
Gastrointestinal complaints with 
abdominal pain are common in the course 
of systemic lupus erythematosus and have 
been noted in 10% to 34% of such 
patients.6'7 Our four patients serve to 
illustrate a number of points. Delay in 
diagnosis, as in cases 1 and 3, is not 
uncommon. Zizic and colleagues8 
reported that abdominal pain had been 
present in two-thirds of patients with sys­
temic lupus erythematosus, for an aver­
age of 34 days (range from 11 to 74 days), 
before the acute abdominal crisis. If sys­
temic lupus erythematosus is not consi­
dered, infection as an underlying cause is 
usually the presumptive diagnosis. All our 
patients were initially treated for bacterial
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peritonitis with broad-spectrum antibi­
otics and failed to respond until steroids 
were used. The second episode of acute 
abdominal pain in case 3 was treated with 
steroids alone and responded quickly.
There are several possible mechanisms 
for abdominal pain in this condition. 
They include peritonitis (with or without 
associated pleuritis and pericarditis), vas­
culitis, vasculitis with perforation, ente­
ritis, pancreatitis and drug-related causes. 
Many of the drugs used produce gastroin­
testinal side effects. Corticosteroids and 
nonsteroidal anti-inflammatory drugs can 
be associated with nausea, vomiting, 
abdominal pain, ulceration, gastrointes­
tinal bleeding and possible perforation 
anywhere from the stomach to the small 
bowel. Likewise hydroxychloroquine and 
azathioprine, which are frequently used, 
may be associated with similar symptoms. 
Azathioprine and corticosteroids have 
also been associated with pancreatitis as 
has systemic lupus erythem atosus 
itself.9-11
Abdominal pain and other gastrointes­
tinal symptoms are variable and non­
specific (Table II1'6’7-12). They range 
from nausea, vomiting and mild abdomi­
nal pain to an acute abdominal crisis. The 
potentially severe manifestations are illus­
trated by our cases and those reported by 
Zizic and colleagues7 who noted 11 
patients with mesenteric arteritis, 2 with 
serositis and 1 with pancreatitis. Of par­
ticular note is that 8 of 14 patients died. 
Other patients with acute abdominal 
symptoms have been found to have spon­
taneous rupture of the spleen or 
liver.13’14 Acute awareness is necessary in 
attributing abdominal symptoms in these 
patients to systemic lupus erythematosus. 
Associated symptoms that suggest the 
abdominal pain may be due to this dis­
ease are pericarditis, pleuritis, cutaneous 
vasculitis, central nervous system involve­
ment, peripheral neuropathy, high titres 
of rheumatoid factor and throm ­
bocytopenia. 8’12'15’16
Management
The patient presenting with either acute 
or chronic abdominal pain should have 
drug-related causes considered and ruled 
out. When drugs are not the cause and 
other common disorders, such as
Table II—Gastrointestinal Manifestations 
of Systemic Lupus Erythematosus1,6'712
Manifestation Incidence, %
Fever 100
Pain, tenderness 90 -  100
Guarding 60 -  100
Rebound tenderness 50 -  80
Absent bowel sounds 30 -  50
Nausealvomiting 60 -  80
Diarrhea 30 -  50
Distension 30 -  50
cholecystitis, are excluded, the possibil­
ity of systemic lupus erythematosus 
should be considered. The history and 
physical examination may be helpful 
(Table I) but routine laboratory investi­
gations are not. Leukocyte counts do not 
correlate with the clinical presentation 
and their fluctuation may be attributable 
to the effect of steroids. Radiologic inves­
tigations are useful in diagnosing lupus 
enteritis. Evidence of mesenteric arteritis 
includes pseudo-obstruction, ileus and 
thumbprinting (scalloping of the border 
of the bowel secondary to submucosal 
edema and hemorrhage)4 and small- 
bowel abnormalities secondary to edema 
which may give a “ stacked coin” appear­
ance on a plain x-ray film .17-19 Pneu- 
mocytosis intestinalis and scleroderma 
have also been reported in systemic lupus 
erythematosus.16,20 In some patients with 
enteritis or lupus vasculitis, the appear­
ance of a plain film may be normal4 even 
when barium studies are done before per­
foration.21'22 The value of angiography 
in assessing such patients is controversial. 
Some groups have found the procedure 
helpful in demonstrating vasculitis8,23’24 
but others have been unable to demon­
strate arteritis by this procedure despite 
subsequent evidence proving its 
presence.12’25,26
As in all patients with an acute abdo­
men, perforation and infection must be 
ruled out. If the patient is taking cor­
ticosteroids or nonsteroidal a n ti­
inflammatory drugs, the usual signs of 
peritoneal irritation may not fully 
develop. Abdominal paracentesis and 
lavage have been advocated by many 
groups.9’17,21’22’27-30 The procedure may 
help to rule out infection associated with 
perforation, intraperitoneal bleeding, and 
demonstrate lupus enteritis cells and 
elevated amylase levels. The frequency of 
spontaneous bacterial peritonitis ranges 
from 1% to 5% in patients with systemic 
lupus erythematosus and may be higher 
if the patient is on corticosteroids,27’28’30’31 
so that a diagnosis of systemic lupus 
erythematosus does not exclude the pos­
sibility of this complication. Conse­
quently, the aspirate of peritoneal lavage 
should be cultured as should the blood 
and samples from all other sites of possi­
ble infection.
A therapeutic trial of high-dose cor­
ticosteroids (60 to 500 mg/d of predni­
sone equivalent) and broad-spectrum 
antibiotics to cover both gram-negative 
and anaerobic infection8’12’32 is logical 
when in doubt. If the peritoneal tap is 
clear and the evidence of a lupus flare 
strong, then a trial of steroids alone is 
indicated.
It is emphasized that patients with 
lupus peritonitis or enteritis should 
respond to steroids within 12 to 24 hours. 
If the patient’s condition deteriorates, 
surgical intervention should be prompt.
The prognosis for those with infarcted or 
perforated bowel is poor, as supported by 
findings of Zizic’s group22 and the study 
of Matolo and Albo33 in which 6 of 10 
patients with acute abdominal syndromes 
or hemorrhage treated medically died, 
while the 4 with early surgical interven­
tion survived. Similar findings have been 
noted by other groups.34-36
Our patients all survived and have done 
well. In two, antibiotic coverage provided 
no improvement while steroids produced 
quick results. If given early and in ade­
quate dosage, steroids may prevent per­
foration by controlling vasculitis, but can 
have disastrous effects if infection is not 
recognized.
Conclusions
Systemic lupus erythematosus should 
be considered in the differential diagno­
sis of acute abdominal pain in young 
women.
Management, when this disease is sug­
gested, should include surgical consulta­
tion and abdominal paracentesis for cul­
ture. Treatment should be started with 
high dosage of steroids with or without 
broad-spectrum antibiotics. A lack of 
notable response within 24 hours, or sus­
picion of a perforated viscous, should 
lead to immediate laparotomy.
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Internal Fixation of Capitellar Fractures 
Using Herbert Screws: a Report of Four Cases
Four patients with displaced fractures of 
the capitellum (capitulum humeri) were 
treated by open reduction and internal 
fixation using Herbert screws. The mean 
follow-up was 16 months (range from 
12 to 21 months). All fractures united 
without evidence of avascular necrosis. 
Postoperatively, the range of motion 
was excellent, except in one 
patient who had a comminuted open 
fracture and other injuries. Three cada­
veric dissections demonstrated that the 
Herbert screw could be inserted without 
detaching the lateral collateral ligament. 
The Herbert screw is useful in treating 
displaced capitellar fractures since the jig 
maintains the reduction and the screw, 
compressing the fracture site, is buried 
beneath the articular cartilage and does 
not have to be removed.
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Quatre patients qui avaient subi une 
fracture avec deplacement du condyle de 
I'humerus ont etd traites par reduction 
ouverte et fixation interne d I'aide de vis 
de Herbert. La periode moyenne de sur­
veillance de postcure a ete de 16 mois 
(ecart de 12 & 21 mois). Toutes les frac­
tures se sont ressoudes sans signe de 
necrose avascuiaire. En postoperatoire, 
on a observe une excellente amplitude 
des mouvements sauf pour un patient
souffrant d'une fracture comminutive 
ouverte et d'autres blessures. Trois dis­
sections cadavdriques ont ddmontrd que 
les vis de Herbert peuvent etre inserees 
sans detachement du ligament lateral. La 
vis de Herbert est utile dans le traite- 
ment des fractures avec deplacement du 
condyle puisque le gabarit maintient la 
reduction et que la vis, qui comprime le 
point de fracture, est enfouie sous le car­
tilage articulaire et n'a pas & etre retiree.
FIG. 1—Dissected cadaver elbow with simulated capitellar fracture. Interval between extensor 
carpi radialis longus and common extensor tendon origin was developed to expose anterior capsule 
of elbow. Lateral collateral ligament is preserved. A = anterior capsule (reflected anteriorly), 
EL = extensor carpi radialis longus (reflected anteriorly), F = capitellar fracture fragment, 
R = radial head, CL = lateral collateral ligament, CE = common extensor origin detached 
and reflected distally.
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The management of type I1 (Hahn- 
Steinthal) fractures of the capitellum 
(capitulum humeri) is controversial. 
Nonoperative treatment, with or without 
closed reduction2’3 has been advocated, 
as has open reduction with4-6 or without 
internal fixation, excision of the frag­
ment4'5'7’8 and prosthetic arthroplasty.9
FIG. 2—Lateral view of same elbow shown 
in Fig. 1. Note capitellar fracture fragment.
There is a risk of avascular necrosis when 
the capitellar fracture fragment is small 
and has little or no soft-tissue attachment. 
Advocates of nonoperative management 
and operative excision of capitellar frac­
ture fragments note the effectiveness and 
simplicity of these modes of treatment 
as opposed to the difficulty of internal 
fixation. However. McAusland and 
Wyman10 and Wilson11 have shown that 
preservation of a large capitellar fragment 
is important in restoring stability if there 
are associated elbow injuries.
Internal fixation of the capitellum is 
difficult since the intra-articular fracture 
fragment is often small, and care must be 
taken not to damage the articular surface. 
Screws,10 Palmer pins4 and Kirschner 
wires11 have been used internally to fix 
capitellar fractures. We have found that 
the double-threaded Herbert screw is use­
ful and effective in stabilizing displaced 
intra-articular capitellar fractures as illus­
trated by the results obtained in four 
patients described in this paper.
Operative Technique
To determine the optimum surgical 
exposure we used a lateral approach in 
three cadaveric dissections. We found 
that adequate exposure could be obtained 
by partially detaching the origin o f exten­
sor carpi radialis longus and by com­
pletely detaching the common extensor
FIG. 3—Fracture fragment (C) was reduced and held firmly by Herbert jig. Note that jig 
is placed over lateral collateral ligament (CL). R = radial head.
tendon but preserving the lateral collateral 
ligament (Fig. 1). A simulated type I frac­
ture o f the capitellum was created with 
an osteotome (Figs. 1 and 2). The frac­
ture fragment could be held firmly in 
place by the jig (Fig. 3) while the screw 
was introduced (Figs. 4 and 5), without 
detaching the lateral collateral ligament. 
Preservation o f  the lateral collateral liga­
ment allows joint motion early after oper­
ation.
Case Reports
Case 1
A 44-year-old right-handed man sustained 
a severely comminuted grade 3 compound frac­
ture of the left distal humerus as well as frac­
tures of the ipsilateral proximal radius and ulna 
in a motor vehicle accident. He underwent 
immediate wound debridement and internal 
fixation of the fractures of the distal humerus, 
radius and ulna. A type I1 capitellar fracture 
was reduced and fixed with a Herbert screw 
(Fig. 6). An osteochondral fracture of the 
trochlea was also fixed with a Herbert screw. 
This restored the articular surface of the dis­
tal humerus. A lateral plate was used to stabi­
lize the supracondylar component of the frac­
ture (Fig. 7). The elbow was mobilized 3 weeks 
later. One year after operation the patient had 
no pain. The range of elbow motion was from 
50° to 75°. The range of forearm rotation was 
from 0° to 50° pronation. There was no radi­
ologic evidence of avascular necrosis. The 
patient underwent a capsular release 1 year 
postoperatively and at arthrotomy the capitel­
lum was united. One year after capsular release 
the range of elbow motion was from 40° to 
120°.
Case 2
A 31-year-old right-handed woman fell on 
her outstretched left hand. She sustained a dis­
placed fracture of the posterior aspect of the 
capitellum (Fig. 8). The fracture was reduced 
and fixed with one Herbert screw using a 
posterolateral approach (Fig. 9). The elbow 
was mobilized 2 weeks later. Twelve months 
postoperatively she had painless, normal range 
of elbow motion. There was no evidence of 
avascular necrosis.
Case 3
A 51-year-old right-handed woman sustained 
a fracture of the right capitellum and a dis­
placed fracture of the lateral humeral epicon- 
dyle (Fig. 10) when she fell, striking her right 
elbow. The capitellar fracture involved the 
lateral half o f the trochlea. Through a lateral 
approach, the capitellar fracture was fixed 
internally with one Herbert screw. The lateral 
epicondyle was stabilized with a single AO cor­
tical screw. The elbow was mobilized 2 weeks 
later. Eighteen months postoperatively the 
patient had no pain in the joint and the range 
of motion was from 10° to 145°. Pronation 
and supination were full. X-ray films obtained 
14 months after operation showed no evidence
VOLUME 30, NO. 3, M AY 1987 /  THE CANADIAN JOURNAL OF SURGERY 189
of avascular necrosis of the capitellum (Fig.
11) .
Case 4n
A 35-year-old right-handed woman sustained 
a fracture of the capitellum associated with a 
posterolateral dislocation of the elbow when 
she fell from her bicycle onto her outstretched 
hand. The dislocation was managed by closed 
reduction. The capitellar fracture was fixed 
with two Herbert screws through a lateral 
approach. The elbow was mobilized 3 weeks 
later. Twenty-one months postoperatively the 
patient had no pain in the joint and the range 
of motion was from 10° to 140°. Pronation
and supination were full. There was no evi­
dence of avascular necrosis.
Discussion
Herbert and Fisher13 designed the 
double-threaded screw to treat scaphoid 
fractures. The Herbert instruments hold 
the reduction and compress the fracture 
fragments while the hardw are is 
introduced. The double-threaded screw 
compresses the scaphoid fracture frag­
ments and is buried beneath the articular 
cartilage. These features make the screw 
useful for internal fixation in capitellar 
fractures. In our cases, the fragments
FIG. 4—Herbert screw (arrow) is completely buried beneath articular cartilage. CL = col­
lateral ligament, R = radial head.
were held firmly by the jig while the screw 
was introduced. The fixation was rigid 
enough to allow early mobilization of the 
elbow. Good results were obtained in 
three of our four patients.
The major disadvantage of the Herbert 
screw is that removal is extremely 
difficult. Care must be taken to bury the 
screw beneath the articular surface (Fig. 
5). Screw removal was not necessary in 
any of our cases. The long-term effects 
of a subarticular screw on joint function 
are unknown, but we believ'e that there 
will be no problems as long as the screw 
is buried beneath the articular surface.
Familiarity with the use of the Herbert
FIG. 5—Lateral view of cadaveric elbow 
from Fig. 4 showing capitellar fracture fixed 
with Herbert screw.
FIG. 6—Case 1. Capitellar fracture fragment 
is reduced and held with reduction clamp and 
Herbert jig. Herbert screw was used to recon­
struct capitellum. Humeral shaft lies in back­
ground. Ulna has already been plated (lower 
left). Penrose drain is around ulnar nerve.
FIG. 7—Case 1. Portion of trochlea has been reconstructed with Herbert screw (arrow). 
Lateral plate has been used to stabilize supracondylar component of fracture.
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instruments is essential for their success­
ful use in the management of type I 
capitellar fractures. Cadaveric dissections 
suggest that a lateral approach, detach­
ing the common extensor tendon at its 
origin but preserving the lateral collateral 
ligament, gives adequate exposure with­
out compromising elbow joint stability.
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Foreign-Body Aspiration in Adults
Although a common problem in children, 
foreign-body aspiration is unusual in 
adults and is often overlooked as a 
cause of airway obstruction. Four cases 
of aspirated foreign bodies in adults are 
reported, outlining a range of clinical 
presentations and emphasizing the need 
to be aware of this condition in adults, 
especially in rural areas. Bones of small 
mammals or birds may be inhaled and 
patients frequently present after an 
asymptomatic interval of varying length, 
leading to delay in diagnosis. Prompt 
treatment using rigid bronchoscopy leads 
to rapid clinical and radiologic resolution 
of the problem.
Probifeme frequent chez I'enfant, I'aspira- 
tion d'un corps Stranger est inhabituel 
chez I'adulte et on y pense rarement 
comme cause d'obstruction des voies 
respiratoires. On decrit quatre cas oil il y 
eut aspiration d'un corps Stranger chez 
des adultes; on souligne I'eventail des 
tableaux cliniques et on insiste sur la 
necessity de soupgonner I'existence de 
cette affection chez I'adulte, tout parti- 
culierement en region rurale. Des os de 
petits mammiteres ou d'oiseaux peuvent 
etre aspires; les patients sont souvent 
repus apr&s un intervalle asymptomatique 
de dur£e variable causant un retard de 
diagnostic. Le traitement immediat a 
I'aide d'un bronchoscope rigide entraTne 
une resolution clinique et radiologique 
rapide du probleme.
Aspiration o f a foreign body into the 
tracheobronchial tree is a frequent clini­
cal problem in children in whom it is a 
cause of substantial morbidity and mor­
tality.1'2 Although the wide spectrum of 
pulmonary aspiration complexes in adults 
has recently been reviewed,3 foreign- 
body aspiration is often overlooked as a 
cause of airway obstruction in this age 
group.3,4
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Of the many reports o f inhaled foreign 
bodies, the earliest comprehensive 
documentation was that appearing in 
1919.5 In a later report, Jackson6 sug­
gested that bones in particular posed spe­
cial diagnostic problems despite their rela­
tive frequency o f inhalation, citing 10 
typical cases of “ overlooked bone” in the 
lung.
In the past few years we have treated 
several adults for an inhaled foreign body 
and the following case reports illustrate 
the spectrum of clinical presentations that 
accompany the aspiration of small mam­
malian or avian bones. The importance 
of these observations for surgeons prac­
tising in rural areas will be discussed.
Case Reports
Case 1
A 68-year-old man, with fever and a produc­
tive cough, was found radiologically to have 
a right lower lobe pneumonia. As an outpa­
tient, the initial prescription was ampicillin 
orally. An x-ray film, obtained because there 
was no substantial improvement in his symp­
toms, showed a right pleural effusion (Fig. 1) 
that proved to be empyema. The aspirate when 
cultured grew mixed anaerobes.
A review of his medical history revealed that 
3 years earlier he had had a transient choking 
episode while eating soup, but had remained 
asymptomatic since then. Despite treatment 
with closed chest-tube drainage and
FIG. 1—Case 1. Chest film showing right 
empyema.
intravenous administration of penicillin and 
clindamycin, cellulitis of the chest wall deve­
loped. Rigid bronchoscopy under general 
anesthesia demonstrated almost total occlusion 
of the right main-stem bronchus by a chicken 
bone which was removed. Thoracotomy was 
also done to ensure adequate drainage of the 
empyema and a follow-up chest x-ray film 
showed marked improvement (Fig. 2).
Case 2
While eating soup, a 32-year-old man aspi­
rated a chicken bone and was referred to an 
otorhinolaryngologist who extracted foreign- 
body fragments from the upper tracheobron­
chial tree under general anesthesia. Over the 
next 2 months the patient experienced progres­
sive coughing, wheezing and dyspnea, which 
was worse when he was lying on his right side. 
Subsequently a right lower lobe pneumonia was 
diagnosed that was unresponsive to  oral 
antibiotics. Rigid bronchoscopy revealed an 
obstruction of the right bronchus intermedius 
by impacted chicken vertebrae. After their 
removal, the patient made a smooth recovery 
and a bronchogram obtained 1 month later was 
entirely normal.
Case 3
A 73-year-old woman came to the emergency 
department with sudden onset of dyspnea. She 
had coughed up a small amount of fresh blood 
just before admission. Physical examination 
revealed diffuse rhonchi and crepitations 
throughout the chest and a chest film demon­
strated right-sided pulmonary edema. Because
FIG. 2—Case 1. Response to treatment.
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of a history of ischemic heart disease a diag­
nosis of acute pulmonary edema was made. 
Her condition did not respond to bronchodi- 
lators and diuretics so rigid bronchoscopy was 
done. A turkey bone was removed from the 
right main-stem bronchus and within 24 hours 
symptoms and radiologic findings were greatly 
improved.
Case 4
A 56-year-old man was admitted with cough 
productive of yellow sputum, wheezing and 
hemoptysis. He gave a history of having 
choked on a rabbit bone while eating stew, 3 
months previously. Apart from a temporary 
sore throat he remained asymptomatic until 1 
week before admission. Rigid bronchoscopy 
demonstrated a rabbit bone occluding the left 
upper lobe bronchus. After its extraction his 
symptoms cleared rapidly. Findings were nor­
mal on follow-up flexible bronchoscopy per­
formed 1 month later.
Discussion
Key points relating to foreign-body 
aspiration in adults are raised by our case 
reports. The diagnosis should be sus­
pected in this age group especially when 
pulmonary symptoms such as wheezing, 
productive cough or unresolved pneumo­
nia develop for the first time. That simi­
lar symptoms in this age group may result 
from other obstructing lesions such as 
bronchogenic carcinoma means that fur­
ther evaluation, including bronchoscopy, 
must be performed without delay.
In the St. John’s area, hunting game 
for food, which is often prepared in the 
form of a soup or stew, may be consi­
dered a “ risk factor” that should not be 
overlooked especially during the fall 
months.
Although a positive history of choking 
on food was obtained in cases 1, 2 and 
4, the asymptomatic interval varied from 
3 years (case 1) to 2 months (case 2), 
resulting in delay in diagnosis and treat­
ment, a characteristic feature in adults of 
aspirating bone.6 The value of a second 
bronchoscopic examination when symp­
toms persist is emphasized by the second 
case, in which the report of the initial 
bronchoscopy, performed by a qualified 
surgeon at another hospital, noted that 
all foreign matter had been extracted. In 
this case, the patient had either re­
aspirated in the interval or, more likely, 
the initial bronchoscopy was inadequate.
Although the patient in case 4 
presented with relatively uncomplicated 
clinical features of foreign-body aspira­
tion, the development of empyema neces­
sitatis (case 1) illustrates that after aspi­
ration or during supportive therapy 
complications may persist. It is interest­
ing to note that this patient had the lon­
gest symptom-free interval (3 years), 
which may be coincidental. Finally, the 
rapid improvement of symptoms follow­
ing bronchoscopy was a notable feature
of each case, including the somewhat 
atypical presentation of unilateral pulmo­
nary edema in case 3.
The classification of adult pulmonary 
aspiration complexes3 is based on a num­
ber of factors, including the level of air­
way obstruction and the nature of the 
aspirated material: particulate or foreign 
body, bacterial aspiration, non-toxic or 
toxic liquid aspiration (Mendelson’s syn­
drome). Additional relevant factors 
include the presence of predisposing con­
ditions such as neurologic disorders, alco­
holism, nasogastric intubation and 
general anesthesia, none of which con­
tributed to the clinical presentations 
described.
While much attention is given to the 
life-threatening blockage of major air­
ways by foreign bodies — the “ cafe 
coronary” 7 — and to the aspiration of 
liquids, especially related to general 
anesthesia,8 the infrequency of particu­
late or foreign-body inhalation in adults 
often causes delay in diagnosis and treat­
ment. Peripheral airway blockage leads 
to progressive alveolar hypoventilation 
and collapse with intrapleural shunting 
ultimately leading to hypoxia. This pre­
disposes the patient to the complications 
of persistent pulmonary symptoms and 
pneumonia (case 1, 2 and 4), suppuration 
(case 1) or respiratory failure (case 3).
Prompt bronchoscopy and removal of 
a foreign body from the tracheobronchial 
tree results in rapid improvement of sym­
ptoms and complications, with preserva­
tion of lung function. 1>3>4 This was con­
firmed by follow-up examination of our 
patients. We recommend rigid bron­
choscopy under general anesthesia as the 
primary diagnostic and therapeutic 
maneuver in all cases of suspected 
foreign-body aspiration, regardless of the 
clinical or radiologic findings at initial 
presentation. We believe that rigid bron­
choscopy is superior to flexible bron­
choscopy in these cases as it offers better 
visualization of the foreign body and ease 
of extraction with forceps. Flexible bron­
choscopy, and occasionally bronchogra­
phy, are used in the follow up of these 
patients.
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Acute Abdomen in Severely Mentally Retarded Patients
Over 5 years, 25 severely retarded 
institutionalized patients accounted for 
29 admissions for laparotomy due to 
acute abdomen. The patients' symptoms 
were always of short duration, yet 38%  
of operations were judged to be delayed. 
This was thought to be due to the 
patients' inability to communicate and to 
altered pain sensation. Pica (depraved 
appetite) accounted for 48% of admis­
sions and perforation was common 
(41%). The death rate was high (4 
[14%] of the 29 admissions and 3 
[21 %] of the admissions associated with 
pica). An unexpected high incidence 
(24%) of peptic ulcer was also seen. 
Unless the patient was admitted in a 
state of shock, usual clinical determina­
tions often failed to distinguish early 
from advanced disease. Young males 
seem at increased risk and a history of 
pica is ominous.
Sur une periode de 5 ans, 25 deficients 
mentaux s6veres places en etablissement 
de sante ont fait I'objet de 29 hospitali­
sations pour laparotomie, a cause d'un 
abdomen aigu. Dans tous les cas, les 
symptomes avaient ete de courte duree. 
Neanmoins, on jugea que dans 38%  des 
cas, l'op£ration avait ete retardee. On 
pense que ceci etait du a I'incapacite de 
communiquer des malades ou a un 
emoussement de la sensibilite a la dou- 
leur. Une perversion du gout (avec perte 
d'appetit) fut a I'origine de I'hospitalisa- 
tion dans 48% des cas et les perfora­
tions intestinales furent frequentes 
(41%). Le taux de mortalite fut Sieve 
(4 [14%] des 29 admissions et 3 [21 % ] 
des admissions pour perversion du gout). 
Une incidence exceptionnellement elevee 
(24%) d'ulceres gastro-intestinaux fut 
aussi observee. A moins que le patient 
n'ait ete regu en etat de choc, les exa- 
mens cliniques habituels, frequemment,
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ne permirent pas de distinguer une mala- 
die au stade precoce d'une au stade 
avance. Les hommes jeunes semblent 
davantage predisposes et des antece­
dents de perversion du goOt sont de 
mauvais presage.
The acute abdomen is the commonest 
emergency confronting the general sur­
geon, and the most important decision to 
be made is whether or not to operate. This 
decision is based on history, physical 
exam ination, investigations and a 
familiarity with the problem. A thorough 
history points to the diagnosis in about 
75% of cases. In severely retarded 
patients these factors are altered to a 
lesser or greater extent. The patients can­
not communicate, so a medical history, 
the most important component of diag­
nosis, cannot be obtained.1-3 Altered 
behaviour, associated congenital anoma­
lies, and altered reaction to pain and 
drugs that depress the central nervous sys­
tem,1,3 give rise to inconclusive results on 
physical examination when abdominal 
tenderness is sought. Abdominal disten­
sion from aerophagia, drugs that affect 
the gastrointestinal tract (e.g., phenothia- 
zines) and a usually distended state alter 
the abdom inal examination. They 
produce x-ray films with abnormal gas 
patterns that do not necessarily have the 
usual surgical significance of ileus or 
obstruction.
A condition peculiar to retarded 
patients, leading to emergency surgery 
and associated with a high death rate is 
pica, named after the black-billed mag­
pie, Pica pica, ubiquitous in the north­
ern hemisphere. This bird is infamous for 
its thieving and craving for nonedible 
objects, particularly shiny items such as 
silver jewellery. Although the syndrome 
named after this bird exists in the general 
population and is noted particularly dur­
ing pregnancy, in retarded people it has 
a much more serious connotation, being 
applied to those who eat foreign objects 
such as shoes, laces, towels, cutlery, toys, 
stones and sticks. Death from pica has 
been quoted at 33%.3 Tejmourian and 
colleagues4 in a review of 101 patients 
with pica found that 33 died, and, for
those needing surgery for this condition, 
the death rate was 58% (15 of 26).
Proximity to the Huronia Regional 
Centre, a provincial institution housing 
about 1000 mentally retarded people, 
gives the staff of the Orillia Soldiers’ 
Memorial Hospital an unusually wide 
experience with emergency problems in 
retarded people. This review documents 
surgical experience over 5 years at the 
Orillia Soldiers’ Memorial Hospital in 
retarded patients with the acute abdomen.
Patients and Methods
The charts of patients from the Huro­
nia Regional Centre booked for emer­
gency laparotomy at Orillia Soldiers’ 
Memorial Hospital, between 1979 and 
1983, inclusive, were reviewed. Diagno­
sis was recorded and operations were clas­
sified as negative (no acute condition 
found at laparotomy), appropriate (acute 
condition found at laparotomy in keep­
ing with the preoperative picture and 
where surgical correction of the lesion 
resulted in amelioration) and late (patients 
who presented moribund or in shock, 
died preoperatively, had gangrene or 
chronic peritonitis from perforation). The 
duration of symptoms, temperature, 
pulse, blood pressure, leukocyte count 
and length of preoperative observation 
were noted in an effort to distinguish 
between these three categories (Table I).
Results
Over the 5 years of the study, 25 
patients accounted for 29 admissions. 
Most patients were profoundly retarded 
and unable to speak, but could under­
stand and follow simple commands. The 
cause of the retardation varied, the com­
monest being brain damage, presumed 
due to hypoxia at birth, congenital defects 
and genetic disorders. Male to female 
ratio was 5 to 1, the age range was from 
14 to 60 years (average 28 years). The inci­
dence of pica was 40%. At the end of the 
study period, the records showed that the 
population of the Huronia Regional 
Centre was 879, with a male to female 
ratio of 2 to 1, an age range from 8 to
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88 years (average 33 years) and a 16% 
recorded frequency of pica.
One patient died of shock en route to 
the operating room (classified as a late 
operation). Of the remaining 28 admis­
sions, which resulted in operations, 3 were 
classified as negative, 15 as appropriate 
and 10 as late (Table I). In order of fre­
quency, the diagnosis at laparotomy for 
the 29 admissions was obstruction by a 
foreign body in nine cases (31%) 
(associated volvulus in two and perfora­
tion in four), volvulus in five (17%) (for­
eign body in two and perforation in one), 
adhesions in four (14%) (foreign body in 
one), peptic ulcer in four (14%), acute 
cholecystitis in two (7%) (one with gan­
grene of the gallbladder and common- 
bile-duct stones), appendicitis in two (7%) 
(both perforated) and miscellaneous in 
four (one each of traumatic rectal per­
foration, gangrenous colon from fecal 
impaction, pancreatic pseudocyst, leak 
from a removed gastrostomy tube) and 
in three cases there were no abnormal 
abdominal findings.
Pica was documented in 10 of the 25 
patients (40%) (14 of the 29 admissions 
[48%]). All four patients with repeat sur­
gical admissions during the study period 
had pica. Perforation was noted in 12 
(41%) of the 29 admissions, associated 
with a foreign body four times, with vol­
vulus once, with peptic ulcer three times, 
with appendicitis twice and with miscel­
laneous conditions twice.
Peptic ulcer was a frequent finding, 
accounting for three perforations, two 
duodenal ulcers and one gastric ulcer. In 
addition, there was one acute non- 
perforated ulcer and one operation for 
presumed gastric obstruction (in the nega­
tive group) in a patient who had under­
gone a previous gastrectomy for duodenal 
ulcer. A sixth patient had pulled out his 
gastrostomy tube which had been inserted 
following gastrectomy for a duodenal 
ulcer. Thus, a total of six episodes were
related to peptic ulcer, accounting for 
24% of the patients in this series.
Four (14%) of the 29 admissions ended 
in death of the patient. One patient 
arrived moribund, was booked for sur­
gery but died before reaching the operat­
ing room in spite of resuscitative efforts 
with fluids and antibiotics. Three of the 
four patients who died had associated 
pica; the fourth patient died of peritoni­
tis after pulling out a gastrostomy tube. 
All the deaths occurred in the late group. 
In no case was there a surgical delay, but 
the history was always short, never longer 
than 48 hours.
Discussion
The acute abdomen in the mentally 
retarded person is a uniquely serious con­
dition. A disproportionate number of 
men seem to be at risk when compared 
to the reference population. Obstruction 
and volvulus are the commonest causes 
and there is a high rate of unusual condi­
tions, not encountered in the general 
population such as foreign-body inges­
tion, gangrene from fecal impaction and 
traumatic rectal perforation. Many 
patients have had multiple previous oper­
ations, giving a high frequency of 
obstruction due to adhesions (14% in our 
series).
Our review confirms the ominous 
nature of pica in surgical patients. 
Whereas pica was present in 16% of the 
reference population, it was seen in 40% 
of the surgical patients, half associated 
with enteric perforation. It was respon­
sible for all repeat admissions during the 
5-year period, and was found in six 
patients who presented too late as well as 
three who died. In our series, 12 of 29 
laparotomies were directly or indirectly 
due to pica; in the other 2, pica was only 
an associated finding. The death rate in 
this group was 25% (3 of 12).
An unexpected finding was the high
Table 1-Breakdown of the Three Groups of Operation According 
to Clinical Parameters of Patients on Admission
Classification
Negative, 
n -  3
Appropriate, 
n -  15
Late, 
n -  11
With pica, no. 2 6 6
History <  24 h, no. 2 9 9
History >  48 h, no. 1 2 0
Temperature, °C
Range 36.5 -  37.8 36.3 -  39.0 26.2 -  39.0
Mean 37.4 37.5 37.7
Pulse, beats/min
Range 80 -  96 80 -  120 80 -  158
Mean 88 98 111*
Blood pressure, mm Hg
Range 120/70 -  130/80 88/60 -  150/92 80/48 -  130/80
Mean 124/73 120/81 107/67*
Leukocyte count, X 109/L
Range 8.3 -  25.2 5.6 -  25.6 6.0 -  21.0
Mean 16.8 13.3 12.1
'Excluding 1 patient in whom pulse and blood pressure were unobtainable on admission.
incidence of peptic ulcer disease in these 
patients. Six of the 25 patients had pep­
tic ulcer disease, and their operations were 
directly or indirectly related to this dis­
ease. Thus, every fourth patient in this 
series needing surgery for acute abdomen 
and every fifth operation carried out for 
acute abdomen in this population is 
directly or indirectly related to peptic 
ulcer disease. This phenomenon has not 
been observed in previous reports deal­
ing with retarded patients. The incidence 
of peptic ulcer in the reference popula­
tion is not known. It would be interest­
ing to know if the institutionalized 
retarded patient is at unusually high risk 
for ulcer disease or whether this is a fea­
ture only of the subgroup likely to present 
with acute abdomen.
In most cases in this series (72%) the 
presenting history was less than 24 hours, 
yet many patients presented in a mori­
bund state with advanced sepsis or 
dehydration and shock. The high death 
rate (14%) is directly related to the seri­
ousness of the condition, late presenta­
tion (100%) and abnormal behaviour.
Table I reveals that all of the para­
meters assessed show a progression 
toward increased abnormality from nega­
tive to late. Nevertheless, there is over­
lap between all groups so that some 
patients in the late group cannot be dis­
tinguished from those in the negative or 
appropriate group by any or all of these 
parameters. These commonly used para­
meters seem to fail to differentiate 
between patients requiring surgery or not. 
Although not brought out in this review, 
abnormal gas patterns on abdominal 
films are often considered normal in 
retarded people, making these studies 
difficult to interpret. Unexpected condi­
tions, not met with in the general popu­
lation, make recognition of the acute 
abdomen in retarded patients difficult for 
a surgeon whose familiarity with its 
causes is limited to those commonly 
found in the general population.
In dealing with the retarded patient, the 
surgeon should remember that a short or 
absent history and apparent lack of pain 
do not exclude advanced disease. At the 
same time, abdominal distension and 
abnormal x-ray films may be considered 
normal in these people. Youth, male sex 
and previous surgery indicate increased 
risk and pica is an ominous finding. These 
modifications to the usual clinical judge­
ment may help the surgeon in dealing with 
this most difficult subgroup of patients.
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Angiosarcoma of the Scalp: 
Case Report and Literature Review
Angiosarcoma of the scalp is a rare 
lesion and generally has a poor progno­
sis, but it may be controlled by wide sur­
gical ablation, local lymph-node excision 
and perhaps palliated by adequate radi­
otherapy. The author describes a 
52-year-old woman with this condition 
who underwent multiple surgical proce­
dures over a 16-year period. He also 
reviews the literature on the subject.
L'angiosarcome du cuir chevelu est rare- 
ment rencontre. Son pronostic est gene- 
ralement mauvais, mais il peut etre stabi­
lise par resection chirurgicale elargie, 
excision ganglionnaire locale et possible- 
ment radiotherapie palliative. L'auteur 
decrit le cas d'une femme de 52 ans 
souffrant de cette affection qui dut subir 
de multiples interventions chirurgicales 
au cours d'une pgriode de 16 annees. II 
passe egalement en revue la litterature 
sur le sujet.
Angiosarcoma of the heajl and neck is 
uncommon, fewer than 100 cases hav­
ing been described.1 From 1926 to 1980, 
only 48 cases of this neoplasm involving 
the scalp were reported.2 The following 
report will draw attention to the features 
of this lesion and its management.
Case Report
A 52-year-old fair-skinned woman was 
referred in March 1972 with two black, ulcer­
ated nodular lesions of the vertex of the scalp. 
They were 1.3 cm in diameter. They had been 
excised elsewhere 19 months earlier but had 
recurred rapidly and enlarged. The lesions were
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excised again, flaps were advanced and the 
wounds closed. After pathological examination 
revealed ulcerated recurrent angiosarcoma with 
extension to the margins of resection, she was 
admitted to the Sir Mortimer B. Davis-Jewish 
General Hospital, where wide local excision, 
including periosteum and the outer table of the 
skull, was performed. Split-thickness skin graft 
was used to close the defect.
A few months later, an enlarged tender 
lymph node appeared in the right mastoid 
region associated with an abscess in the grafted 
area of the scalp. The enlarged node was 
believed to be inflammatory, but because it did 
not resolve, it was excised in May 1973. Patho­
logical examination revealed moderately 
undifferentiated angiosarcoma, metastatic to 
lymph node. A left occipital lymph node was 
excised in September 1973, and two others 
from the right and left jugular cervical regions 
in November 1973.
The patient presented in February 1974 with 
symptomatic gallstones and examination at 
that time revealed two enlarged lymph nodes, 
one in the right anterior cervical region and the 
other in the left mastoid region. Both were 
excised and revealed the previously noted 
pathological changes. Another gland was 
removed from the same region of the right side 
of the neck in June 1974 with similar patho­
logical findings.
The patient was followed up at approxi­
mately 3-month intervals, with negative phys­
ical and radiologic findings. An incisional her­
nia was repaired in February 1976, at which 
time exploration of the upper abdomen failed 
to reveal any metastases. A benign verruca was 
removed from the right side of her face in June 
1980.
Two bluish-red flat discolourations appeared 
on her forehead in December 1985, one cen­
trally and the second to the right of the mid­
line. Biopsy by a dermatologist revealed recur­
rent, probably metastatic, angiosarcoma. She 
was again referred to me and wide local exci­
sion with flap-advancement closure of the 
defect was performed. Tumour was present at 
the margin of excision. Consideration was 
given to radiotherapy, but this might have 
eliminated any further surgical intervention. 
Accordingly, total and full-thickness excision 
of the forehead skin was carried out and 
replaced with a full-thickness defatted skin 
graft in March 1986. At the time of writing, 
the wound is healing well, with no evidence of 
tumour recurrence, although the pathological 
examination of the specimen revealed residual
foci of low-grade angiosarcoma at the edges 
of the resection.
Before the last surgical excision, investiga­
tion for metastases was negative. The patient 
will probably receive radiotherapy to the 
involved margins of the resected area when 
healing is complete.
Literature Review and Discussion
The first clinical and histopathological 
report o f angiosarcoma o f the scalp was 
by Livingston and Klemperer in 1926,3 
and Wilson Jones4 was the first to 
recognize the lesion as a distinct clinical 
entity in 1964.
Lesions may be red, blue, violaceous 
or black, varying in size, single or multi­
ple, and of superficial spreading, nodu­
lar or ulcerating clinical types. Macules 
and plaques, an area of persistent edema 
or the appearance of chronic cellulitis 
may be the mode o f presentation.5 
Eosinophilia of 5% to 15% may be found 
on examination of the peripheral blood.6 
There are no predisposing benign lesions, 
and trauma and actinic effects have not 
been considered causative.7,8
Histologically, the lesions resemble 
angiosarcoma complicating lymphedema. 
The histogenesis of the lesion is unknown, 
and electron microscopic and immuno- 
histochemical studies may be done to con­
firm the diagnosis of angiosarcoma. 
Histologic differential diagnoses include 
amelanotic melanoma, metastatic carci­
nomas, hemangiopericytoma, lymph- 
angiosarcoma, pyogenic granuloma, 
Kaposi’s sarcoma and intravascular 
angiomatosis. Immunohistochemical 
studies include Factor VUI-related anti­
gen (Factor VIII RAG), laminin, Ulex 
europaeus agglutinin type I (UEA I), 
alkaline phosphatase reaction and mag­
nesium activated ATPase reaction.5
Wide surgical excision is probably the 
procedure of choice.9 Where this is not 
possible, especially when there is mul­
ticentricity or recurrence following sur­
gery not amenable to repeat excision, then 
some palliation may be obtained from
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electron-beam radiotherapy.8 A total 
tumour dose of 6000 rad to 7000 rad to 
a field several centimetres larger than the 
gross limits of the tumour is recom­
mended.10 Angiosarcomas often show 
peripheral extension and multicentricity 
at a distance from the clinically apparent 
tumour.4 The lesion spreads by local 
infiltration through the skin, beneath the 
dermis. For these reasons, frozen section 
of the margins at surgery, combined with 
a wide surgical excision, deep into the 
underlying fat, is recommended. Advo­
cates of radiotherapy then give wide-field 
radiation postoperatively as an adjunct to 
eradicate any microscopic foci.7 Radia­
tion alone does not give good survival 
results.1’2’4’6,11
Metastases occur by lymphatic or 
hematogenous spread. Unlike most sar­
comas, angiosarcoma of the scalp fre­
quently metastasizes to the cervical lymph 
nodes.1 Node clearance by radical neck 
dissection is recommended for patients 
with a lateral lesion or with palpable lym- 
phadenopathy at the time of initial 
presentation.7 Bilateral neck dissection is 
not recommended, however, for lesions 
that are large and cross the midline of the 
scalp, with drainage to both sides of the 
neck. Following the lymph nodes, lungs 
and liver are next in frequency, with 
involvement of the spleen, bone, kidney, 
intestines, retroperitoneum and heart also 
reported.2
Chemotherapy, using a combination of 
doxorubicin, dactinomycin and cis- 
platinum , has given unsatisfactory 
results.2,5’8’12
Prognosis is generally poor in angiosar­
coma of the scalp. Five cases were 
reported7 from the Mayo Clinic from 
1920 to 1970, and no patient survived 5 
years. Knight and colleagues2 reported 
48 cases occurring from 1926 to 1980, and 
the majority of patients were dead in 10.7 
months. Survival ranged from 1 month 
to 5 years after the diagnosis was made. 
The cause of death was metastases to the 
cardiorespiratory system or local tissue 
invasion.2 Maddox and Evans6 reported 
17 patients with angiosarcoma of the 
scalp and face seen at the M.D. Ander­
son Hospital before 1976. The median 
survival for the entire series was 20 
months. Favourable prognostic factors 
would appear to be tumours less than 5 
cm in dimension and moderate or marked 
lymphoid infiltrate in and around the 
tumour. There was no correlation with 
mitotic activity and degree of differenti­
ation on histologic section. Nine patients 
in the series showed long-term disease- 
free survival, one as long as 158 months. 
Successful excision of recurrence with 
conversion to a disease-free state was 
accomplished in one case. Late local 
recurrence and metastasis is observed 
occasionally.6 A similarly poor outlook
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was presented by Wilson Jones8 in his 
series of 20 scalp tumours. Of 42 face and 
scalp lesions, only 3 survived longer than 
4 years.
Summary and Conclusions
A case of angiosarcoma of the scalp, 
occurring in a fair-skinned middle-aged 
woman has been reported. The clinical 
features corresponded to those described 
in the literature. Repeated wide surgical 
excision of the primary and metastatic 
lesions, including scattered cervical lymph 
nodes, was carried out. The patient’s clin­
ical course to date extended to over 16 
years, unusual considering the short dura­
tion between treatment of the primary 
lesion and first appearance of involved 
cervical lymph nodes.
It is emphasized that the true extent of 
angiosarcoma is greater than is clinically 
apparent. A radical surgical approach 
with wide surgical excision is recom­
mended. Palliation may be achieved with 
wide-field radiotherapy, but available 
chemotherapy is not effective.
I thank Dr. Maynard Shapiro, associated 
with this case since its inception, who has skil­
fully carried out all the plastic surgical repairs.
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ANTIBIOTIC
ACTION
In v itro  studies demonstrate that the 
bactericidal action of cefoxitin, a cephamycin 
derived from cephamycin C, results from the 
inhibition of bacterial cell wall synthesis. 
Evidence suggests that the methoxy group in 
the 7a position is responsible for the 
resistance of cefoxitin to degradation by 
bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - Gynecological in fections such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections 
Appropriate culture and susceptibility studies 
should be performed to determine the 
susceptibility of the causative organism(s) to 
MEFOXIN* Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available. 
Organisms particularly appropriate for 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coli
K l e b s i e l l a  species ( in c lu d in g  K. 
pneumoniae)
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria. 
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are also receiving carben ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
pa tien ts w ith  bacterem ia, bacte ria l 
septicemia, or other severe or life-threatening 
infections, or for patients who may be poor 
risks because of lowered resistance resulting 
from such deb ilita ting  conditions as 
malnutrition, trauma, surgery, diabetes, heart 
failure, or malignancy, particularly if shock is 
present or impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and 
abdominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, 
intraoperative (after clamping the umbilical 
cord) and postoperative use of MEFOXIN* 
may reduce the incidence of surgery related 
postoperative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
administration of any antibiotic beyond 
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24 hours fo llow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection. 
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
s e n s it iv ity  re a c tio n s  to  M E F O X IN ', 
cephalosporins, penicillins or other drugs. 
MEFOXIN* should be given with caution to 
penicillin-sensitive patients.
There is some clinical and laboratory evidence 
of p a rtia l c ro s s -a lle rg e n ic ity  between 
cepham ycins and the other beta-lactam 
antibiotics, penicillins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been rep o rte d  w ith  most beta-lactam  
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is im portant to consider a diagnosis of 
pseudomembranous colitis in patients who 
develop diarrhea in association with antibiotic 
use. W hile studies indicate that a toxin 
oduced by C lostrid ium  d iffic ile  is one 
primary cause of antibiotic-associated colitis, 
other causes should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution. 
If an allergic reaction to MEFOXIN* occurs, 
a d m in is tra tio n  of the drug should be 
d isco n tin u e d . Serious hypersensitiv ity  
rea c tio n s  may requ ire  trea tm ent w ith 
epinephrine and other emergency measures. 
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
h igh and p ro lo n g e d  serum a n tib io tic  
concentrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict's or Fehling's solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
va lues in serum  may o ccu r if serum 
concentrations of cefoxitin exceed 100 /vg/mL. 
Serum samples from patients treated with 
MEFOXIN* should not be analyzed fo r 
creatinine if withdrawn within two hours of 
drug administration.
Increased nephrotoxicity has been reported 
fo llow ing  concom itant administration of 
c e p h a lo s p o r in s  and a m in o g ly c o s id e  
antibiotics.
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
e s ta b lish e d . If the a d m in is tra tio n  of 
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug. 
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient’s condition 
is essential and if super-infection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100mg/kg/day and 
above) have been associated w ith an 
increased incidence of eosinophilia and 
elevated SGOT.
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rare ly  required cessation of 
treatment and usually have been mild and 
transient.
Local Reactions
T h ro m b o p h le b it is  has occu rre d  w ith  
intravenous administration. Some degree of 
pain and tenderness is usually experienced 
after intramuscular injections using water. 
Induration has occasionally been reported. 
Allergic
M aculopapular rash, urticaria, pruritus, 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
T ra n s ie n t e o s in o p h ilia ,  le u k o p e n ia , 
neutropenia, hemolytic anemia, and thrombo- 
cy to p e n ia  have been reported. Some 
individuals, particularly those with azotemia, 
may develop positive direct Coombs tests 
during therapy with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rarely. The ro le  of 
MEFOXIN* in changes in renal function tests 
is d i f f ic u l t  to  assess, s ince  fa c to rs  
predisposing to prerenal azotemia or to 
impaired renal function have often been 
present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered in tra ­
venously or intramuscularly when required. 
(See complete monograph for full details on 
ADMINISTRATION and RECONSTITUTION.) 
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1g or 2g  of 
MEFOXIN* every 6 to 8 hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of Daily 
of infection Dosage
Frequency 
and Route
Uncomplicated 
forms* of in­
fections such as 
pneumonia, 
urinary tract 
infection, soft 
tissue infection
3-4 g 1 g every 6-8 h 
I.V. or I.M.
Moderately 
severe or severe 
infections
6-8 g 1 g every 4 h
or
2 g every 6-8 h I.V.
Infections 
commonly 
needing anti­
biotics in higher 
dosage (e.g. gas 
gangrene)
12 g 2 g every 4 h
or
3 g every 6 h I.V.
‘ Including patients 
absent or unlikely
in whomi bacteremia is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
A f te r  a lo a d in g  dose, the  fo l lo w in g  
recommendations for maintenance dosage 
may be used as a guide:
RENAL CREATININE
FUNCTION CLEARANCE DOSE F R E Q U E N C Y
m L /m in
Mild
impairment
Moderate
50-30 1-2 g every 8-12 h
impairment
Severe
29-10 1-2 g every 12-24 h
impairment
Essentially
9-5 0.5-1 g every 12-24 h
no function <5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2g should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
Prem ature Infants 
w ith  Body Weights 
Above 1500 g 20-40 mg/kg every 12 h I.V.
Neonates
0- 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
Children 20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
In severe infections, the total daily dosage in 
in fants and children may be increased to  
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN* is not recommended for the ther­
apy of meningitis. If meningitis is suspected, 
an appropriate antibiotic should be used.
At present there is in su ffic ie n t data to  
recommend a specific dosage for children 
with impaired renal function. THowever, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations fo r 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN is recommended as follows: 
Vaginal or abdominal hysterectom y and 
abdominal surgery
2 g a d m in is te re d  in tra m u s c u la r ly  o r 
in tra v e n o u s ly  ju s t p r io r  to  s u rg e ry  
(approximately one-half to one hour before 
initial incision).
The second and third 2 g doses should be 
administered at 2-6hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2 g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2 g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst 
Std.) is supplied as sterile powder in boxes of 
10 vials:
No. 3356 1 g cefoxitin as sodium salt 
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
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COUMADIN
(W a rfa rin  sod ium ) A N T IC O A G U L A N T
INDICATIONS COUMADIN®. Prophylaxis and treatment of venous thrombosis and its extension, treat­
ment o f atrial fibrillation w ith embolization, prophylaxis and treatm ent o f pulmonary embolism, and 
as an adjunct in the treatment of coronary occlusion.
The following are some of the more common clinical disorders which may be associated w ith or 
predispose patients to the above indications: 1. Thrombophlebitis 2. Congestive heartfailure 3. Surgical 
procedure or trauma associated with a high risk of thromboembolism 4. Myocardial infarction 5. Cerebral 
em bolism . It may also be useful as an adjunct in the treatment o f transient cerebral ischemic attacks 
due to intravascular clotting.
CONTRAINDICATIONS Any localized or general physical condition or personal circumstance in which 
the hazard o f hemorrhage might be greater than its potential clinical benefits, such as:
Pregnancy: COUMADIN® Is contraindicated in pregnancy because the drug passes through the 
placental barrier and may cause fatal hemorrhage to the fetus in utero. Furthermore, there have been 
reports o f b irth  malformations in children born to mothers who have been treated w ith warfarin during 
pregnancy. Women of childbearing potential who are candidates for anticoagulant therapy should be 
carefully evaluated and the indications critica lly reviewed w ith the patient. If the patient becomes preg­
nant while taking this drug, she should be apprised of the potential risks to the fetus, and the possibility 
of term ination of the pregnancy should be discussed in light o f those risks. Hemorrhagic tendencies 
or blood dyscrasias. Recent o r contemplated surgery of: 1. central nervous system 2. eye 3. traumatic 
surgery resulting in large open surfaces. Bleeding tendencies associated with active ulceration or overt 
bleeding of: 1. gastrointestinal, genitourinary or respiratory tracts 2. cerebrovascular hemorrhage 3. 
aneurysms -  cerebral, dissecting aorta 4. pericarditis and pericardial effusions 5. subacute bacterial 
endocarditis. Threatened abortion, eclampsia and preeclampsia. Inadequate laboratory facilities or un­
supervised senility, alcoholism, psychosis, or lack o f patient cooperation. Spinal puncture and other 
diagnostic o r therapeutic procedures w ith potential fo r uncontrollable bleeding. Miscellaneous: major 
regional, lum bar block anesthesia and malignant hypertension.
WARNINGS The most serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis 
and/or gangrene of skin and other tissues. The risk o f hemorrhage is related to the level of intensity 
and the duration o f anticoagulant therapy. Hemorrhage and necrosis have in some cases been reported 
to result in death or permanent disability. Necrosis appears to be associated w ith local thrombosis and 
usually appears w ithin a few days of the start of anticoagulant therapy. In severe cases of necrosis, treat­
ment through debridement or amputation of the affected tissue, limb, breast or penis has been reported. 
Careful diagnosis is required to determine whether necrosis is caused by an underlying disease. War­
farin therapy should be discontinued when warfarin is suspected to be the cause of developing necrosis 
and heparin therapy may be considered for anticoagulation. Although various treatments have been 
attempted, no treatment for necrosis has been considered uniform ly effective. See below for informa­
tion on predisposing conditions. These and other risks associated w ith  anticoagulant therapy must be 
weighed against the risk of thrombosis or embolization in untreated cases.
Warfarin sodium  is a potent drug w ith a half-life of 2.5 days: therefore, its effects may become more 
pronounced as daily maintenance doses overlap. It cannot be emphasized too strongly that treatment 
o f each patient is a highly individualized matter. Dosage should be controlled by periodic determina­
tions of prothrom bin time or other suitable coagulation tests. Determinations of whole blood clotting 
and bleeding tim es are not effective measures for control of therapy. Heparin prolongs the one-stage 
prothrombin time. Therefore, to obtain a valid prothrombin time when heparin and COUMADIN® are 
given together, a period of at least 5 hours should elapse after the last intravenous dose and 24 hours 
after the last subcutaneous dose of heparin, before blood is drawn. Caution should be observed when 
administered in any situation or in the presence of any predisposing condition where added risk of hemor­
rhage or necrosis is present. Administration o f anticoagulants in the follow ing conditions w ill be based 
upon clinical judgement in which the risks of anticoagulant therapy are weighed against the risk of throm­
bosis o r embolization in untreated cases. The following may be associated w ith  these increased risks:
•  Lactation -  Coumarins may pass into the m ilk of mothers and cause a prothrombinopenic state in 
the nursing infant. •  Severe to moderate hepatic o r renal insufficiency. •  Infectious diseases or distur­
bances of intestinal flora -  sprue, antibiotic therapy •  Trauma which may result in internal bleeding.
•  Surgery or trauma resulting in large exposed raw surfaces. •  Indwelling catheters. •  Severe to moderate 
hypertension.
Known or suspected heredity, familial or clinical deficiency in protein C: This condition, which should 
be suspected if there is a history o f recurrent episodes of throm boem bolic disorders in the patient or 
in the family, has been associated w ith an increased risk o f developing necrosis following warfarin ad­
m inistration. Skin necrosis may occur in the absence of protein C deficiency. It has been reported that 
initiation of anticoagulation therapy w ith heparin for 4 to 5 days before initiation of therapy with 
COUMADIN® may minimize the incidence of this reaction. Warfarin therapy should be discontinued when 
warfarin is suspected to be cause of developing necrosis and heparin therapy may be considered for 
anticoagulation.
Miscellaneous: polycythemia vera, vasculitis, severe diabetes, severe allergic and anaphylactic 
disorders. Patients w ith  congestive heart failure may become more sensitive to COUMADIN,® thereby 
requiring more frequent laboratory monitoring, and reduced doses of COUMADIN.® Concurrent use 
o f anticoagulants w ith  streptokinase or urokinase is not recommended and may be hazardous. (Please 
note recom m endations accompanying these preparations.) Abrupt cessation of anticoagulant therapy 
is not generally recommended: taper dose gradually over three to four weeks.
PRECAUTIONS Periodic determination of prothrombin time or other suitable coagulation testis essential.
Numerous factors, alone or in combination, including travel, changes in diet, environment, physical 
state and medication may influence response o f the patient to anticoagulants. It  is generally good prac­
tice to monitor the patient's response with additional prothrombin time determinations in the period 
immediately after discharge from the hospital, and whenever other medications are initiated, discon­
tinued or taken haphazardly. The following factors are listed for your reference: however, other factors 
may also affect the prothrombin response.
The following factors, alone in or combination, may be responsible for increased prothrombin time 
response: ENDOGENOUS FACTORS: Carcinoma; collagen disease; congestive heart failure; diarrhea; 
elevated temperature; hepatic disorders -  infectious hepatitis; hypothyroidism; jaundice; poor nutri­
tional state; vitam in K deficiency -  steatorrhea. EXOGENOUS FACTORS: A lcoho lf; allopurinol; 
aminosalicylic acid; amiodarone; anabolic steroids; antibiotics; bromelains; chloral hydratef; chlor­
propamide; chym otrypsin; cimetidine; cinchophen; clofibrate; COUMADIN® overdosage; dextran; 
dextrothyroxine; diazoxide; dietary deficiencies; diflunisal; d iure ticst; disulfiram; drugs affecting blood 
elements; ethacrynic acid; fenoprofen; glucagon; hepatotoxic drugs; ibuprofen; indomethacin; influenza 
virus vaccine; inhalation anesthetics; mefenamic acid; methyldopa; methylphenidate; metronidazole; 
miconazole; monoamine oxidase inhibitors; nalidixic acid; naproxen; oxolinic acid; oxyphenbutazone; 
pentoxifylline; phenylbutazone; phenyramidol; phenytoin; prolonged hot weather; prolonged narcotics;
pyrazolones; quinidine; quinine; ranitidinet; salicylates; sulfinpyrazone; long-acting sulfonamides; sulin- 
dac; thyroid drugs; tolbutamide; triclofos sodium; trimethoprim/sulfamethoxazole; unreliable prothrombin 
time determinations.
The following factors, alone or in combination, may be responsible for decreased prothrombin time 
response: ENDOGENOUS FACTORS: Edema, hereditary resistance to coumarin therapy, hyperlipemia, 
hypothyroidism. EXOGENOUS FACTORS: Adrenocortical steroids; a lcoho lf; antacids; antihistamines; 
barbiturates; carbamazepine; chloral hydratef; chlordiazepoxide; cholestyramine; COUMADIN® under­
dosage; diet high in vitam in K; d iure ticsf; ethchlorvynol; glutethimide; griseofulvin; haloperidol; 
meprobamate; oral contraceptives; paraldehyde; primidone; ranitidinef; rifampin; unreliable prothrombin 
time determinations; vitam in C. A patient may be exposed to a combination of the above factors, some 
of which may increase and some decrease the patient's sensitivity to COUMADIN.® Because the net 
effect on prothrombin time response may be unpredictable under these circumstances, more frequent 
laboratory m onitoring is advisable. Drugs not yet shown to interact or not to interact w ith coumarins 
are best regarded w ith suspicion, and when their administration is started o r stopped, the prothrombin 
time should be determined more often than usual. Coumarins also affect the action of other drugs. 
Hypoglycemic agents (chlorpropamide, tolbutamide and glyburide) and anticonvulsants (phenytoin and 
phenobarbital) may accumulate as a result of interference with their metabolism or excretion. 
ADVERSE REACTIONS Potential side effects may include: •  Hemorrhage from  any tissue or organ. This 
is a consequence of the anticoagulant effect. Signs and symptoms w ill vary according to location and 
degree or extent o f bleeding. Therefore, the possibility of hemorrhage should be considered in evaluating 
the condition of any anticoagulated patient with complaints which do not indicate an obvious diagnosis. 
Bleeding during anticoagulant therapy does not always correlate w ith prothrombin activity. (See TREAT­
MENT FOR OVERDOSAGE.) Bleeding which occurs when the prothrombin time is within the therapeutic 
range warrants diagnostic investigation, since it may unmask a previously unsuspected lesion, e.g. tumor, 
ulcer, etc. •  Necrosis of skin and other tissues. (SEE WARNINGS). •  Other adverse reactions are infrequent 
and consist of alopecia, urticaria, dermatitis, fever, nausea, diarrhea, abdominal cramping, a syndrome 
called “ purple toes," and hypersensitivity reactions. •  Priapism has been associated with anticoagulant 
administration, however, a causal relationship has not been established.
DOSAGE: Should be gauged according to prothrombin time determinations by a suitable method. Blood 
prothrombin time should be determined daily after the administration of the in itial dose until prothrom­
bin time results stabilize in the therapeutic range. Intervals between subsequent prothrombin time deter­
minations should be based upon judgement of the patient’s reliability and response to warfarin in order 
to maintain the individual within the therapeutic range. Acceptable intervals for prothrombin time deter­
minations have usually fallen within the range of one to four weeks. Satisfactory levels for maintenance 
of therapeutic anticoagulation are 1.5 to 2.5 times the normal prothrombin time (e.g. 18 to 30 seconds, 
w ith a control o f 12 seconds).
Induction -  Induction may be initiated w ith 10 to 15mg daily and thereafter (usually 2 or 3 days) 
adjusted according to prothrombin time response. The basis for the no-loading dose regimen is that 
the depression of Factors II, IX, and X is not accelerated by the administration of a loading dose. Avoidance 
of a large prim ing dose may minimize the possibility of excessive increases in prothrombin time.
Maintenance -  Most patients are satisfactorily maintained at a dose of 2 to 10mg daily. Flexibility 
is provided by breaking scored tablets in half. The individual dose and interval should be gauged by the 
patient's prothrombin response. Alternatively, 40 to 60mg for average adult or 20 to 30mg for elderly 
and/or debilitated patients fo r one dose only.
Duration o f therapy -  The duration of therapy in each patient should be individualized. In general, 
anticoagulant therapy should be continued until the danger o f thrombosis and embolism has passed.
Treatment during dentistry and surgery- Management of patients requires close liaison between 
attending physicians, surgeons and dentists. Interruption of anticoagulant therapy may precipitate 
thromboembolism, conversely, at full doses, some patients may hemorrhage excessively. If it is elected 
to administer anticoagulants prior to, during, or immediately following dental or surgical procedures, 
it is recommended the dosage be adjusted to maintain the prothrombin time at approximately 1.5 to 
2.5 times the control level. The operative site should be limited to perm it the effective use of local pro­
cedures for hemostasis including absorbable hemostatic agents, sutures, and pressure dressings if 
necessary. Under these conditions dental and surgical procedures may be performed without undue 
risk of hemorrhage.
COUMADIN® with heparin -  Since a delay intervenes between the administration of the initial dose 
and therapeutic prolongation of prothrombin time, it may be advisable in emergency situations to ad­
minister sodium heparin in itially along w ith COUMADIN.® Heparin may affect the prothrombin time, 
and therefore, when patients are receiving both heparin and COUMADIN,® the blood sample for pro­
thrombin time determination should be drawn just prior to the next heparin dosage, at least 5 hours 
after the last intravenous injection or 24 hours after the last subcutaneous injection.
SYMPTOMS AND TREATMENT OP OVERDOSAGE Excessive prothrombinopenia, w ith or without 
bleeding, is readily controlled by discontinuing COUMADIN,® and if necessary, by the oral or parenteral 
administration of vitamin K , . The appearance of microscopic hematuria, excessive menstrual bleeding, 
melena, petechiae or oozing from  nicks made while shaving are early manifestations of hypoprothrom- 
binemia beyond a safe and satisfactory level. In excessive prothrombinopenia w ith mild or no bleeding, 
omission of one or more doses of COUMADIN® may suffice, and if necessary, small doses of vitamin 
K, orally, 2.5 to 10mg will usually correct the problem. If m inor bleeding persists, or progresses to frank 
bleeding, vitamin K, in doses o f 5 to 25mg may be given parenterally (please note recommendations 
accompanying vitam in K, preparations prior to use.) Fresh whole blood transfusions should be con­
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Repair and Survival
of the Innominate Artery Late After Transection
Survival of major thoracic arteries tran­
sected by blunt trauma usually depends 
on immediate surgical repair. However, 
the authors report a case in which a 
54-year-old man had survived an 
untreated complete transection of the 
innominate artery 20 years before. He 
presented with subclavian steal syn­
drome and transient ischemic attacks. 
There was wide separation between the 
proximal and distal stumps of the artery 
with no apparent continuity of tissue 
between them. A 10-mm Gore-Tex graft 
was successfully used as a bypass from 
the ascending aorta to the distal carotid 
bifurcation. Survival of the innominate 
artery transection without treatment and 
late onset of symptoms has not previ­
ously been described.
Dans les cas de dissection transversale 
par traumatisme ferme la survie des prin- 
cipales artEres thoraciques dEpend d'une 
reparation chirurgicale immediate. Les 
auteurs signalent toutefois le cas d'un 
homme de 54 ans qui a survecu a une 
dissection transversale complete du 
tronc arteriel brachiocephalique subie 20 
ans plus tdt. II a ete admis presentant un 
syndrome de vol sous-clavier et des Epi­
sodes d'accidents cerebrovasculaires 
transitoires de nature ischemique. II exis- 
tait une separation large entre les seg­
ments proximal et distal de I'artEre et 
aucune permeabilite apparente entre eux. 
Un greffon de Gore-Tex de 10 mm a per- 
mis d'etablir une derivation entre I'aorte 
ascendante et la bifurcation carotidienne 
distale. La survie sans traitement du 
tronc arteriel brachiocephalique & une 
dissection transversale et I'apparition tar­
dive des symptomes n'avaient pas EtE 
dEcrites jusqu'a maintenant.
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Blunt chest trauma can be associated with 
lethal injuries to the aorta and great ves­
sels. Although the most common site of 
injury is the aortic isthmus, the literature 
also reports cases of acute injury to the 
innominate origin as another common 
site.1 Survival o f these major arteries 
depends upon immediate surgical repair. 
In the acute situation these types o f injury 
are quite lethal even with early surgical 
treatment. The following case describes 
survival after complete transection of the 
proximal innominate artery without sur­
gical treatment, the patient presenting 20 
years later with subclavian steal syndrome 
and transient ischemic attacks.
Case Report
A 54-year-old man presented for a work-up 
and therapy of recurrent transient ischemic 
attacks involving amaurosis fugax of his right 
eye as well as vertebral basilar symptoms of 
dizziness. The episodes had started approxi­
mately 6 weeks before admission and were 
becoming increasingly frequent. Examination 
revealed a carotid bruit on the right side and 
an old healed scar over the right sternoclavic­
ular joint and manubrium. There was a blood 
pressure differential between the left and the 
right arms, the pressures being 140/70 mm Hg 
and 90/60 mm Hg, respectively. An angiogram 
of the aortic arch and major vessels (Figs. 1 
and 2) showed a small blind pouch at the ori­
gin of the innominate artery and retrograde fill­
ing of the right subclavian and right carotid 
arteries by way of the right vertebral artery. 
There was no communication between the aor­
tic arch and the innominate bifurcation.
Careful review of this man’s medical history 
revealed that he had been involved in a motor 
vehicle accident 20 years previously. He had 
sustained major head and chest injuries and 
was hospitalized for approximately 6 weeks. 
Immediately after the injury he was comatose 
for several hours. His chest injuries included 
a fractured sternum, fractured right clavicle 
and dislocated shoulder. He also described a 
laceration of the right anterior chest wall. No 
hospital records were available from the previ­
ous injury.
At operation the aortic arch and vessels were 
exposed through a median sternotomy with 
extension along the right sternomastoid mus­
cle. On dissection there was indeed complete 
transection of the proximal innominate artery 
with wide separation of the proximal and dis­
tal stumps and no evident tissue continuity
FIG. 1—Angiographic appearance of prox­
imal innominate stump.
FIG. 2—Angiographic appearance of retro­
grade distal subclavian artery filling by way of 
vertebral artery.
VOLUME 30, NO. 3, M AY 1987 /  THE CANADIAN JOURNAL OF SURGERY 201
between these areas. There was marked fibro­
sis surrounding the aortic arch and origin of 
the innominate artery which had become some­
what aneurysmal (Fig. 3). The patient was 
heparinized and, with a partially occluding 
clamp, reinforced sutures were placed across 
the base of the aneurysmal innominate stump. 
A 10-mm Gore-Tex graft was then used as a 
bypass from the ascending aorta to the distal 
carotid bifurcation (Fig. 4). Postoperatively, 
there was equalization of the pressure in both 
upper extremities and the patient’s neurologic 
symptoms were alleviated.
Discussion
Avulsion or transection injuries at the
origin of the innominate artery are 
immediately life-threatening, and most 
patients die before reaching the hospi­
tal.2’3 This is an unusual injury, occur­
ring only in patients sustaining major 
chest trauma and then in only 2% of 
them.4 The fact that a patient sustained 
such an injury and survived the acute 
insult as well as the late sequelae, present­
ing 20 years later with subclavian steal 
syndrome, is remarkable.
From descriptions of injury, two pos­
sible mechanisms can be postulated — 
posterior dislocation of the sternoclavic­
ular joint, crushing and severing the 
innominate artery at its origin between the
Fig. 3a Fig. 3b
FIG. 3—(a) Operative photograph with (b) accompanying drawing demonstrating prox­
imal innominate artery aneurysm and distal subclavian carotid bifurcation with no tissue con­
tinuity between. A = cut edge of midline sternotomy, B = ascending aorta, C = innominate 
vein, D = proximal aneurysmal innominate stump, E = distal carotid subclavian bifurcation, 
F = common carotid artery, G = proximal subclavian artery, H = proximal vertebral artery.
Fig. 4a Fig. 4b
FIG. 4—(a) Completed graft showing distal anastomosis at subclavian carotid bifurcation 
and (b) accompanying diagram. A = cut edges of midline sternotomy, B = ascending aorta, 
C = innominate vein, D = Gore-Tex graft with distal anastomosis, E = carotid subclavian 
bifurcation.
sternum and vertebral column,5 and a 
shearing injury caused by displacement of 
great vessels with hyperextension of the 
cervical spine.6,7 Injuries to the great ves­
sels as a result of blunt chest trauma in 
the acute clinical situation are well 
described in the literature. Occasionally, 
patients present with stable vital signs, 
and in these cases acute awareness of the 
condition is necessary, since x-ray films 
may not reveal mediastinal widening in 
approximately 28% of such patients.8 
Not only was the diagnosis not made at 
the time of our patient’s injury but also 
he survived without exsanguinating 
hemorrhage which is often the terminal 
event in injuries to the great vessels. 
Marked spasm of the severed vascular 
stumps and perhaps some element of tam­
ponade must have averted major hemor­
rhage at the time of the injury, although 
this is conjecture. Late presentation, due 
to neurologic sequelae of the subclavian 
steal syndrome, resulted because of other 
atherosclerotic involvement of his 
cerebral circulation with some com­
promise of what was previously adequate 
cerebrovascular supply.
A review of the literature revealed 
descriptions of patient presentation with 
acute injuries to the great vessels as well 
as potential complications9 and descrip­
tion of various surgical repairs under­
taken on these injuries. No previous 
description could be found of long-term 
survival of such an injury without surgi­
cal treatment and of the late presentation 
of patients sustaining and surviving such 
injuries.
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Jejunal Atresia Secondary to Intrauterine Intussusception,
Presenting as Acute Perforation
Intussusception in neonates is rare. The 
authors report the second case in the 
Western literature of neonatal intus­
susception presenting as pneu­
moperitoneum. A male infant was 
referred 30 hours after birth because of 
possible midgut volvulus after emesis 
and failure to pass meconium. An 
abdominal x-ray film revealed a large 
amount of free air in the peritoneal 
cavity. At operation a type 3 jejunal atre­
sia was found, with a 2-mm perforation 
in the dilated proximal end and a viable 
intussusceptum just inside the distal end. 
The authors conclude that this case 
represents an atresia secondary to in- 
utero intussusception, with perforation 
occurring after birth (secondary to air­
swallowing and gastrointestinal secre­
tions).
L'intussusception chez le nouveau-ne est 
un phenomene rare. Les auteurs decri- 
vent le second cas signale dans la presse 
medicale occidentale, cas oil I'intussus- 
ception neonatale s'est exprimee dans 
un tableau de pneumoperitoine. Un b6be 
de sexe masculin a ete recu 30 heures 
apres sa naissance pour volvulus pre­
sume de I'intestin moyen se traduisant 
par des vomissements et I'incapacite 
d'evacuer le meconium. Une radiographie 
abdominale a revele une quantite consi­
derable d'air libre dans la cavity perito- 
neale. A la chirurgie, une atrdsie jejunale 
de type 3 fut ddcouverte, de meme 
qu'une perforation de 2 mm dans la par- 
tie proximale dilatee, et une invagination 
viable juste d I'interieur de I'extremitg 
distale. Les auteurs concluent que ce cas 
reprgsente une atrdsie secondaire a une
From the Department o f  Surgery, Section 
o f  Pediatric Surgery, University o f  Michi­
gan Medical School, Ann Arbor, Mich.
Accepted for publication Aug. 1, 1986
Reprint requests to: Dr. D.N. Reed,
G-1134 South Linden Rd., Flint, M I 48504, 
USA
intussusception in utero, la perforation 
survenant apres la naissance (apr&s aspi­
ration d'air et action des secretions 
gastro-intestinales).
Intussusception in infants is not uncom­
mon, but is rare in the neonate.1 When 
it presents in the first few days of life, 
the intussusception is considered to have 
occurred in utero.2 A few cases of intes­
tinal atresia secondary to intrauterine 
intussusception have been reported in the 
world literature.3-9 We report a neonate 
who presented with free air in the 
abdominal cavity and, at laparotomy, 
was found to have an atretic jejunal seg­
ment with perforation in the proximal end 
and an intussusceptum into the distal end.
Case Report
After an uncomplicated delivery at 35 weeks’ 
gestational age in another hospital, a male 
infant (weight 2260 g) suffered repeated eme­
sis and failed to pass meconium. Abdominal 
x-ray films 24 hours after birth revealed 
absence of air in the distal small bowel and 6 
hours later he was referred to University Hospi­
tal with a possible diagnosis of midgut vol­
vulus.
Initial examination revealed a healthy well- 
developed male infant who appeared prema­
ture but in no acute distress. The abdomen was 
mildly distended but soft, with active bowel 
sounds. Repeat abdominal x-ray films revealed 
a large amount of free air in the peritoneal 
cavity. Laparotomy was carried out immedi­
ately.
A large amount of meconium-stained fluid 
was found in the peritoneal cavity. A  type 3 
atresia10 was found in the jejunum 40 cm dis­
tal to the ligament of Treitz. A small perfora­
tion (approximately 2 mm in size) was found 
in the dilated distal end of the proximal seg­
ment, which was thought to be the origin of 
the peritoneal air and fluid (Fig. 1). The prox­
imal end of the distal segment o f jejunum 
appeared dilated, though the end was well- 
rounded and smooth. An opening was made 
just distal to this dilatation and a viable intus­
susceptum was found.
The dilated portions of both segments were 
resected and an end-to-end anastomosis was 
performed. The baby tolerated the procedure 
well and had an uncomplicated postoperative 
course.
Discussion
Neonatal intussusception appearing in 
the first few days of life is exceedingly 
uncommon.8 Rachelson and colleagues,1 
in an exhaustive search of the literature, 
reported that only 0.3% of all infantile 
intussusception occurred in the first 
month of life. In the 30 years since that 
study there have been occasional reports 
from different parts of the world of 
neonates who have undergone 
laparotom y for mechanical bowel 
obstruction and have been found to have 
atretic segments of intestine with a via­
ble intussusceptum in the distal end.1-7,9
Although Rachelson and colleagues1 
did not recognize that the type 3 ileal atre­
sia in their case represented in-utero intus­
susception, theirs was the first such 
report. Three years later Parkkulainen2 
from Finland reported three cases and 
recognized that the problem arose from 
an intrauterine occurrence. We found 
reports of 30 cases in the past 30 years 
throughout the world, the largest num­
ber coming from Japan.7
Studies by Louw10 and Abrams11 have 
convincingly demonstrated that intrauter­
ine blockage of mesenteric vessels results 
in intestinal atresia in experimental 
animals. Louw10 described the four types 
of intestinal atresia that can result, and 
it is types 2 and 3 that, clinically, appear 
to follow intrauterine intussusception. 
Todani and associates7 described what
FIG. 1—Atretic jejunal segment with 
resected ends. Dilated segment to right was 
proximal end with perforation; distal end con­
taining viable intussusceptum is seen at left.
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we believe is the likely mechanism for 
atresia following intussusception.
The particular presentation of our 
patient, with free intra-abdominal air 
secondary to perforation of the dilated 
jejunal end proximal to the atresia, 
appears to be exceedingly rare, the only 
previous case being reported by Nixon in 
1955.3 Neonates with this clinical picture 
usually present within 1 to 4 days of birth. 
At celiotomy, besides perforation, a type 
2 or 3 atresia is found with a dilated prox­
imal end and possibly an intussusceptum 
just inside the distal end. Because of 
problems with motility, the dilated ends 
should be resected (provided an excessive 
length of intestine is not sacrificed) and 
an end-to-end anastomosis constructed. 
The prognosis is favourable.
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Delayed Union and Nonunion of the Tibia: 
Experience in a Community Teaching Hospital
Delayed union and nonunion are frequent 
sequelae of high-energy tibial fractures, 
particularly compound ones. The authors 
studied 45 such cases; of these. 20 
fractures were compound. The authors 
analysed the initial management but 
found no apparent correlation between 
the initial management of these fractures 
and subsequent delayed union or 
nonunion.
The Phemister bone-grafting technique 
was used to achieve union and was con­
sidered a safe, efficacious method. 
Aggressive initial management of the 
soft-tissue component of tibial fractures 
is recommended to minimize the possible 
development of chronic osteomyelitis, a 
serious complication that occurred in 
eight patients and necessitated below- 
knee amputation in three.
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L'union retardee et la disunion sont des 
sequelles frequentes des fractures tibia- 
les de haute energie, particulierement 
celles qui sont multiples. Les auteurs 
etudi&rent 45 de ces cas dont 20 consti- 
tuaient des fractures multiples. Les 
auteurs analys&rent le traitement initial 
mais ne trouverent aucune correlation 
apparente entre le traitement initial de 
ces fractures et le delai subequent 
d'union ou de desunion.
La technique de Phemister fut utilise 
pour realiser l'union et fut consid6re 
comme une methode securitaire et effi- 
cace. Le traitement agressif initial de la 
composante de tissu mou des fractures 
tibiales est recommande pour minimiser 
les risques de developpement 
d'osteomyelite chronique, une complica­
tion s6rieuse qui s'est manifestee chez 
huit patients et qui a necessiste une 
amputation sous le genou chez trois 
d'entre eux.
Noninvasive methods using electrical 
stimulation have recently been advocated 
to treat fractures of the tibia that have 
failed to unite.1,2 Good results have been 
reported3 utilizing surgical techniques of
internal fixation without bone grafting. 
However, basic principles should not be 
forgotten since they can be combined with 
the newer methods for even better results. 
The purpose of this paper is to report our 
experience in the treatment of delayed 
union and nonunion after fracture of the 
tibia in a community hospital where the 
Phemister bone grafting technique4 was 
the primary method used to achieve bony 
union.
Patients and Methods
From 1974 to 1984, 249 fractures of the 
tibial shaft in adults were treated at the 
Toronto East General and Orthopaedic 
Hospital; 212 were closed and 37 open. 
Fractures in 45 patients (36 men, 9 
women) were still not united 5 months or 
more after injury; 20 of these were com­
pound. A diagnosis of nonunion was 
made when there was pain or movement, 
or both, at the fracture site, without radi­
ologic evidence of normal progression to 
union at a minimum of 5 months after 
injury.
Of the 45 patients, fractures in 30 were 
attributed to high-velocity injuries from 
motorcycle or motor vehicle accidents or 
pedestrians struck by a moving vehicle;
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20 of the 30 fractures were compound and 
10 were closed. Of the 15 low-velocity 
injuries, the fractures in 10 occurred as 
a result of falls and in 5 from direct 
blows.
The average age of the patients was 34 
years (range from 15 to 73 years). The 
average follow-up was 5.6 years.
Nine of the 45 fractures occurred in the 
proximal tibia, 5 in the middle third, 27 
in the distal third and 4 were two-level 
segmental fractures. Fibular fractures 
were present in all patients. Fourteen frac­
tures were comminuted.
The 20 open fractures were all treated 
initially by debridement of the wound, 
irrigation, local and systemic antibiotic 
therapy and closed reduction. An exter­
nal fixator (Roger-Anderson apparatus) 
was used to stabilize three fractures 
(Table I). Five were immobilized in 
above-knee non-weight-bearing plaster 
casts and nine were treated with pins 
inserted into the proximal tibia and os 
calcis, incorporated into an above-knee 
cast. Three were treated in traction 
through an os calcis pin with the leg sup­
ported on a Bohler-Braun frame before 
applying an above-knee plaster incor­
porating the pin. Internal fixation was not 
used to stabilize any of these open frac­
tures. According to the classification of 
Gustilo and Anderson,5 nine compound 
fractures were classified as type III and 
all required plastic surgery for skin 
closure. Deep infection (chronic 
osteomyelitis) occurred in eight patients; 
in one — a closed injury — open reduc­
tion and internal fixation were used to 
stabilize the fracture; five infections 
occurred with type III injuries and two 
with type II injuries.
Of the closed fractures, eight were 
treated by the application of an above­
knee plaster cast and six had pins inserted 
into the proximal tibia and os calcis, 
incorporated into an above-knee plaster 
(Table I). Six were treated by traction 
using an os calcis pin with the leg sup­
ported on a Bohler-Braun frame. Open 
reduction was performed on five patients 
with unstable closed fractures. Two were 
treated by screw fixation and a patellar 
tendon-bearing cast, and three by open 
reduction and internal fixation using a 
rigid AO plate and screws.
The average time between the initial 
injury and bone grafting was 30 weeks 
(range from 21 to 39 weeks). Pseudar-
T a b le  1— In it ia l  F r a c tu r e  M a n a g e m e n t
M e th o d
F r a c tu r e  ty p e  
C o m p o u n d  C lo s e d
A b o v e -k n e e  c a s t  o n ly 5  8
P in s  a n d  c a s t 9  6
O s  c a lc is  t r a c t io n  (c a s t ) 3  6
E x te r n a l f ix a to r 3
O p e n  re d u c t io n 5
throses were described as hypertrophically 
active (the so-called elephant foot or vas­
cular pseudarthrosis) in 35 cases (Fig. 1) 
and atrophic (nonreactive avascular 
pseudarthrosis) in 10 (Fig. 2).
In 37 patients, tibial surgery for 
nonunion was performed through an 
anterolateral approach, employing the 
Phemister grafting technique on 32 occa­
sions. Cortical onlay grafting was used in 
three patients and compression plating 
without grafting in two. A posterolateral 
approach and Phemister grafting was per­
formed in eight patients, all with infected 
nonunion. Im m obilization o f the 
pseudarthrosis after bone grafting 
involved the application of a plaster cast 
only in 21 patients, a metal buttress plate 
without compression in 14, an AO plate 
with compression in 7 and an intramedul­
lary rod in 1 patient. Two hypertrophic 
pseudarthroses were treated with a com­
pression plate using only local callus for 
grafting.
Results
Surgical treatment for nonunion was 
successful in 42 of the 45 patients. The 
Phemister technique was used in 40 
patients and was successful in 37 (92.5%). 
Clinical union, indicated by full weight 
bearing without pain or movement at the
FIG. 1—Hypertrophic vascular pseudarthro­
sis which characteristically has appearance of 
elephant’s foot, with exuberant new bone and 
callus formation.
fracture site, occurred on average at 14 
weeks after operation. Three patients with 
type III fractures and infected nonunion 
had at least two further bone grafting 
procedures and one patient was treated, 
unsuccessfully, with a pulsing electromag­
netic field after unsuccessful Phemister 
grafting. All had amputation. There were 
no operative wound infections or injuries 
to local neurovascular struc tu res 
attributable to the surgical techniques 
used to establish union.
Discussion
Our series is not extensive but reflects 
the collective experience of orthopedic 
surgeons at a suburban hospital in the 
treatment of delayed union and nonun­
ion of tibial fractures. The Phemister 
grafting technique was successful in 
92.5% of our cases. The role of internal 
metallic fixation as an adjunct to bone 
grafting was not defined in this series. 
Various methods of fixation were used as 
a supplement to bone grafting in 53% (24) 
of our patients. The remainder (21) were 
immobilized simply in a plaster cast. 
Internal metallic fixation may be required 
for stability, particularly when realign­
ment of the fracture is necessary. In our 
series, removal of the callus was required 
in only two patients to facilitate realign-
FIG. 2—Atrophic nonreactive avascular 
pseudarthrosis: fracture site appears indolent 
with no evidence of callus or attempt at frac­
ture healing. Bone appears osteoporotic in area 
of fracture.
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ment and, in both, metallic fixation was 
used to enhance stability (Fig. 3). In the 
remaining cases in which internal fixation 
was used as an adjunct to bone grafting, 
the indications for its use were not as 
clearly defined. No appreciable difference 
in healing rate was noted between patients 
who had plaster casts only to immobilize 
bone after grafting (14.7 weeks) and those 
who had internal fixation (13.9 weeks), 
except when the fracture was infected. 
Phemister6 advocated leaving the frac­
ture callus intact. In his opinion callus 
affords stability to fracture fragments, 
preventing displacement during recon­
structive surgery. Although immobiliza­
tion of the tibia undoubtedly is important 
after grafting, the use of autogenous can­
cellous bone strips (with or without inter­
nal fixation) appears to be the single most 
important factor contributing to subse­
quent bony union. The study illustrates 
that successful management of an 
ununited fracture of the tibia is possible 
in a high percentage of cases when this 
technique is used.
Our failure rate in cases of established 
deep infection was high. Three below- 
knee amputations were performed in 
eight patients with infection of an 
ununited fracture. This is in accord with 
Nicholl’s7 observation that the develop­
ment of infection is associated with a high
FIG. 3— Internal metallic fixation. This frac­
ture was stabilized with metal plate and screws 
when Phemister bone grafting was performed. 
Nonunion was healed completely.
incidence of nonunion and subsequent 
risk of amputation.
We could not demonstrate from this 
review a correlation between the initial 
fracture management and subsequent 
nonunion. Rosenthal and colleagues8 
reported a high incidence of nonunion in 
two patient treatment groups — those 
whose initial management was open 
reduction and internal fixation and those 
who had pins incorporated above and 
below the fracture in plaster. They found 
a much lower incidence of nonunion in 
patients treated conservatively (cast only) 
with or without early weight bearing. In 
our series, a substantial number of 
patients in both the open (12) and closed 
(12) groups were treated initially with pins 
incorporated into an above-knee cast. 
Both groups include fractures managed 
initially with an os calcis traction pin. This 
might suggest that pin techniques pro­
mote nonunion; however, all of these 
injuries were unstable high-energy frac­
tures treated in this manner to establish 
stability or facilitate wound treatment, in 
an era before the development of efficient 
external fixators (Fig. 4). Delayed union 
with external fixators, as well as the 
propensity for nonunion in high-energy 
fractures, particularly those that are com-
FIG. 4—Pins incorporated into plaster for 
fracture stabilization. This two-level segmen­
tal fracture of tibia was stabilized with pins 
inserted through tibia and incorporated into 
above-knee plaster cast. This type of fracture 
would now be treated with external fixator.
pound, has been reported by others.9 
Such injuries tend to occur predominantly 
in young men with inherent economic 
sequelae. A strong argument can there­
fore be made for early grafting of high- 
energy fractures. Success can be expected 
when the basic techniques of bone graft­
ing as advocated by Phemister are fol­
lowed. We recommend the anterior ap­
proach to the tibia due to its simplicity, 
and reserve the posterior approach for 
those fractures that are infected.
Conclusions
In the treatment of delayed union and 
nonunion of tibial fractures, solid bony 
union can be anticipated in a high percen­
tage of cases using the Phemister bone­
grafting technique. Union can also be 
anticipated in a substantial number of 
cases without internal fixation of frag­
ments when grafting is required. The 
Phemister technique is safe and effica­
cious. There is an indication for early 
bone grafting in the treatment of high- 
energy tibial fractures. Deep infection, 
when it occurs, is disastrous. Aggressive 
management of the soft-tissue component 
of these injuries is important to minimize 
the likelihood of osteomyelitis. The role 
of initial management of these fractures, 
with respect to the development of non­
union, is unclear. Our review affirms the 
observation that nonunion is a frequent 
sequela of high-energy tibial fractures, 
particularly those that are compound.
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Sporadic Hemorrhagic Colitis 
Associated With Escherichia coli, Type 0157:H7: 
Unusual Presentation Mimicking Ischemic Colitis
Hemorrhagic colitis is a bacterial infec­
tion of the colon, associated with a 
verotoxigenic strain of Escherichia coli, 
commonly serotype 0157:H7. This 
recently described disease is usually self- 
nmiting. Because recai cultures are nega­
tive for the usual pathogens and the 
clinicopathologic features closely mimic 
ischemic colitis, the patient is exposed 
to the risk of unnecessary surgery. One 
such situation is described and differenti­
ation between hemorrhagic and ischemic 
colitis is discussed.
La colite hemorragique est une infection 
bactdrienne du cdlon relive a une souche 
tres toxigene A'Escherichia coli dont le 
serotype commun est 0157:H7. Cette 
maladie dont la description est rdcente 
evolue habituellement naturellement vers 
la gu6rison. Parce que les cultures de 
selles donnent habituellement des resul- 
tats negatifs pour les pathogfenes habi- 
tuels et comme les caracteristiques clini- 
copathologiques se confondent 
facilement avec celles de la colite ische- 
mique, le patient peut etre expose aux 
risques d'une intervention chirurgicale 
inutile. Une telle situation est dScrite et 
on commente les entires de difterencia- 
tion entre la colite hemorragique et la 
colite ischemique.
Hemorrhagic colitis is an infectious dis­
ease caused by Escherichia coli, mainly 
serotype 0 1 5 7 :H 7 .1-5 It is usually 
associated with the consumption of 
undercooked hamburgers. It occurs both 
sporadically3-6 and in epidemics,1’2’7 and 
is characterized by colicky abdominal 
pain, profuse watery diarrhea that rapidly 
turns bloody, and frequent nausea and 
vomiting. Endoscopic findings are non­
specific;1,5 radiologic studies show
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“ thumb-printing” of the cecum and 
ascending and transverse colon.1’5 The 
condition is usually self-limiting and sub­
sides in 6 to 10 days, with or without the 
administration of antibiotics.
Laooraiory nnamgs of intravascular 
coagulation may be seen later in the 
course of disease,8 further confusing the 
picture. These circumstances, along with 
the absence of common stool pathogens, 
delay in establishing a microbiologic 
diagnosis1’5,6 and rarity o f the disease, 
can lead to the misdiagnosis of ischemic 
colitis or other surgical conditions, and 
a patient may undergo laparotomy 
unnecessarily.1’6 We report one such case 
in which surgical intervention was con­
templated, and compare and contrast the 
features of hemorrhagic and ischemic 
colitis.
Case Report
A 61-year-old white woman was admitted to 
the Emergency Service of University Hospital, 
London, Ont., with colicky abdominal pain, 
bloody diarrhea, nausea and vomiting, all of 
3 days’ duration. The cramps were generalized, 
diminishing in intensity on the second day, only 
to worsen again on the day of admission. The 
abdominal pain decreased only slightly with 
defecation. Diarrhea was almost continuous, 
starting with watery stools that became mixed 
with fresh blood on the second day. The patient 
had not eaten hamburgers in the week before 
the onset of diarrhea. She had recently moved 
from one trailer park to another that had a 
separate water supply. No one else in her neigh­
bourhood, including her husband, was ill. 
There was no recent change in body weight and 
no history of a similar illness. Her appetite had 
been poor and 6 months before admission she 
had complained of dysphagia, but radiologic 
investigations had not revealed any abnor­
mality.
On examination, she was afebrile and vital 
signs were normal. There was no pallor, cya­
nosis or jaundice. The abdomen was soft and 
not tender, and bowel sounds were present. 
Rectal examination showed a small amount of 
blood-tinged feces, but no masses were palpa­
ble. Abdominal x-ray films showed occasional 
slightly dilated small intestinal loops with air- 
fluid levels. There was no free air in the 
peritoneal cavity. Laboratory investigations 
revealed leukocytosis (total leukocyte count 
17.7 x 109/L ) with 89% neutrophils. The
hemoglobin level, electrolyte values and blood 
urea nitrogen, creatinine, bilirubin and albu­
min levels were within normal limits. A work­
ing diagnosis of infectious gastroenteritis was 
made and she was treated with appropriate 
intravenous fluids and hyoscine butylbromide 
(Buscopan; Boehringer Ingelheim, Canada 
Ltd., Burlington, Ont.) intramuscularly.
On hospital day 2, her abdomen became 
diffusely tender with guarding and exquisite 
rebound tenderness. Bowel sounds were present 
and vital signs were stable. Fecal cultures 
(specimen obtained on day 1) were negative for 
enteric pathogens, including Yersinia, Shigella, 
Salmonella, Campylobacter and Clostridium 
difficile, as well as for trophozoites, cysts and 
ova. A gram smear showed 3 + pus cells. An 
abdominal x-ray film showed air in the colon 
with “ thumb-printing” in the transverse and 
descending colon. A Flex sigmoidoscopic 
examination (up to 40 cm) showed erythema­
tous and markedly edematous mucosa with 
patchy exudate in the middle and proximal por­
tions of the sigmoid colon. No obvious 
ischemic area was seen. Biopsies of mucosa 
from rectum and sigmoid colon were inter­
preted as normal with surface exudate. Ther­
apy with gentamicin and metronidazole was 
instituted.
She continued to have periodic exacerbations 
of non-localized abdominal pain and tender­
ness. Oliguria was corrected with appropriate 
fluids intravenously. Her diarrhea decreased 
and she developed ascites. Daily abdominal x- 
ray films showed resolution of the colonic 
mucosal edema and no evident megacolon. 
Repeat sigmoidoscopy showed flattened rec­
tosigmoid mucosa with pale exudate and 
absence of the previously noted edema. Biop­
sies showed nonspecific inflammation.
Her hemoglobin continued to fall from 144 
g/L on hospital day 1 to 132 g/L  on day 4 to 
88 g /L  on day 8. There was mild reticulocyto- 
sis (97 x 109/L , reference range 10 to 75 x 
109/L ) fragmented erythrocytes and a low 
haptoglobin level (0.15 g/L , reference range 
0.4 to 1.6 g/L ). On day 6 the platelet count 
had fallen to 21 x 109/L  with prothrombin 
and partial thromboplastin times in the nor­
mal range; thrombin time increased (11.5 
seconds, reference range 6 to 10 seconds) and 
the fibrinogen degradation products increased 
from 40 to 80 /ig/ml (reference range 0 to 10 
/ig/ml). At this point, septicemia due to 
ischemic bowel, severe enteritis or perforation, 
as well as the possibility of drug-related throm­
bocytopenia and hemolysis were considered. 
Exploratory laparotomy was considered, but, 
since the patient was clinically unchanged and 
stable, observation was continued.
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Her symptoms decreased daily, the hemato­
logic abnormalities resolved, and pain and 
tenderness gradually eased. Her ascites resolved 
and she was started on oral feeding. She was 
discharged from hospital on day 23 and has 
experienced no complications since.
Microbiologic Study
An extract of the fecal specimen col­
lected on day 1 was tested on vero cells 
to detect C. difficile and other toxins.8 A 
cytopathic effect, different from that due 
to C. difficile, was observed after 3 days’ 
incubation.
A fecal specimen collected on the day 
of admission grew a strain of E. coli that 
was also found to produce a cytotoxin for 
vero cells. This strain was typed as 
0157:H7, a verotoxigenic strain recently 
implicated in both epidemic1,2'7 and 
sporadic hemorrhagic colitis.4-6 Cultures 
were negative for other bacterial patho­
gens. Examination for protozoa also 
yielded negative results.
Discussion
Since they were first described in 
1982,1 both sporadic4-6 and epidemic2,7 
forms of hemorrhagic colitis have been 
reported. The infection is generally a 
benign, self-resolving one associated with 
verotoxigenic strains of E. coli, of which 
type 0157:H7 is the most common. Our 
patient, by contrast, suffered increasing 
abdominal pain with distension, guard­
ing, tenderness and rebound. This, along 
with evidence of intravascular hemoly­
sis,7-9 could have been confused with 
gangrenous ischemic colitis and endotoxic 
shock. The absence of common fecal 
pathogens and the technical delay 
involved in determining verotoxigenicity 
can only add to the confusion. Other 
problems involved in differentiating these 
two diseases (Table I) include preferen­
tial involvement of the right colon in 
hemorrhagic colitis,10 inaccessible by a 
sigmoidoscope, and the dangers inherent 
in performing colonoscopy in the
presence of acutely inflamed, possibly 
gangrenous mucosa. Reports in the early 
1970s of “ ischemic colitis in young 
adults” ,11 characterized by a low inci­
dence of strictures and occurrence of 
right-sided lesions, may well have been 
examples of hemorrhagic colitis.
Ischemic colitis10,12 usually involved 
persons over 50 years of age with known 
predisposing conditions including 
atherosclerotic cardiac disease, congestive 
cardiac failure, and hypercoagulable and 
hyperviscosity syndromes. Pain and 
tenderness are more marked on the left 
side of the abdomen, sometimes with a 
mass in the left iliac fossa. Sigmoidoscopy 
shows13 mucosal necrosis, focal ulcers, 
bluish-black nodules of necrotic mucosa 
and a sharp line of demarcation. Sporadic 
hemorrhagic colitis, by contrast, can be 
seen in patients of any age and is 
associated with consumption of contami­
nated meat or dairy products. The lesion 
is commonly confined to cecum, ascend­
ing colon and proximal transverse colon, 
and stools are positive for both verotoxin 
and verotoxigenic E. coli. Most microbi­
ology laboratories are not equipped to 
perform these tests. Even those that are 
take 3 to 7 days to report positive results.
The increasing reports of such cases 
emphasize the need for physicians to be 
aware of the condition so that unneces­
sary invasive procedures are not per­
formed. Sporadic cases and the first few 
cases of an outbreak of hemorrhagic coli­
tis, especially, are likely to be misdiag­
nosed as ischemic colitis or other acute 
abdominal surgical emergencies.
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Malignant Hyperthermia: a Dilemma for the Cardiac Surgeon
Malignant hyperthermia is an inherited 
disease of skeletal muscle characterized 
by acute elevations of body temperature. 
The hyperthermic crisis is triggered by a 
variety of drugs and by volatile 
anesthetics or it may occur in response 
to stress. In this report the authors 
describe the case of a patient with 
malignant hyperthermia who underwent 
emergency aortocoronary bypass surgery 
for unstable angina. They outline the 
anesthetic and surgical management for 
individuals susceptible to hyperthermic 
crises who require open-heart surgery.
L'hyperthermie maligne est une maladie 
hereditaire de la musculature squeletti- 
que qui se caracterise par des elevations 
subites de la temperature corporelle. La 
crise hyperthermique est declenchee par 
divers medicaments dont des anesth6si- 
ques volatiles, ou elle peut survenir en 
reponse a un stress. Dans cet article, les 
auteurs decrivent le cas d'un patient qui 
eut a subir d'urgence un pontage aorto- 
coronarien pour angine instable. Ils souli- 
gnent les approches anesthesique et chi- 
rurgicale qui doivent etre mises en 
oeuvre chez les sujets predisposes aux 
crises hyperthermiques et qui necessitent 
une chirurgie a coeur ouvert.
Malignant hyperthermia is a rare, 
inherited disorder of skeletal muscle 
characterized by sudden elevations of 
body temperature, resulting from a dras­
tic increase in muscle metabolism.1 
Hyperthermic crisis may be precipitated 
by volatile anesthetics and a variety of
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drugs that cause an increase in mycoplas- 
mic calcium levels. In this paper we 
describe a patient with malignant hyper­
thermia who underwent myocardial re­
vascularization for unstable angina, we 
discuss the pathophysiology of malignant 
hyperthermia and outline the manage­
ment for individuals susceptible to hyper­
thermic crisis who require open-heart 
surgery.
Case Report
A 67-year-old white woman was admitted to 
the Coronary Care Unit of the Victoria General 
Hospital in Halifax with unstable angina. 
Cardiac catheterization revealed the presence 
of triple-vessel disease, which was managed by 
emergency coronary bypass because of con­
tinuing rest pain despite maximum medical 
therapy.
The patient had carried a malignant hyper­
thermia identification card for a number of 
years after the investigation of her six children, 
although she had never had a muscle biopsy. 
Two of her children appeared to be unaffected. 
One child suffered from muscle spasms, one 
had an abnormal muscle biopsy, one had 
elevated serum phosphokinase levels and 
another died suddenly of unknown cause. The 
patient had two sisters, one of whom had two 
children, both with a positive muscle-biopsy 
result from caffeine-halothane stimulation test­
ing. The second sister had two children not 
known to be affected with malignant hyper­
thermia. However, one of this sister’s offspring 
had three children, one of whom died from 
hyperthermic crisis during an appendectomy, 
another suffered muscle spasms and the third 
had an abnormal muscle biopsy.
Our patient received diazepam for preoper­
ative sedation and was given a loading dose of 
dantrolene sodium (3 mg/kg) administered 
slowly over 1 hour before induction of anesthe­
sia. Anesthesia was induced and maintained 
with a combination of fentanyl citrate and 
diazepam and the anesthetic apparatus was 
cleansed to avoid exposing the patient to previ­
ous volatile anesthetics. A radial artery catheter 
was inserted for continuous blood pressure 
monitoring and a no. 7 French Swan-Ganz 
thermodilution catheter (Abbott Laboratories, 
Salt Lake City, Utah) with oxygen saturation 
capacity was inserted into the pulmonary 
artery. This specialized Swan-Ganz catheter 
was connected to a Shaw catheter oximetry 
instrument (model no. 1270A; McLean Medi­
cal Specialties, Oakville, Ont.) that would pro­
vide continuous measurements of venous oxy­
gen saturation.
The chest was opened through a median ster­
notomy and the aorta cannulated with a no. 
24 Argyle cannula (Sherwood Medical, St. 
Louis, Mo.) after the systemic administration 
of heparin. The venae cavae were cannulated 
with two no. 34 USCI cannulas (C.R. Bard, 
Inc., Santa Ana, Calif.), and a Sams vent 
(Sarns Inc., Ann Arbor, Mich.) was inserted 
through the right superior pulmonary vein. 
Cardiopulmonary bypass was then established 
and both venae cavae were snared. Core tem­
perature was maintained at 37°C throughout 
the period of extracorporeal circulation. The 
heart was arrested with crystalloid cardiople­
gia (potassium 25 meq/L) at 4°C, and the sep­
tal temperature was monitored continuously 
and maintained within the range of 12° to 14°C 
with frequent infusions of crystalloid cardiople­
gia, combined with the judicious use of topi­
cal iced saline. Although a three-vessel bypass 
was accomplished without problems, the ini­
tial attempt at weaning the patient from 
extracorporeal circulation was unsuccessful. 
Cardiopulmonary bypass, however, was dis­
continued 30 minutes later without difficulty 
and without the need for ionotropic support.
Cardiac output and venous oxygen satura­
tions were monitored during and for 24 hours 
after the operation. Cardiac output ranged 
between 2.2 and 2.8 L/min and measured 
venous oxygen saturations were consistently 
between 55% and 60%. These data demon­
strate a stable perioperative course without any 
tendency toward hypermetabolism. Core tem­
perature was maintained at 37°C during cardi­
opulmonary bypass with no tendency toward 
hyperthermia in the first 24 hours after oper­
ation. The creatine phosphokinase level meas­
ured 96 gg/L during induction o f anesthesia 
(normal from 15 to 108 gg/L) and increased 
to a maximum of 807 /rg/L, 12 hours after the 
operation, returning to normal within the next 
24 hours. This elevation is within the normal 
range of values after a sternotomy incision 
(unpublished observations).
The electrocardiogram was unchanged after 
operation, a thallium perfusion scan demon­
strated normal regional perfusion, and digital 
venous angiography confirmed the patency of 
all three grafts. The patient’s postoperative 
convalesence was uncomplicated and she was 
discharged 10 days after operation.
Discussion
Malignant hyperthermia was first 
recognized in 1922 but has only recently
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been managed successfully.1 This dis­
order of skeletal muscle may be inherited 
as an autosomal dominant or autosomal 
recessive factor; in some families it 
appears to have a multifactorial in­
heritance with a range of individual sus­
ceptibilities. The Japanese have the 
highest incidence of malignant hyperther­
mia, although all racial groups appear to 
be affected.2 Hyperthermic crisis is trig­
gered by a sudden rise in the concentra­
tion of mycoplasmic calcium which 
causes a drastic increase in cellular 
metabolism. The sudden rise in cytosolic 
calcium may be precipitated by stress, 
extreme variations in core temperature, 
volatile anesthetics and a variety of drugs 
that increase mycoplasmic calcium. These 
medications include the potent inhalation 
agents (halothane, enflurane, methoxy- 
flurane), the amide anesthetics, lidocaine, 
digoxin, calcium, depolarizing muscle 
relaxants, vasopressors and any ionotrope 
that increases the release of catechola­
mines.3
The pathophysiology of malignant 
hyperthermia has been extensively studied 
in swine because certain strains are par­
ticularly susceptible to hyperthermic 
crises. Hyperthermia occurs in response 
to a sudden increase in the concentration 
of mycoplasmic calcium. A moderate 
increase in the mycoplasmic calcium level 
accelerates cellular metabolism which 
results in increased heat production, 
increased production of lactic acid and 
accelerated oxygen consum ption.4 
Greater increases in calcium may activate 
myosin ATPase and sarcoplasmic retic­
ulum ATPase, which further accelerates 
heat production by increasing the break­
dow n o f adenosine triphosphate. 
Mycoplasmic calcium may also inhibit 
triponin which then permits muscle con­
traction, thus explaining the symptoms of 
muscle rigidity and muscle contractures 
that are associated with the syndrome. 
Although the increase in cytosolic calcium 
could result from fluxes of calcium 
through the cellular membrane, the 
increase appears to result from altered 
kinetics of calcium release from the 
sarcoplasm ic reticulum . Kim and 
associates4 isolated the sarcoplasmic 
reticulum from muscle cells of normal 
pigs and pigs susceptible to hyperthermic 
crisis. Stimulation of calcium release from 
the sarcoplasmic reticulum by halothane 
indicated that the rate of calcium released 
from malignant hyperthermia sarcoplas­
mic reticulum was 70% greater than that 
from normal sarcoplasmic reticulum. 
Likewise, the amount of calcium released 
was twofold greater from malignant 
hyperthermic sarcoplasmic reticulum. 
Kim and associates have hypothesized 
that the calcium channels are abnormal 
in malignant hyperthermia, permitting 
excessive efflux of calcium into the 
mycoplasm.
Malignant hyperthermia should be sus­
pected in individuals with a genetic back­
ground or a family history of the dis­
order. They often have a history of 
muscle cramps, and 60% of them will 
have elevated serum creatine phos- 
phokinase enzyme levels.5 Skeletal mus­
cle biopsy may reveal abnormal variations 
in the size of the myofibrils, degeneration 
of myofibrils and atrophy of muscle 
fibres,6 but the definitive diagnosis rests 
upon abnormal contractures observed in 
muscle biopsy specimens that have been 
exposed to a combination of caffeine and 
halothane.
Hyperthermic crisis is likely when a 
patient receiving a general anesthetic 
develops a sudden increase in core tem­
perature, a severe metabolic acidosis, an 
unexplained rise in oxygen consumption, 
muscle rigidity or cardiac arrhythmias. 
Interestingly, the crisis may not be 
precipitated in those proven to have the 
disease, even after exposure to a known 
triggering agent. One person, known to 
have the disease, was reported to have 
received 12 previous anesthetics before 
suffering a hyperthermic crisis.2 The 
recommended treatment includes the 
immediate cessation of the anesthetic, 
administration of dantrolene sodium, cor­
rection of the metabolic acidosis and core 
cooling, which may be accomplished by 
systemic vasodilatation, gastric and 
peritoneal lavage with cold intravenous 
fluids, or in some cases cardiopulmonary 
bypass.7 Despite immediate and 
appropriate therapy the death rate with 
established hyperthermia is reported to be 
25%, emphasizing the need for adequate 
prophylaxis in susceptible patients.2
Dantrolene sodium is a benzathiazepine 
derivative and is the only known medi­
cation that will reduce the death rate in 
malignant hyperthermia or that may be 
used prophylactically to prevent its onset 
in susceptible persons.8 The actual 
mechanism by which dantrolene sodium 
exerts its beneficial effects on cellular 
metabolism is unknown, although most 
experimental data suggest that the drug 
prevents the release of calcium from the 
sarcoplasmic reticulum by reducing the 
number of calcium-releasing sites on the 
sarcoplasmic reticulum membrane. Des- 
medt and Hainaut9 have shown that 
dantrolene does not affect calcium move­
ment into resting or depolarizing skele­
tal muscle but appears to change the 
balance of calcium within the mycoplasm. 
Further, the reduction of cytosolic cal­
cium is not related to the net movement 
of calcium back into the sarcoplasmic 
reticulum but appears to be related to the 
inhibition of calcium released from the 
sarcoplasmic reticulum. Although there 
have been no controlled trials to deter­
mine the efficacy of dantrolene sodium, 
Harrison10 showed that there is a 100% 
death rate in swine susceptible to malig­
nant hyperthermia after the onset of the 
condition, and pre-treatment with dantro­
lene resulted in survival by reducing mus­
cle rigor and heat production, and by 
preventing metabolic acidosis. Clinical 
experience with the drug indicates that the 
death rate from hyperthermic crisis in 
treated patients is 9%, which is in direct 
contrast to a rate of 25% in nontreated 
patients after the onset of the syn­
drome.2 The optimum dose for pre­
treatment is not known although Britt8 
recommends 3 mg/kg before operation, 
repeated every 8 hours for 72 hours 
postoperatively. She suggests that the 
drug be infused slowly because it causes 
muscle weakness, which may result in 
respiratory embarrassment.
Malignant hyperthermia creates a real 
dilemma for the cardiac surgeon because 
many of the routine procedures that are 
carried out in the performance of an 
open-heart operation have been impli­
cated as triggering agents for malignant 
hyperthermia. Patients who undergo 
cardiac operations experience large fluc­
tuations in core temperature, are max­
imally stressed as indicated by high cir­
culating levels of catecholamines, and 
frequently receive anesthetics and drugs 
that may precipitate a hyperthermic cri­
sis. Moderate hypothermia is routinely 
used during cardiopulmonary bypass to 
augment protection of the myocardium, 
while rewarming frequently results in 
hyperthermia during the early postoper­
ative period. The cardiac surgeon often 
uses intravenous calcium, vasopressors 
and ionotropes to wean patients from 
cardiopulmonary bypass, and ventricular 
and atrial arrhythmias are commonly 
treated with lidocaine and digoxin. These 
drugs are known to increase mycoplasmic 
calcium, which may trigger a hyperther­
mic crisis.
The recommended anesthetic agents for 
patients with malignant hyperthermia 
include diazepam and barbituates in addi­
tion to a non-depolarizing muscle relax­
ant, thereby avoiding the potent inhala­
tion anesthetics and depolarizing muscle 
relaxants. We suggest the insertion of a 
Swan-Ganz catheter with oxygen satura­
tion capacity, during the induction phase, 
to facilitate continuous monitoring of 
venous oxygen saturations, thus provid­
ing valuable information on the patient’s 
metabolic status. Dantrolene sodium 
should be administered as recommended 
by Britt.8 Normothermia may be used 
during the operation, avoiding moderate 
systemic hypothermia, to prevent large 
fluctuations in core tem perature. 
Myocardial protection is afforded with 
frequent infusions of cardioplegia, com­
bined with topical hypothermia. Col­
lateral flow, which would accelerate 
rewarming, is minimized by venting and 
caval snaring. If the patient cannot be 
weaned from cardiopulmonary bypass
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upon completion of the operation, bypass 
should be resumed for a short period to 
rest the myocardium. Should a further 
attempt fail, an intra-aortic balloon 
should be inserted rather than risk the use 
of intravenous calcium, vasopressors or 
inotropes that might precipitate a hyper­
thermic crisis. Ventricular ectopy should 
be treated with procainamide rather than 
lidocaine, and atrial arrhythmias with 
intravenous Inderal or cardioversion, 
rather than risk the use of digoxin. Ven­
tilatory support should be discontinued 
slowly after open-heart surgery, with 
careful attention to weaning parameters 
and an awareness that dantrolene sodium 
may cause skeletal muscle weakness.
To our knowledge there has only been 
one previous report in the world litera­
ture describing a patient with malignant 
hyperthermia who successfully underwent 
myocardial revascularization.11 The 
anesthetic and surgical management of 
this patient was similar to our own pro­
tocol. However, venous oxygen satura­
tions were not monitored during the oper­
ation and core hypothermia was utilized 
during cardiopulmonary bypass. We 
believe that venous oxygen saturations 
provide valuable information for the sur­
gical team concerning the patient’s meta­
bolic status and will immediately alert the 
anesthesiologist to the onset o f hyper­
metabolism, since the venous blood 
represents the effluent from skeletal mus­
cle. Also, core cooling is probably 
unnecessary during the period o f  
extracorporeal circulation and should be 
avoided because large fluctuations in core 
temperature have been known to precipi­
tate a hyperthermic crisis. Furthermore, 
our experience indicates that the 
myocardium may be adequately protected 
without the use of core hypothermia. 
Myocardial temperature may be lowered 
and maintained within the range of 12° 
to 14°C as long as collateral flow is kept 
to a minimum and cardioplegia and top­
ical cooling are administered frequently 
during the arrest.
The need for open-heart surgery in a 
patient with malignant hyperthermia 
poses a dilemma for the cardiac surgeon 
because many of the routine procedures 
and medications used in the performance 
o f cardiac operations are contraindicated 
in persons susceptible to hyperthermic cri­
sis. In this report we have highlighted 
some of these difficulties and proposed 
a method o f managing patients with 
malignant hyperthermia who require 
open-heart surgery.
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Closure of Postproctectomy Perineal Sinus 
With Gracilis Muscle Flaps
Between 1975 and 1985, 21 patients 
underwent muscle-flap repair of a persis­
tent perineal sinus. All had previously 
undergone a proctectomy for ulcerative 
colitis (7 patients), Crohn's disease (10), 
trauma (2) or cancer (2). A total of 133 
(mean 6.8, range from 1 to 25) previous 
surgical attempts had been made to 
eradicate the sinus. At follow-up after 
muscle-flap repair (mean 47 months), the 
sinus was completely healed in 14 
patients. However, 10 of these patients 
had required further perineal operations 
(mean 1.9, range from 0 to 9). In those 
with a successful result, the average 
time taken for the sinus to heal was 2.3 
months (range from 1 to 24 months). In 
three patients, a wound that had initially 
healed reopened (mean 7 months) and 
has remained unhealed. Although a 
gracilis flap will likely cure a refractory 
perineal sinus, the healing period may be 
prolonged, and reoperation is frequently 
required.
Entre 1975 et 1985, 21 patients ont 
subi une reparation d’un sinus perineal 
persistant par greffe d'un lambeau mus- 
culaire. Tous avaient prealablement subi 
une proctectomie pour colite ulcereuse 
(7 patients), maladie de Crohn (10), trau- 
matisme (2) ou cancer (2). Au total, il y 
avait eu 133 tentatives chirurgicales 
(moyenne 6.8 , ecart de 1 a 25) pour fer- 
mer le sinus. Aux examens de controle 
(moyenne de 47 mois), le sinus etait 
completement gu6ri chez 14 patients. 
Neanmoins, 10 de ces patients avaient 
n6cessit<§ d'autres interventions perinea-
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les (moyenne de 1.9, ecart de 0 £ 9). 
Pour ceux dont les resultats furent cou- 
ronnes de succ&s, le temps moyen de 
cicatrisation du sinus fut de 2.3 mois 
(ecart de 1 a 24 mois). Chez trois 
patients, une plaie qui s'etait initialement 
cicatrisee s'est reouverte (apres 7 mois 
en moyenne) et est demeuree non gu6- 
rie. Meme si la greffe d'un lambeau du 
muscle droit interne de la cuisse est 
capable de guerir un sinus p6rin6al 
rebelle, la periode de guerison peut etre 
longue et des ^interventions sont sou- 
vent necessaires.
A proctectomy wound that remains 
incompletely healed at 6 months is some­
what arbitrarily called a persistent 
perineal sinus.1 Despite variations in the 
management of the perineal defect at the 
time of proctectomy,2,3 no method is 
absolute in its ability to prevent this com­
plication,1 and suggestions that primary 
closure lowers incidence4’5 have not been 
substantiated by the results of the only 
controlled trial currently available.6 
Patients with inflammatory bowel disease 
appear to be most at risk, having roughly 
three times the incidence of persistent 
perineal sinus compared with those who 
underwent proctectomy for cancer.7 An 
intersphincteric or “close” excision of the 
rectum does not appear to change this sit­
uation.8
The wide variety of procedures availa­
ble for treating a persistent perineal sinus 
attests to the potential obstinacy of this 
problem. Although some defects are 
superficial and easily managed, others 
communicate with huge cavernous spaces 
anterior to the sacrum, and a successful 
outcome may require great ingenuity and 
patience. One such ingenious method of 
managing a persistent perineal sinus is by 
gracilis muscle or myocutaneous flap, as 
first described by Bartholdson and 
Hulten.9 In this report, we document the 
Mayo Clinic experience with this oper­
ation.
Patients
From 1975 to 1985, 21 patients (10 
women, 11 men) underwent muscle-flap
repair of a persistent perineal sinus. All 
had previously undergone a proctectomy 
for ulcerative colitis (7 patients), Crohn’s 
disease (10), trauma (2) or cancer (2). At 
the time of proctectomy, 10 (48%) had 
preoperative evidence of perineal sepsis, 
consisting of fistula or abscess, or both, 
and 2 (10%) had been irradiated. Seven 
(33%) were receiving steroid treatment. 
The proctectomy wound had been closed 
primarily in 13 (62%) patients and packed 
open in the others (38%). Prior to the flap 
procedure, 133 (mean 6.8, range from 1 
to 25) surgical attempts to eradicate the 
sinus had been made on these 21 patients 
at various institutions.
At the time of flap repair, the mean age 
was 37 years (range from 20 to 61 years). 
A mean of 58 months (range from 1 to 
228 months) had passed since the proc­
tectomy. Preliminary debridement with 
curettage of the wound was carried out 
a few days before the reconstruction in 
14 of the patients. Sixteen (76%) patients 
had a unilateral gracilis muscle-flap 
repair. In 6 of the 16, a skin island was 
left attached to the muscle (myocutane­
ous flap). Four patients (19%) had 
bilateral gracilis flaps (only one with skin 
islands), and one (5%) underwent a 
bilateral gluteus maximus myocutaneous 
flap procedure. One patient (no. 16, 
Table I) with a unilateral gracilis flap sub­
sequently had the operation repeated, 
using the gracilis muscle from the other 
leg. Another patient (no. 10), who ini­
tially had bilateral gracilis muscle flap 
repair, required further operation, and a 
semimembranosus flap was made.
Statistical analysis was carried out by 
the x2 and binomial distribution “ exact” 
confidence limit methods.
Operative Procedure
The patient is placed in the lithotomy 
position, prepared and draped in such a 
way that the legs can be unflexed at the 
thigh and straightened at the knees after 
the muscle flaps are dissected. The gracilis 
muscle is isolated by proximal and distal 
incisions in the medial thigh over a line 
extending from the gracilis tendon at the 
medial extreme of the inguinal crease to
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the more medial of the two tendons pal­
pable just above the popliteal fossa. Once 
the muscle is identified, the portion of the 
overlying skin intended for use in the 
musculocutaneous flap is marked. It is a 
good idea to tack the skin edges to the 
underlying muscle to avoid having it 
sheared off during transposition of the 
flap to the perineal defect.
The muscle is divided in its distal ten­
dinous portion, thus becoming a flap 
based on its proximal vascular pedicle 
(Fig. 1A). A tunnel is made from the 
proximal portion of the incision to the 
perineal defect, allowing the flap to be 
brought subcutaneously to the perineal 
sinus (Fig. IB). If the muscle appears to 
be too short, an additional 3 to 6 cm may 
be obtained by bringing the legs down 
from the lithotomy position, thereby 
relaxing the muscle. The tendinous por­
tion of the muscle is transfixed to the far­
thest edge or deepest aspect of the defect. 
Muscle or skin, or both, are then sutured 
to tissues or skin around the introitus of 
the defect, and a suction catheter is placed 
through a separate stab wound (Fig. 1C).
The thigh and perineal incisions are 
closed, and a drainage catheter is left in 
the donor muscle bed. The leg is wrapped 
in an elastic bandage to prevent hema­
toma formation. The patient is kept in 
bed for 24 hours with freedom to move, 
provided the hips are not flexed more 
than a few degrees. Full flexion of the 
hips is allowed only after 2 weeks.
Results
Four patients (19%) showed evidence 
of perineal sepsis in the flap wound, based 
on the finding of purulent drainage and 
partial flap separation within the first 10 
days postoperatively. In all cases, this was 
managed conservatively with antibiotics, 
irrigation and saline compresses. In four 
of the eight patients in whom a myocu- 
taneous flap was used, there was partial 
or complete sloughing of the skin island.
At follow-up, a mean of 47 months 
(range from 11 to 104 months) later, the 
sinus had healed completely in 14 (66%) 
patients. However, 10 (71%) of the 14 
required further perineal operations to 
achieve a successful outcome. An aver­
age of 1.9 (range from 0 to 9) further 
operations were performed in this group. 
The average time required for the wound 
to heal was 2.3 months (range from 1 to 
24 months). Similarly, five of seven 
patients with currently unhealed sinuses 
underwent an average of 2.7 (range from 
0 to 8) further unsuccessful procedures. 
In five patients, a wound that had initially 
healed reopened (mean 7 months, range 
from 1 to 24 months). In two of them 
(nos. 6 and 19), the wound subsequently 
healed.
No important relation was found 
between satisfactory outcome and the 
type of disease, previous radiotherapy, 
postoperative flap sepsis or type of flap 
used. The 95% confidence limits for the
percentage of successful results were 
43.03% to 85.41%.
The long-term sequelae of the opera­
tion have been minimal. No patient noted 
any serious weakness in the leg from 
which the graft was taken, although five
FIG. 1—Repair o f persistent perineal sinus 
by bilateral gracilis myocutaneous flaps. 
Bilateral gracilis flaps are raised, each with skin 
island (myocutaneous flaps). (A) Perineal 
defect is curetted. (B) Flaps are created based 
on proximal vascular pedicle. (C) Flaps are tun­
nelled to perineal defect and sewn into place. 
(Modified from Woods and Beart.17)
Table 1-Patient Data
Patient
no.
Age,
yr Disease
No. of 
previous 
operations Flap
Time after 
proctectomy, 
mo
Additional
operations
Time to 
closure, 
mo
Follow-up,
mo Status
1 42 Crohn's 2 Single 10.2 6 — n Unhealed
2 37 Crohn's 15 Single 34.2 1 1 n Healed
3 39 U colitis 2 Single 82.5 0 — 25 Unhealed
4 20 Crohn's 18 Single MC 9 5 24 102 Healed
5 33 Crohn's 2 Single MC* 82.8 0 3 70 Healed
6 24 Crohn's 2 Bilateral 36 1 3; reopened 
at 3 mo
34 Healed
7 61 Cancer 0 Single MC' 63.4 2 5 104 Healed
8 27 U colitis 6 Single 48.9 0 7 58 Healed
9 22 U colitis 3 Single 23.3 0 8 63 Healed
10 42 Crohn's 3 Bilateral 17.6 9 12 70 Healed
11 39 U colitis 24 Single MC 37.8 2 5 59 Healed
12 21 Trauma 25 Single* 228.4 1 1; reopened 
at 24 mo
85 Unhealed
13 55 Cancer 2 Bilateral MC 10.9 1 1 21 Healed
14 26 Crohn's 1 Single 35.7 0 — 31 Unhealed
15 23 Crohn's 17 Bilateral 125.9 1 1 66 Healed
16 42 Crohn's 1 Single 43.2 2 1 63 Healed
17 25 Crohn's 8 Single 29.3 8 1; reopened 
at 5 mo
16 Unhealed
18 58 U colitis 3 Single 216.9 3 — 36 Unhealed
19 31 Trauma 6 Bilateral 
gluteus 
maximus MC*
1.2 2 10; reopened 
at 1 mo
15 Healed
20 26 U colitis 2 Single MC 76.2 0 1 30 Healed
21 36 U colitis 1 Single MC 13.7 1 3; reopened 24 Unhealed
at 3 mo
'Sepsis.
MC -  myocutaneous, U -  ulcerative.
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experienced numbness along the medial 
aspect of the thigh and one complained 
of an aching sensation in the area after 
prolonged standing. Two others had dis­
comfort in the perineum when sitting on 
firm surfaces.
Of the seven patients whose sinus 
remained unhealed, five were considera­
bly improved; they had intermittent 
mucus discharge which was easily 
managed by a protective pad. Two of 
these patients still required occasional 
curettage of their defects at other centres 
11 to 16 months after the flap procedure. 
The remaining two patients felt no bet­
ter off than before the operation and con­
sidered the procedure a failure.
Discussion
As a starting point in the management 
of patients with an unhealed proctectomy 
wound, it is important to realize that suc­
cessful healing may take a long time, even 
under satisfactory conditions. In patients 
with inflammatory bowel disease, reports 
o f incomplete healing of the perineal 
wound range from 25% to 62% at 6 
months after operation.8-10' 12 Yet, the 
same reports show that in a substantial 
number of patients with sinuses unhealed 
at 6 months, healing had occurred by 1 
year. Thus, the adequate passage of time 
is one of the most powerful measures 
available to the surgeon dealing with a 
postproctectomy perineal sinus in an 
individual with inflammatory bowel dis­
ease. While awaiting spontaneous heal­
ing, the wound should be kept clean by 
frequent sitz baths and light packing to 
prevent premature skin closure. Firm or 
deep packing only serves to retard 
healing.
One should not be as willing to delay 
reoperation when proctectomy has been 
performed for benign noninflammatory 
disease or cancer. In such situations, heal­
ing should progress readily, and exami­
nation under anesthesia is indicated in 
patients whose wounds do not heal within 
3 months. In the former case, a foreign 
body may be present, whereas in the lat­
ter, persistent or recurrent cancer may be 
responsible for delayed healing.
When operation is necessary, there are 
a number of surgical options. Curettage 
of the cavity is frequently the initial 
procedure and may, by removing debris 
and granulation tissue, provide a surface 
that encourages epithelialization and so 
decreases the size of the defect. It is 
reasonable to repeat this operation if 
results seem encouraging, although it is 
often difficult to tell whether it is the 
procedure itself or merely the passage of 
time that contributes most to the resolu­
tion of many of these cases.
Saucerization of the wound and appli­
cation of split-thickness skin grafts have 
been reported as another method of
managing a persistent perineal sinus. In 
48 patients treated by this method, 
Anderson and Turnbull13 reported com­
plete healing in 7, notable improvement 
in 37 and poor results in 4. McLeod and 
colleagues14 stated that seven of their 
nine patients similarly treated had com­
plete healing of their sinuses, although 
they also noted that most had some 
mucus discharge from the wound and 
required a gauze pad for protection, sug­
gesting the presence of an unepithelialized 
area in the depths of the wound.
Unfortunately, deep mature sinuses 
leading to large presacral cavities are 
unlikely to be resolved by these methods. 
Such defects consist of a tough fibrous 
shell lined by granulation tissue. As such, 
they are unlikely to collapse and usually 
remain as a permanent reservoir, intermit­
tently discharging foul-smelling mucus. 
Successful management requires either 
taking down the walls of the cavity or fill­
ing it with vascularized tissues. Silen and 
Glotzer15 described three cases in which 
the cavity was taken down or “ marsupi- 
alized” successfully by removing the coc­
cyx and lower aspect of the sacrum. Alter­
natively, muscular or myocutaneous flaps 
may be used to fill the defect.9-16-17
In this review, 133 previous procedures 
had been performed on the 21 patients 
studied. All had failed. In most cases, 
patients were referred from major medi­
cal centres, and all had substantial, deep 
defects. The achievement of a 66% heal­
ing rate in such a group is encouraging 
and firmly establishes the use of the flap 
procedure in the management of persis­
tent perineal sinus.
Despite this eventual success rate, most 
patients required further operations 
before healing was achieved. Although 
subsequent procedures frequently con­
sisted only of debridement of sloughed 
superficial tissues or curettage of gradu­
ally diminishing defects, the difficulty in 
obtaining a final resolution is evident. 
Also, two of these subsequent procedures 
did consist of a repeat transposition of 
muscle. Healing was obtained in both of 
these cases.
This kind of clinical course indicates 
the importance of a strong working rela­
tionship between physician and patient. 
Both must realize that primary healing, 
without subsequent treatment, is the 
exception rather than the rule, but that 
with persistence, a successful outcome can 
be expected in two-thirds of cases. In our 
institution, these patients are managed by 
a team consisting of plastic and colorec­
tal surgeons. We have tried to optimize 
the likelihood of a successful result by 
using the skills of both specialists.
Although it is accepted that inflamma­
tory bowel disease more often leads to a 
persistent perineal sinus than do nonin­
flammatory disorders, patients with 
inflammatory bowel disease in this study
fared no worse after the gracilis flap oper­
ation than did the others. Interestingly, 
in the two patients who received perineal 
radiotherapy the sinus healed, suggesting 
that the muscle-flap procedure remains 
useful in the management of such 
patients.
In assessing the outcome of procedures 
aimed at treating a persistent perineal 
sinus, prolonged follow-up must be main­
tained. In three cases in this series, an 
apparently healed wound broke down an 
average of 7 months later and remains 
unhealed. In one patient, the wound 
remained satisfactorily healed for 2 years 
before reopening.
In conclusion, gracilis-muscle-flap 
repair was successful in two-thirds of 
patients who presented with a persistent 
perineal sinus after proctectom y. 
However, the healing period after the flap 
operation was often prolonged, and sub­
sequent perineal procedures were fre­
quently required, even in those patients 
who ultimately had a successful outcome. 
We believe that this operation can play 
an important role in the management of 
persistent perineal sinus but should be 
reserved for those who have not 
responded to lesser procedures.
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Harvey, in solitary fashion, conducted 
the research that led to the publication in 
1628 of his famous treatise De Motu 
Cordis. Later he joined other anatomists 
in scientific research and, after becoming 
a fellow and office holder, assumed a 
position of prominence in the Royal Col­
lege of Physicians. There he was an 
active member, attending meetings, car­
rying out his duties as an Elect, as Lum- 
leian Lecturer, as censor and frequently 
as a member of special committees. Har­
vey the scientist cannot be separated 
from Harvey the physician. His work in 
London both as Physician-in-Ordinary to 
King Charles I and as Physician to St. 
Bartholomew's Hospital is outlined. His 
fate however, was, irrevocably tied to 
the Royalist cause and the Parliamentary 
Party was instrumental in having him dis­
missed from the hospital in 1643. After 
1650 his reputation was again on the 
rise. Apothecaries were practising medi­
cine with increasing boldness, and Har­
vey devoted considerable effort to 
defending the monopoly of physicians 
through the offices of the Royal College 
of Physicians. He fought the "empirics" 
with every available weapon and in the 
process introduced a number of needed 
reforms. In his work as scientist and 
physician, Harvey epitomized the close 
links that bound together classically edu­
cated physicians, experimental inquiry 
and anatomical innovation. He made it 
understood that learned men, not 
"empirics" were responsible for the
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great improvements under way in what 
was to become modern medicine.
Harvey, seul, conduisit la recherche qui 
aboutit & la publication en 1628 de son 
fameux traite De Motu Cordis. Plus tard, 
il s'associa £ d'autres anatomistes dans 
la recherche scientifique et, apr£s etre 
devenu membre et administrateur, 
assuma un poste pro6minent dans Le 
College royal des m£decins. L£, il fu t un 
membre actif, assistant £ des reunions et 
remplissant ses fonctions d'Elu, de con- 
ferencier Luml6en, de censeur et fr£- 
quemment de membre de comit£s sp6- 
ciaux. Harvey le scientifique ne peut pas 
§tre s£par£ d'Harvey le m£decin. Son 
travail £ Londres, tant comme m£decin 
personnel du roi Charles I, que comme 
m£decin de I'hfipital St-Barth£lemy, est 
souligng, Cependant, il 6tait irr£vocable- 
ment li£ £ la cause Royaliste et Le Parti 
parlementaire fut £ I'origine de son con- 
g£diement de I'hdpital en 1643. Apr£s 
1650, sa reputation 6tait de nouveau en 
hausse. Les apothicaires pratiquaient la 
m£decine avec audace accrue, et Harvey 
consacra un effort considerable & defen- 
dre le monopole des medecins £ travers 
Le College royal des medecins. II com- 
battit les "empiriques" avec toutes les 
armes disponibles et dans le processus 
introduisit un certain nombre de r6formes 
necessaires. Dans son travail de scientifi­
que et de medecin, Harvey etablissa les 
liens etroits unissant les medecins de 
formation classique, la recherche exp6ri- 
mentale et I'innovation anatomique. II fit 
bien comprendre que les hommes ins- 
truits, et non les "empiriques", etaient 
responsables des grands progrds realises 
dans ce qui deviendrait la medecine 
moderne.
When Harvey published his treatise De 
M otu Cordis in 1628, he was very much
an oddity in English medical life: a clas­
sically educated physician who advanced 
the science of medicine as well as one who 
practised its art. Not that there was any 
lack of university trained physicians. 
Since the middle o f the 16th century their 
numbers had more than quadrupled, with 
the largest increase in London (whose 
population by 1600 had reached 200 000). 
In his position as a fellow and office­
holder in the Royal College of Physicians 
after 1610, Harvey must have been 
acquainted to some degree with all the 
London physicians o f his day.
The College of Physicians organized 
the medical elite of the greater metropolis, 
worked assiduously to protect their 
monopoly and, after 1628, used Harvey’s 
accomplishments as medical author and 
anatomical physician to defend their 
intellectual preeminence and professional 
privileges. They even provided a sort of 
“ continuing education” in the form of  
occasional anatomies, dissections and lec­
tures, including Harvey’s own Lumleian 
lectures. Over the next decades, English 
medicine made great progess, producing 
six or seven internationally famous 
anatomists, and more than a dozen scien­
tists researching anatomical problems.* 
All these physicians represent a coterie of 
followers o f Harvey.
All felt in varying degrees, and for varying 
lengths of time in their careers, inspired by
T h eir number included anatomists George 
Ent, Francis Glisson, Nathaniel Highmore, 
Thomas Wharton, Walter Charleton and 
Thomas Willis. Willis applied chemistry and 
anatomy to clinical problems. Physiologists 
whose work was published before the Resto­
ration included Harvey’s close friend Charles 
Scarburgh, Jonathan Goddard, Daniel Whis­
tler, Henry Power, Robert Boyle, Ralph 
Bathurst, Philip Stephens, Timothy Clarke and 
Walter Needham, to mention only a few 
prominent ones.
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Harvey’s accomplishment, attracted by the 
scientific problems it left unsolved, and incli­
ned to direct their own work according to the 
canons of... dissection and careful experimen­
tation explicit in Harvey’s writing and 
teaching.1
The Spread of Harvey’s Influence
Harvey’s influence was intimately con­
nected to his anatomical research and its 
fruits, the result of unrelenting dissection, 
exploration of the heart, the discovery of 
the circulation of the blood and the 
delineation of embryonic growth — all 
leading to the reversal or overthrow of the 
ancients. He was not without his detrac­
tors and critics. There were open chal­
lenges to the validity of his new doctrine 
of the circulation, as Harvey had antici­
pated, but gradually the influence of his 
discoveries spread among the small but 
distinguished body of anatomists in 
England, then to the “ hatcheries” of the 
English intelligentsia, the universities of 
Oxford and Cambridge and, finally, to 
the Continent. John Aubrey said of Har­
vey’s circulation that “ with much adoe 
at last, in about 20 or 30 yeares time, it 
was received in all the universities in the 
world” .2
Everywhere by the 1650s there could be 
found evidence of Harvey’s acceptance. 
In 1654, Seth Ward agreed with John 
Webster’s praise of Harvey’s circulation, 
and of recent progress in anatomy, but 
pointed out that one could not expect 
such advances in the theory of medicine 
to change the day-to-day practice of 
medicine radically. In any case, said 
Ward, it was the learned physicians like 
Harvey, rather than Webster’s empirics, 
who had mastered medical practice. Had 
not Dr. Harvey performed “ cures of 
desperate Ulcers and diseases, even of 
cancer?” 3
Harvey the scientist and Harvey the 
practising physician are inseparable. For 
example, on the title page of De Motu 
Cordis, he identifies himself as “ Profes­
sor of Anatomy at the College of Physi­
cians of London” , and in his dedication 
of this book to the president and fellows 
of the College, he makes clear that his 
official college (Lumleian) lectures 
provided an important forum for the 
development and testing of the ideas con­
tained in it about the movement of the 
heart and blood. His writings and lectures 
are replete with references to case histo­
ries of human patients, as well as with 
theoretical discussions of disease and its 
treatment.
Harvey’s Work as a Physician
It is easy to become so absorbed in 
Harvey’s scientific endeavours as to for­
get that he made his living as a physician.
He was a doctor to the highest and lowest 
in the English society of his day. This 
meant that his anatomical and biologic 
investigations were necessarily interrupted 
by various professional activities and 
duties, including the treatment and advis­
ing of individual patients and involvement 
in the corporate affairs of the College of 
Physicians, the professional body to 
which he belonged and for which he had 
great respect and affection. Throughout 
a long and eventful association with the 
College, Harvey devoted much of his 
energies to the defence of his profession; 
he anxiously watched over the preroga­
tives of physicians against conflicting 
claims advanced by surgeons and apothe­
caries, claims that to the modern mind 
seem justified.
From 1609 on, Harvey’s time was 
divided between his hospital duties at St. 
Bartholomew’s, his private practice, his 
anatomical and physiological research 
and his various duties at the College of 
Physicians. To some, his “vegetative” 
existence as a conventional London and 
court physician has been considered 
altogether less interesting, almost dis­
sociated from his brilliant investigations 
in the field of experimental biology. 
However, the facts of his medical prac­
tice and activities do not bear this out; 
and in addition to the intrinsically 
interesting professional life Harvey led, 
there was the situation that generated des­
tructive rivalries between physicians and 
surgeons and between physicians and 
apothecaries. Underlying all these events 
prior to 1640 was the unstable political 
situation that culminated in an even more 
destructive civil war, which, for Harvey, 
produced much suffering and a virtual 
isolation imposed on him by political cir­
cumstances of the Puritan Common­
wealth. His loyalty to the monarch who 
was his patient was to cost him dearly.*
Harvey’s Associations With the 
Royal College of Physicians
From 1610 to the 1630s Harvey was an 
active, respected and extremely influen­
tial member of the College of Physicians. 
In addition to frequent attendance at 
meetings (Comitia), at one time or 
another he was an officeholder and
*His position as physician to Charles I bound 
him to the King’s cause, and Harvey’s fortunes 
declined with those of the monarch. In 1643, 
his apartments at Whitehall were sacked by 
parliamentary soldiers and the manuscripts 
representing the work of a lifetime were des­
troyed. These precious papers contained 
accounts of dissections, autopsies and obser­
vations made on patients, as well as his notes 
on the development of insects and on compara­
tive anatomy. His request in 1648 to attend the 
imprisoned King was refused. In 1650, Har­
vey required parliamentary permission to enter 
London to attend a patient. And on the Con­
tinent he was rumoured to be dead!
vigorously carried out the duties 
associated with these positions, as well as 
giving lectures.* As a returning student 
from Padua, Harvey had to wait 3 Vi 
years for a medical appointment; in May 
1603 he was given permission to practise 
medicine in the London area, but not 
until 1607 did he attain the dignity of a 
fellowship at the College of Physicians.
The College enjoyed many privileges, 
including the statutory right of exercising 
a general supervision over the various 
grades within the medical profession. Sur­
geons belonging to the Barber-Surgeons’ 
Company, and apothecaries (associated 
with the Grocers’ Company until 1617, 
after which they became a separate soci­
ety) were left to manage their own affairs, 
provided that they were careful not to 
tread on the areas of practice (internal 
medicine) preserved exclusively for phy­
sicians. The College and its fellows 
regarded as a major responsibility the 
prevention of any intrusion into the prac­
tice of medicine by those lacking authori­
zation. All those eligible to serve as phy­
sicians were required to register as 
licentiates and to pay substantial annual 
licence fees.
The Challenge to the Medical 
Profession of the “Empirics”
A considerable part of Harvey’s duties 
as an officer of the College was devoted 
to the enforcement of its wide legal 
powers over the control of the practice of 
medicine. With the others, he was deter­
mined to preserve all its privileges, espe­
cially its monopoly over the practice of 
internal medicine. The disputes between 
surgeons and physicians, and the 
challenges to the physicians’ authority 
from apothecaries were never-ending. 
This diverse class of unorganized practi­
tioners was labelled by the College as 
illiterate “ empirics” . Most of what Har­
vey did for the College was related to 
these disputes, and after 1610 he had his 
work cut out for him.
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* At the College of Physicians Harvey was elec­
ted a censor in 1613, 1615 and again in 1629. 
The censors, four in all, supervised all those 
who practised medicine in London, and took 
proceedings, if necessary, against “quacks” or 
“ empirics” . They visited the shops of apothe­
caries and tested the drugs to make sure they 
were genuine and conformed to a reasonable 
standard. In 1627, he was made one of the 
“ Elect” , a body of eight men who examined 
candidates for qualifications to practise medi­
cine and from whose number the president was 
chosen. In 1620 Harvey was made treasurer of 
the College.
The College made few concessions to chan­
ging conditions in a growing urban environ­
ment. Above all, it was resistant to increasing 
the size of its fellowship or even expanding the 
number of candidates permitted at any one 
time. Between 1590 and 1640 it preserved a 
membership of 30 including, after 1618, the 
royal physicians.
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To begin with, few physicians were 
willing to come forward and register 
voluntarily as licentiates, paying regular 
fees. Both surgeons and apothecaries were 
numerous and firmly entrenched in city 
companies; with wealth and influence 
they were able to assault the bastions of 
privilege preserved for the classically 
trained physicians, and they increasingly 
trespassed upon the practice of internal 
medicine. Outside the London companies 
there were hordes of unauthorized medi­
cal practitioners, recruited from every 
social class and every nationality; they, 
too, dared to infringe upon the monop­
oly of the College physician.4 According 
to one source, in the 50 years before 1600, 
the College took action against 236 
unlicensed practitioners, and in a large 
number of cases the result was inconclu­
sive or positively unfavourable to the 
College.
After Harvey came on the scene, the 
problem escalated, so that between 1601 
and 1640 actions were brought against 
435 individuals. Often Harvey was drawn 
directly into the proceedings. In 1613, the 
year he was appointed censor, Comitia 
meetings were often held weekly, largely 
to deal with the problem of empirics. 
Such remedies sought to defend the Col­
lege against them included lobbying court 
and Parliament or seeking redress in law. 
In that year the largest identifiable group 
of delinquents included six apothecaries 
and five surgeons. (Apothecaries were 
usually charged with dispensing medicines 
without prescriptions by physicians, and 
surgeons with trespassing into the prac­
tice of internal medicine.)
Harvey on the Proper Relations 
Between Physician and Surgeon
When Harvey received his appointment 
as physician at St. Bartholomew’s Hospi­
tal, one of the two institutions in London 
for the general care of the needy and sick 
poor, his charge, dated Oct. 14, 1609, did 
not precisely define the relation of phy­
sician to surgeon. But Harvey was to clar­
ify this relationship later.5
In practice, the surgeon’s status was 
inferior. He had to operate under the 
supervision of the physician. In the early 
17th century the operating theatre, as we 
know it, was still in the distant future; but 
some illustrations showing surgeons at 
their work suggest that they were to some 
extent segregated for that purpose. When 
Harvey received his appointment, his sur­
gical colleagues at St. Bartholomew’s 
were Joseph Fenton, Richard Mapes and 
John Collston. Roger Gwynne was 
apothecary, having gained appointment 
in 1599. None of these men achieved any 
special distinction in their calling. Har­
vey, on his part, was full of practical wis­
dom and appears to have been well able 
to direct his surgical colleagues and
preserve the accepted line of authority.
The medicines Harvey prescribed for 
patients were made up and dispensed by 
the apothecary, for whom a special build­
ing, “ the first dispensary” , was put up in 
1614. One of Harvey’s predecessors, Dr. 
Bright, had been too casual and failed to 
attend properly to his duties. Dr. Harvey, 
on the other hand, was more punctilious 
and was never called upon to answer for 
any negligence during his 35 years at St. 
Bartholomew’s.6
Support for a Separate Society 
of Apothecaries
But the difficulties with apothecaries 
would not go away. Harvey was one of 
the majority of College fellows who sup­
ported the establishment of a separate 
society of apothecaries, on the assump­
tion that their secession from the Grocers’ 
Company would secure higher status for 
them and work to the advantage of the 
College. Once their position was consoli­
dated, however, the apothecaries allied 
themselves with the surgeons and 
mounted a vigorous campaign at both the 
parliamentary and popular level for the 
extension of their rights. Star Chamber 
proceedings during 1634-1635 reveal a 
case wherein two apothecaries quoted 
Magna Carta in favour of their right to 
display and sell any wares!
In addition to apothecaries and sur­
geons, there were several categories of 
“ specialists” as they would now be called, 
who were also employed as needed, such 
as one who would cut for the stone, or 
one skilled in setting broken bones. These 
practitioners worked at both London 
hospitals, St. Bartholomew’s and St. 
Thomas’s, and were paid for individual 
operations.
There was, as documents of the time 
record, “ much jealousy between the Col­
lege and the members of the barber- 
Surgeons Company” . On the one hand, 
physicians were expected to call in a sur­
geon to a “ viewing” of any patient 
thought to be suffering from a surgical 
lesion, and, on the other hand, only phy­
sicians were allowed to prescribe internal 
medicines for administration by a sur­
geon. There was no reciprocity. The sta­
tutes of the College permitted a physician 
to perform such surgical operations as he 
might think necessary. (There is no evi­
dence that Harvey performed surgical 
operations or midwifery at St. Bar­
tholomew’s, but we know that he did else­
where.)
Every effort was made by physicians to 
keep surgeons in a subordinate position 
and this was naturally resented. A basis 
for the inequality in the first place arose 
from the inferior education of the sur­
geons, who could not, as a rule, under­
stand Latin, the accepted language of 
communication in medicine at that time.
When Harvey on behalf of the College 
presented to the Privy Council a detailed 
set of proposals for the better control of 
apothecaries and surgeons, the apothecar­
ies fought back, and in response to the 
College’s accusation that apothecaries 
were guilty of the unscrupulous exploita­
tion of dangerous drugs, the Society of 
Apothecaries filed a complaint that it was 
physicians who were guilty of dangerous 
practices. They specifically named Wil­
liam Harvey and accused him of being 
responsible for the death of a patient at 
St. Bartholomew’s.7 After an investiga­
tion launched by the College, Harvey was 
cleared by his colleagues of any respon­
sibility for the patient’s death.
The crisis that faced Harvey and his 
colleagues as members of the College of 
Physicians in the decades before 1640 can 
be regarded as an important factor in a 
fuller understanding of Harvey the phy­
sician. There need not be any artificial 
separation between his work in the fields 
of physiology and embryology and his 
day-to-day work as a practising physician 
and senior figure in the College to which 
he was so intensely loyal. By the time of 
the Civil War, all monopolies, including 
that exercised by physicians had been 
swept away. The turbulent decades 
ushered in after 1640 were to work pro­
found changes in English society, and no 
physician’s status was more in jeopardy 
than Harvey’s, as the cause of the 
Royalists, or Cavaliers, gradually disin­
tegrated.
New challenges would arise to replace 
the old ones. For Harvey there were more 
important ideals and higher goals.
Harvey regarded the positive stance o f his col­
leagues with respect to experimental science as 
fundamental for maintaining the social status 
of the academically educated physician. For the 
College o f Physicians during the Puritan revo­
lution to have become identified as the uncom­
promising adherent o f the Galenic system of 
medicine, would have severely added to its 
difficulties.... Especially after 1640, following 
the maxims of Harvey, and utilizing his gener­
ous benefactions for the prom otion of 
experimental science, the College successfully 
cultivated a modern, indeed avant-garde 
image.8
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BOOK REVIEWS 
continued from  page 154
light the text. They are as good as any I have 
seen.
My criticism is that the chapters on postoper­
ative and chronic pain are incomplete; a book 
published in 1985 should give a more complete 
description of the use of epidural narcotics for 
postoperative pain relief.
Very few texts provide complete information 
without being cumbersome and costly,-but this 
book goes a long way toward that goal. It pro­
vides a well-organized approach to regional 
anesthesia that is excellent reading for all phy­
sicians. At the price I would recommend it for 
your personal library, if not, at least for your 
hospital or department.
P hilip Hamilton, md, m sc, frcpc
Department of Anesthesia,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6
MANUAL OF UPPER GASTROINTESTI­
NAL SURGERY. William H. ReMine, 
W. Spencer Payne and Jon A. van Heer- 
den. 124 pp. Illust. Springer-Verlag New 
York, Inc., Secaucus, NJ, 1985. $125. 
ISBN 0-387-96148-8.
Do we really need yet another atlas of abdomi­
nal surgery? This question can be resoundingly 
answered in the affirmative if the authors either 
have something new to say or can show us bet­
ter than others how to do a particular opera­
tion. On both counts this slim manual fails the 
test. Yes, it is lavishly produced on coated 
paper and most of the illustrations are easy to 
understand and are in colour, but what a dis­
appointment it is. I settled down to enjoy an 
evening learning from three master surgeons 
at the Mayo Clinic. An hour later I had 
finished the book but learned nothing.
The manual is divided into three sections: 
that on achalasia, hiatus hernia and carcinoma 
of the cardia is written by Payne; the section 
on peptic ulcer is by van Heerden; and the short 
final chapter on gastric cancer is the work of 
ReMine. The first section by Payne is the best 
part of the manual in that there is a good 
description of the anatomy and physiology of 
the esophagogastric junction and a clear expla­
nation of when and how to do a two-hole 
Ivor-Lewis esophagogastrectomy and a 
thoracoabdominal total gastrectomy.
The chapters by van Heerden are poor. The 
descriptions of gastric physiology and the etiol­
ogy of peptic ulcer disease are outdated and 
confusing and would better have been omit­
ted. The surgical descriptions can also be criti­
cized; not so much because of their emphasis 
but for the lack of attention to detail. For 
example, in one figure the left gastric artery 
is labelled as the right gastric artery; the loca­
tions of the vagus nerves are described as at 
11 and 7 o’clock and then a few pages later as 
at 2 and 7 o’clock; and the Jaboulay proce­
dure is wrongly described as a pyloroplasty. 
More importantly, no help is offered the neo­
phyte to locate the posterior vagus nerve even 
though failure to find this nerve is the com­
monest cause of incomplete vagotomy. The 
results of parietal cell vagotomy are presented 
in a rather flattering and biased manner. Few 
surgeons would accept that the recurrent ulcer­
ation rate after this operation is only 5% .
A reasonable account of total gastrectomy 
for gastric cancer by ReMine is spoiled when 
the text describes a Roux-Y esophagojejunal 
anastomosis but the figures illustrate a loop 
esophagojejunostomy.
This manual “ was compiled as an aid to sur­
geons, residents and students who want to 
acquire a broader knowledge of the surgical 
techniques used in the upper gastrointestinal 
area” . Medical students will certainly find in 
this manual clear descriptions of the operations 
mentioned in their surgical textbooks, but this 
information is currently available in their 
hospital library.
M.M. Cohen, mb, ch b, frcsc,
FRCS(EDIN)
Professor of surgery,
University of Toronto,
Ste. 440,
600 University Ave.,
Toronto, Ont.
M5G 1X5
PEDIATRIC ORTHOPAEDICS. Vol. One 
and Two. 2nd ed. Edited by Wood L. 
Lovell and Robert B. Winter. 1191 pp. 
Illust. J.B. Lippincott Company, Philadel­
phia, 1986. Price not stated. ISBN 
0-397-50706-2 (set).
This book has been substantially improved 
since the inaugural edition of 1977. Certainly 
the text must be considered essential to the 
library of every orthopedic surgeon working 
in the field of pediatrics and an essential refer­
ence for all residents in training. The text does 
not deal with fractures but serves its purpose 
as an excellent reference for nontraumatic con­
ditions.
The number of coauthors has increased as 
have the chapters — in particular chapters on 
partial growth plate arrest, overuse injuries, 
neurofibromatosis and child abuse are excel­
lent, timely additions.
In general, the pictures and schematic dia­
grams are good, but in some chapters they are 
below standard. For example, the photographs 
in the chapter on bone dysplasia are poor and 
the 40-page chapter on bone tumours does not 
contain a single picture — a glaring omission 
in a basic textbook. Other chapters excel both 
in text and pictures — in particular those on 
metabolic and endocrine abnormalities, genetic 
aspects of orthopedics, cerebral palsy and leg- 
length discrepancy. Other chapters have omis­
sions or limited discussion on diagnosis and 
management; more is necessary on the com­
monest bone dysplasias and on the foot and 
ankle in spina bifida. There is nothing on suba­
cute or bone-scanning osteomyelitis, or on non­
specific discitis or disc herniation and discus­
sion is scanty on slipped epiphysis. The pictures 
on spinal fractures are poor.
Despite such variation in quality, the authors 
have put together an excellent text for anyone 
interested in this field. There is a good descrip­
tion of the approach to management, outlin­
ing all choices without cluttering the text with 
surgical detail. The bibliography is very com­
plete. Although fractures (except spinal) are not 
covered in this book of “ cold”  orthopedics, 
this is not a deficiency since it allows the 
authors more freedom in discussing the com­
mon everyday elective problems in the field. 
The addition of overuse injuries is appropri­
ate at a time when physical fitness is empha­
sized, as is the excellent chapter on child abuse.
As with all multiauthor textbooks, there are 
differences in completeness of text, organiza­
tion, illustrations and approach to management 
but, in general, this second edition is an 
improvement over the first and is highly recom­
mended.
M ichael A. Rosman, md, frcsc
Orthopedic surgeon-in-chief,
Shriners Hospital for Crippled Children, 
1529 Cedar Ave.,
Montreal, PQ 
H3G 1A6
PRINCIPLES AND PRACTICE OF SUR­
GERY. A Surgical Supplement to David­
son’s Principles and Practice o f Medicine. 
A.P.M . Forrest, D.C. Carter and I.B. 
Macleod. 672 pp. Illust. Churchill Living­
stone, Edinburgh; Academic Press Canada, 
Don Mills, Ont., 1985. $46.50, paper- 
bound. ISBN 0-443-01565-1.
This textbook was planned as a companion to 
Davidson’s Principles o f  Medicine. As one who 
used Davidson’s textbook as an undergradu­
ate and developed some affection for it, I wel­
comed the opportunity to review this new 
volume. The authors state in the preface that 
they are not attempting to follow the trend of 
shorter textbooks of surgery for undergradu­
ates. Our students currently spend 12 weeks in 
surgery in their final undergraduate year. I read 
the text in approximately this time, and believe 
that it could adequately be covered by students 
during their surgical clerkship. All branches of 
surgery except orthopedics are covered.
The first 15 chapters are devoted to a dis­
cussion of the principles of surgery. The infor­
mation they contain is up to date and easy to 
read. Students tend to ignore these chapters, 
but I think that their format will be appeal­
ing. Broad principles are stated clearly without 
masses of extraneous details to cloud the issue.
Most of the remainder of the book is about 
general surgery but there are chapters on 
cardiac and thoracic surgery, peripheral vas­
cular disease, neurosurgery and urologic sur­
gery. As a general surgeon I cannot critically 
assess these chapters, but I did not find any 
major defects. Most of the general surgery 
chapters start with a short discussion of surgi­
cal anatomy and physiology. The anatomy is 
more functional than morphologic and the 
physiology is confined to those aspects of dis­
ease that are of surgical importance.
Surgical investigation is well covered and 
good reasons are given for particular prefer­
ences. Coverage of the symptoms and signs of 
common surgical conditions is thorough. The 
principles of surgical treatment are clearly 
stated without a mass of options that can leave 
the undergraduate confused. I particularly 
liked the chapter on endocrine surgery. In 
many textbooks, thyroid surgery is included in 
head and neck and the rest of the endocrine 
system is ignored.
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The book is profusely illustrated with line 
drawings. The artists are to be commended on 
their clarity and accuracy. The only inaccuracy 
I noted was the drawing of the volvulus rotat­
ing in a clockwise direction, although the text 
stated that the rotation is usually anticlockwise.
I have some minor criticisms. The term 
“ perianal haematoma”  is preferred over 
“ thrombosed external pile” . Most proctolo­
gists prefer the latter term and believe that the 
operation is excision of the thrombosed vein 
rather than evacuation of a hematoma. In the 
discussion of ulcerative colitis, mucosal proc­
tectomy with ileal pouch formation is not men­
tioned. Perhaps this will be remedied in the 
next edition. In the chapter on the liver and 
biliary system there is no mention of non­
drainage of the gallbladder bed. This may not 
be important to the undergraduate but is to the 
surgical trainee. I also suspect that biliary leak­
age is more commonly due to damage to the 
ducts in the bed of the gallbladder than to divi­
sion of an accessory cystic duct. Although 
Mondor’s disease is included in the lymphatic 
system, I have always believed that it is due 
to a superficial phlebitis affecting the veins of 
the breast.
The last chapter, named “ appendices” , is 
devoted to surgical handicrafts, antibiotics in 
surgical practice and medicolegal problems. 
This chapter will be of help to the intern and 
junior resident.
The authors are to be congratulated on 
producing a surgical textbook of moderate size 
and great clarity. Good editing has produced 
uniformity of style. I recommend the book for 
undergraduates in surgery and those in the 
early years of their surgical training.
S . M EBAN , MB, FRCSC, FRCS(EDIN)
Ste. 269,
737 Parkdale Ave.,
Ottawa, Ont.
K1Y 1J8
REOPERATIVE ARTERIAL SURGERY. 
Edited by John J. Bergan and James S.T. 
Yao. 620 pp. Dlust. Grune & Stratton, Inc., 
Orlando, Fla.; Academic Press Canada, 
Don Mills, Ont., 1986. $144.50. ISBN 
0-8089-1789-7.
This volume deals with the surgical consider­
ations arising from failed vascular reconstruc­
tive procedures and associated complications. 
It addresses most of the known causes of graft 
failure as well as the complications related to 
the use of vascular prostheses. Current tech­
niques to minimize complications of vascular 
reconstructive procedures and extend the life 
of the grafts are also discussed, but the main 
emphasis of the book is to outline techniques 
and specialized maneuvers for dealing with 
failed grafts and the seemingly innumerable 
complications that may arise from their use. 
The text is broadly structured into nine differ­
ent sections, the first two covering current con­
cepts of basic vascular pathophysiology and the 
value of certain diagnostic imaging techniques 
in reoperative vascular surgery. The remain­
ing sections cover reoperative vascular recon­
struction under general anatomical categories 
including aortic, renovascular/mesenteric, 
femoropopliteal, femorodistal and cerebrovas­
cular. The investigation and management of 
patients with recurrent symptoms due to the 
thoracic outlet compression syndrome are also 
described and the problems encountered with 
access surgery for hemodialysis are discussed.
Each section is divided into chapters aimed 
at specific problems in vascular surgery, and 
the authors give a short account of their 
approach to diagnosis and treatm ent, 
emphasizing alternative reconstructive tech­
niques that may be applied to specific compli­
cations and types of graft failures. The authors 
tend to be well-known figures in the field of 
vascular surgery who were apparently chosen 
for their research and technical expertise in par­
ticular areas. The list includes prominent vas­
cular surgeons from the United States, Canada, 
Great Britain and France as well as some of 
their younger colleagues. Although there are 
more than 70 contributors, there is remarka­
bly little overlap and the presentations are 
generally the polished efforts of experienced 
men, well-versed in their subject.
A superb chapter by Rutherford on review­
ing the literature begins the book and empha­
sizes the vagaries of reporting on vascular sur­
gical patients without standardized methods. 
It points out some of the misconceptions that 
can be generated by looking at tests of statisti­
cal significance without understanding the 
data. The book is concise, yet covers the major 
topics completely, with references to classic 
papers as well as to recent publications. There 
are few weaknesses.
The text is intended for readers familiar with 
the basic problems of vascular surgery and for 
this reason is not suitable for medical students, 
interns or junior residents. Vascular fellows, 
established vascular surgeons and others faced 
with complex reoperative vascular surgery will 
find the text succinct, thorough in the subjects 
covered and easy to read. It will serve as a valu­
able reference work to practising vascular sur­
geons and would be of particular value to can­
didates for certification in this field; most 
examiners will be familiar with it.
C. W m . C o l e , m d , frcsc
Assistant professor of surgery,
University of Ottawa,
Ottawa Civic Hospital,
C.P.C. Ste. 258,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
TREATMENT OF SHOCK. Principles and 
Practice. 2nd ed. John Barrett and Lloyd 
M. Nyhus. 242 pp. Illust. Lea & Febiger, 
P hiladelphia, 1986. $36.50. ISBN 
0-8121-1008-0.
“ A practical orientation for the physician who 
is called on to manage patients in shock” is 
the stated objective of this text. In my opin­
ion, this goal is achieved.
This edition replaces the first, published in 
1974. The many advances in knowledge of the 
pathogenesis and physiology of shock are 
clearly presented. The monitoring parameters 
and established modes of therapy are discussed. 
Where controversy persists, the differing views 
are presented. The bedside and laboratory 
assessment and management of the various 
types of shock are clearly described.
The primary authors, surgical experts in clin­
ical and research fields, have enlisted contri­
butions from international authorities in the 
basic and specialty fields to produce a valua­
ble, concise treatise on the subject.
The text is in three parts: treating the 
microvascular-cellular and blood flow 
organs and treating the underlying cause.
Discussion of microcirculatory changes 
begins with a detailed examination of subcel- 
lular, cellular and microvascular-cellular, 
microvascular-cellular and blood rheology 
changes associated with shock. Therapeutic 
measures to maintain cellular integrity are 
reviewed and new directions in research are 
examined.
Fluid shifts and replacement, blood trans­
fusion and alternative oxygen-carrying solu­
tions are reviewed. Monitoring oxygen trans­
port and the hemodynamics are outlined clearly 
and concisely with appropriate tables and 
explanatory diagrams. This section provides an 
excellent basic understanding of the many 
changes that occur in response to shock at the 
cellular and general microcirculatory level. 
Most of this knowledge has been gained in the 
past 10 years.
In part two, which makes up half the text, 
the pathology, physiology and therapy of shock 
are discussed at the vital organ level. Separate 
chapters are devoted to the lung, brain, heart, 
kidney and liver. This provides the reader with 
a clear view of the relationship between the 
lesion, its effect on function and methods of 
supporting the organ system. The pros and 
cons of therapeutic interventions are reviewed.
The reader is then well prepared for the final 
section devoted to the treatment of the under­
lying causes of shock in adults and children. 
The treatment of traumatic and septic shock 
is emphasized. Separate chapters are devoted 
to the immune system and pharmacologic treat­
ment, both of which are supported with 
descriptive tables and diagrams.
In only 224 pages, the reader is treated to 
an excellent update on the body’s response to 
shock and its management. For those seeking 
more detail, there is extensive reference listing 
with each chapter.
This is an excellent reference text for students 
and clinicians. Libraries in departments of sur­
gery, intensive care, anesthesia, emergency 
medicine and trauma services should include 
this well-organized and written text.
C.M. Bu r n s , m d , fr c sc , facs
Associate professor of surgery,
Director, Trauma Services,
Health Sciences Centre,
700 William Ave.,
Winnipeg, Man.
R3E 0Z3
TUMOR MARKERS AND THEIR SIG­
NIFICANCE IN THE MANAGEMENT 
OF BREAST CANCER. Proceedings of a 
Workshop held in Bethesda, Maryland, 
March 6, 1985. Edited by Thomas Dao, 
Angela Brodie and Clement Ip. 147 pp. 
Illust. Alan R. Liss, Inc., New York, 1986. 
$36. (US). ISBN 0-8451-5056-5.
This book describes some of the proceedings 
of a workshop held in Bethesda, Md. in March 
1985. It is part of a series dedicated to progress
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in clinical and biologic research. The book is 
divided into three sections, dealing with cir­
culating tumour markers, breast cancer anti­
gens and the place of estrogen in breast cancer. 
The studies on the process of estrogen- 
regulated cell proliferation help in the under­
standing of the development of breast cancer. 
Estrogens promote the genesis and growth of 
human breast cancers by a mechanism as yet 
unknown. The “biochemical epidemiology” of 
breast cancer is also discussed as well as 
attempts to explain the aggressiveness of some 
tumours. A reliable screening serum test for 
breast cancer would be an attractive method 
for monitoring the results of treatment. This 
might be achieved through tumour-associated 
antigens and monoclonal antibodies.
This text is highly specialized and of more 
use to basic research workers than clinicans, 
although the latter can glean useful informa­
tion from browsing through it. Unfortunately, 
by the time this review is published the material 
will be 2 years old and is only a partial collec­
tion of the manuscripts given at the 1985 work­
shop. This nicely bound book belongs in 
libraries and research laboratories rather than 
in one’s personal collection.
P.J. F i t z p a t r i c k , m b , b s , f r c r , f r c p c
The Princess Margaret Hospital, 
500 Sherbourne St.,
Toronto, Ont.
M4X 1K9
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McMASTER UNIVERSITY
CHAIRMAN
DEPARTMENT OF SURGERY
M cM aste r Un ivers ity  inv ites app lications 
or nom inations for the position of Cha ir­
man, Departm ent o f Surgery. The term  of 
th is  appointm ent is five  years, renewable 
once.
Th is position, availab le Ju ly  1, 1988, 
requires an ind iv idual w ith  adm inistrative 
experience in an academ ic or institutional 
setting and a strong com m itm ent to 
research. The Chairm an is responsib le for 
ensuring that the academ ic d iscip lines 
represented in the  departm ent are of the 
h ighest quality.
In accordance w ith  Canadian  immigration 
requirem ents, th is advertisem ent is d irec­
ted to  Canadian c itizens and permanent 
residents of Canada.
App lica tions and/or nom inations, accom ­
panied by a detailed curriculum  vitae and 
nam es o f three referees, should be direc­
ted to:
Dr. S.M. MacLeod 
Dean, Faculty of Health Sciences 
McMaster University 
1200 Main Street West 
Hamilton, Ontario L8N 3Z5
- S 8 7 - 4 9
McMaster -J 
University—
University of Alberta 
Edmonton
D irecto r
C ard io v ascu la r an d  
T horacic S u rg e ry
Department of Surgery 
Faculty of Medicine
Applications are invited for the position of Director of 
the Division of Cardiovascular and Thoracic Surgery, at 
the rank of Associate or Full Professor. The successful 
candidate will be expected to provide leadership in the 
development and maintenance of teaching and research 
programs and will have the Fellowship of the Royal 
College of Physicians and Surgeons of Canada or its 
equivalent. The level of appointment will depend on 
qualifications and accomplishments of the candidate.
Applications, complete with curriculum vitae and names 
of three references should be submitted before May 30, 
1987 to:
Dr. Bryce Weir
Chairm an, Departm ent o f  Surgery  
University o f Alberta  
Edmonton, Alberta 
T6G 2B7
— S87-50
The University of Alberta  is an equal  o p p o r tu n i ty  employer.
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept suitable classified advertisements. The deadline is 1 month before issue 
date. Regular classified rates (for each insertion): $40.00 for the first 40 words or less, additional words 50C each (additional $16.00 for frame). Special Displav 
under 75 words, 2 A x 2 $100.00. $6.00 charge (first insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
MICROSURGICAL COURSE: -  The Department 
of Surgery, McMaster University is now offering 
one week, on-going courses in microsurgery, us­
ing animal facilities and videotapes. These courses 
are for ajiyone interested in small vessel anasto­
mosis, nerve repairs, vas and fallopian tube recon­
structions. The laboratory is organized to guide 
you through the basic microsurgical techniques to 
more advanced tasks with the help of an assis­
tant on a one-to-one basis. Please call: Dr. A. Tho­
rns at (416) 523-0019 for further information.
— S86-23
ADVERTISERS’ INDEX
CarsMed Careers
Associates • Locums • Purchase/Sale ot Practices
GENERAL SURGEON 
Ref. #87009 — Toronto area 
Ref. #87010 — Eastern Canada 
Ref. #87011 — Southern Ontario 
Ref. #87021 — Downtown Toronto 
For further information on this and other 
assignments please contact:
CanMed Careers 
659 Mississauga Crescent 
Mississauga, ON L5H 1Z9
(416) 274-0707
-S 87-48
INTERNATIONAL CONSULTANTS TO EXECUTIVES ANO PROFESSIONALS IN 
THE HEALTH CARE SECTOR
CLINICAL FELLOWSHIPS 
Ewart Angus Intensive Care Unit 
Wellesley Hospital 
Toronto
Available July 1, 1987 for a one year period 
in a Medical — Surgical Unit. Duties comprise 
clinical research in a strong academic and 
teaching unit. Present research includes the 
clinical epidemiology of ICU care, nutrition, 
and respiratory muscle physiology.
Reply to: Dr. I.M. Fraser, Director, EAICU 
Ste. 246, E.K. Jones Bldg 
160 Wellesley St.E 
Toronto, ON M4Y 1J3.
Tel. (416) 926-7747 -S 8 6 -3 5
Bard Canada Inc.
146
Becton Dickinson Canada Inc.
160, 161
Davis & Geek
Outside Back Cover
Du Pont Pharmaceuticals
Coumadin 200, Inside Front Cover 
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Mefoxin 172, 173, 198, 199
Glaxo Laboratories
Zantac 148,211
Johnson & Johnson Inc.
Adaptic Inside Back Cover
Bioclusive 162
Pharmacia (Canada) Inc.
Port-A-Cath 180
Rhone-Poulenc Pharma Inc.
Stemetil 169
Royal College of Physicians 
and Surgeons of Canada, The
194
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Metamucil 178, 179
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FELLOWSHIP IN STONE DISEASE -  University of 
Toronto. Applications are invited for the position 
of clinical fellow in Stone Disease commencing 
July 1, 1987. This fellowship will be in the divi­
sion of urology, based at The Wellesley Hospital, 
where the Ontario lithotripter will be installed with 
adjacent interventional room equipped with C-arm 
for percutaneous and endoscopic stone manage­
ment. In excess of 1000 cases will be managed 
per year. Interdisciplinary activities with interven­
tional radiology and nephrology will be stressed. 
Preference will be given to applicants with 
residency training in urology. In accordance with 
Canadian immigration requirements, this adver­
tisement is directed to Canadian citizens and per­
manent residents. Please send cv and references 
to: Michael A.S. Jewett, Chief, Division of Urolo­
gy, The Wellesley Hospital, Jones Building, Suite 
212, 160 Wellesley St. E., Toronto, ON M4Y 1J3. 
Tel. (416) 926-7753. -S87-47
GENERAL SURGEON: ON — required immedi­
ately to serve the community of Arnprior and 
surrounding area. Sole practice draws from a 
community population of 6000 and a catch­
ment area of approximately 14 000. Current 
medical staff includes 9 GPs, 3 of which are 
GP anesthetists. Also available are weekly on­
site radiologic services for ultrasound and bar­
ium studies. Arnprior hospital is fully 
accredited with 50 acute and 20 chronic care 
beds. We have 2 fully equipped operating 
rooms and an additional cysto/ortho room. 
Prospective candidates should have some 
training in orthopedic work as well as do emer­
gency and repeat ceasarean sections. Arnpri­
or is situated on the Ottawa River 
approximately 70 km from downtown Otta­
wa. Our community offers excellent schools 
and recreational areas including golf courses, 
a curling club, a community sports centre with 
ski hills nearby. Attractive grant available to 
assist with relocation and/or establishment of 
practice. For further information please con­
tact: R.J. Kedrosky, Administrator, Arnprior & 
District Memorial Hospital, 350 John St., N., 
Arnprior, ON K7S 3H4. Tel. (613) 623-3166.
— S87-45
CLINICAL FELLOWSHIP: ON — position in 
orthopedic surgery for 1 year period beginning 
July 1, 1988. We have fellowships available 
in joint reconstruction, spine surgery, sports 
medicine and knee surgery, hand surgery and 
rehabilitation, each involving some aspect of 
trauma, due to Sunnybrook being the home of 
The Regional Trauma Unit. If interested please 
forward a letter of application stating your par­
ticular orthopedic interest, and include a copy 
of your curriculum vitae to: Dr. J. Schatzker, 
Chief, Division of Orthopedic Surgery, Room 
D5505, Sunnybrook Medical Centre, 2075 
Bayview Ave., Toronto, ON M4N 3M5. Please 
also state whether you will be self-funded or 
require support from Sunnybrook Medical 
Centre. -S87-46
ASSISTANT PROFESSOR: AB -
(current salary range: $31 612 -  $45 340) re­
quired for the Department of Surgery (Division of 
Plastic Surgery) at the University of Alberta. Ef­
fective date of appointment: January 1, 1988. 
Preference will be given to investigators who have 
recently completed post-doctoral training. At least 
75% of time will be spent on research-related ac­
tivities. Applicants should be surgical scientists 
with PhD training at a recognized institution, and 
with experience in the use of stable and radioac­
tive isotope tracers in both animal models and hu­
mans. A background in protein and substrate 
metabolism, familiarity with mass spectroscopy 
and the principles of indirect calorimetry are all re­
quired. The University of Alberta is an equal op­
portunity employer, but in accordance with 
Canadian immigration requirements this advertise­
ment is directed at Canadian citizens and perma­
nent residents. Application deadline: July 31, 
1987. Forward applications, curriculum vitae and 
the names and addresses of three references to: 
Dr. J.D.M. Alton, Firefighters' Burn Professor of 
Surgery, Division of Plastic and Reconstructive 
Surgery, Department of Surgery, 2D3.83 Macken­
zie Health Sciences Centre, University of Alber­
ta, Edmonton, AB T6G 2B7.
-S87-51
See also page 221
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